NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Bank of America Corporation (NYSE:BAC) and certain of the company’s senior executives for securities fraud after a significant stock drop resulting from potential violations of the federal securities laws.
If you invested in Bank of America, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/bank-of-america-class-action-lawsuit.
Key Details of the Bank of America ($BAC) Class Action:
Lead Plaintiff Deadline: December 15, 2026Alleged Misconduct: Securities fraud alleging Bank of America misrepresented the scope and financial consequences of its Bank Secrecy Act and anti-money laundering compliance failuresStock Drop: October 14, 2026 – 4.8% Stock DropCourt: U.S. District Court for the Southern District of New YorkAction: Contact BFA Law to discuss your rights Investors have until December 15, 2026 to ask the Court to be appointed to lead the case. The complaint asserts securities fraud claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in Bank of America stock. The class action is pending in the U.S. District Court for the Southern District of New York. It is captioned New England Teamsters Pension Fund v. Bank of America Corporation, et al., No. 26-cv-9137.
Why is Bank of America Being Sued for Securities Fraud?
Bank of America is a multinational bank holding company that conducts most of its banking business through its subsidiary, Bank of America, N.A. (“BANA”). In 2024, the Office of the Comptroller of the Currency issued a cease-and-desist order against BANA that required it to take comprehensive corrective actions to address deficiencies in its Bank Secrecy Act and anti-money laundering compliance programs.
According to the complaint, Bank of America misled investors by touting the company’s progress in carrying out those required corrective actions while downplaying the scope and financial consequences of its compliance failures. Bank of America allegedly failed to adequately remediate its Bank Secrecy Act and anti-money laundering compliance programs despite years of internal warnings and regulatory intervention.
Why did Bank of America’s Stock Drop?
On October 13, 2026, the U.S. Treasury Department announced more than $1.21 billion in penalties against Bank of America for violations of sanctions and anti-money laundering laws. The fines represent the third largest penalty in Treasury Department history and the largest in the history of the Office of the Comptroller of the Currency.
On this news, Bank of America’s stock dropped $2.57 per share, or 4.8%, from a closing price of $53.96 per share on October 13, 2026, to $51.39 per share on October 14, 2026.
Click here for more information: https://www.bfalaw.com/cases/bank-of-america-class-action-lawsuit.
What Can You Do?
If you invested in Bank of America, you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis; there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It has been named a top plaintiff law firm by Chambers USA, The Legal 500, and ISS SCAS, and its attorneys have been named “Elite Trial Lawyers” by the National Law Journal, “Litigation Stars” by Benchmark Litigation, among the top “500 Leading Plaintiff Financial Lawyers” by Lawdragon, “Titans of the Plaintiffs’ Bar” by Law360, and “Super Lawyers” by Thomson Reuters.
Most recently, The Legal 500 awarded BFA the most client satisfaction accolades of any plaintiff’s securities litigation law firm, with clients noting: “[t]here is no better service provider in the practice area,” “[t]he interest of the client is always front and center,” and “[t]here isn’t a better firm in this space.” One testimonial described the firm as “nimble and entrepreneurial,” with a “relentless focus on adding value for clients.”
BFA’s notable successes include a recovery of over $900 million in value from Tesla, Inc.’s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
For more information about BFA and its attorneys, please visit https://www.bfalaw.com.
Disney has embraced TikTok's Live feature to do red-carpet interviews for premieres, featuring personalities like Carter Kench. Julian Hamilton/Getty Images Creators are jumping among an ever-wider mix of platforms and formats — and brands are scrambling to follow them.
We asked the most innovative marketers working with influencers which platforms and tactics have their attention right now — and why.
Marketers from Disney, e.l.f. Beauty, and others told us they're using platforms like TikTok to own the red carpet, Substack to align with tastemakers, and Threads to experiment.
"YouTube is a home for creators. TikTok is a great way to get discovery," said Ian Trombetta, the National Football League's senior vice president of global social, creator, and content marketing. "And then Instagram is another big one for us as it relates to discovery. Even platforms like X and Reddit have a really important role to play."
Beyond platforms, brands like Keurig Dr Pepper are also exploring ways to work directly with creators, involving them earlier in the campaign process.
"A major shift has been pivoting away from rented reach to true collaboration," said Samim Sadrzadeh, Disney's director of creator content and partnerships. "For a long time, the industry treated creators as ad placements. We think that significantly undersells the value they actually bring."
Substack, Threads, and moreYouTube and creators are taking over the living room, and marketers like e.l.f. Beauty and St. Jude's fundraising organization ALSAC are leaning in, not wanting to be left behind.
"We have a lot of plans around long-form content, and that's a great place to show up," said Patrick O'Keefe, e.l.f. Beauty's chief integrated marketing officer. "We've been on YouTube for years. We're now looking at it from the lens of entertainment."
Others, like Poppi and Rothy's, are embracing the newsletter platform Substack to partner with creators. For some creators, Substack has become a way for them to get more personal with their biggest fans. That helps Poppi plan collaborations, said Sophia Sesto, Poppi's vice president of culture.
Under creator marketer Kemma Kefalas, Yahoo has leaned into Threads to try out new things. Yahoo Yahoo has found value in Meta's Threads as a way to try out ideas in a lower-key environment before putting them out on bigger platforms, especially if it's jumping on a cultural moment and isn't sure how the effort will go over. When Taylor Swift released "Patient Zero," Yahoo riffed on it with a Thread that tied the "Os" in its name to the song.
"I think it's a little less precious over there, and it feels like a fun place to kind of gut check certain things, see how they'll perform," said Kemma Kefalas, Yahoo's senior director and head of Creative Lab. "It's just been a nice kind of litmus test for us."
Disney has especially found success with TikTok's Live feature, finding it a customizable way to build excitement for premieres. For "Zootopia 2," it had the viral squirrel character Nibs interview cast on the red carpet, while internet personality Carter Kench played host for the "Hannah Montana 20th Anniversary Special."
"Those moments work because we treated the platform as a canvas for a new kind of storytelling that connects directly to audiences in real time," Sadrzadeh said.
Brands are going directPlatforms may always be a necessary part of doing business with creators. But going direct has become a bigger buzzword as many brands seek to bypass platforms entirely.
Keurig Dr Pepper, for one, wouldn't typically hire a creator through a platform's marketplace, said Lindsay Burstein, senior director of integrated social and communications, using TikTok as an example.
"We would hire the creator, have them post on TikTok. Then we have the ability to use that content and distribute it across multiple channels, but slice it up in different ways that make sense for that channel."
Influencers spent a long time trying to convince marketers to take them seriously. This year, marketers are expected to spend $44 billion with creators, more than tripling in five years, per the Interactive Advertising Bureau.
As brands increasingly treat creators as long-term partners, they're engaging with them earlier in the marketing process.
Yahoo's approach is to find creators who are entertaining and figure out how to insert itself into their work, rather than vice versa, as it did with TV persona Kyle Cooke to promote its new Yahoo Weather app.
"We're working with them for the entertainment that they bring to people, and we'll Yahooify it," Kefalas said. "Our briefs are often loose in those regards. We're not doing a lot of 'talk to camera, promote products' kind of thing. We've gotten a lot of positive feedback from creators that they've loved that opportunity to just do what they do best."
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Lucia Moses You're currently following this author! Click to unsubscribe from email alerts.
Lucia Moses covers the media and entertainment business, with a focus on how creators build businesses, how media companies intersect with creators, and how marketers adopt entertainment tools. She's broken stories about MrBeast's ambitions, Google's movie initiative, and Netflix's push into podcasts.She previously reported on media and managed teams at Digiday and Adweek.
FILE PHOTO: Exxon Mobil logo and stock graph are seen through a magnifier displayed in this illustration taken September 4, 2022. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo Purchase Licensing Rights, opens new tab
CompaniesHOUSTON, Oct 30 (Reuters) - ExxonMobil (XOM.N), opens new tab beat Wall Street expectations for third-quarter profit on Friday, as soaring refining margins driven by the US-Israeli war on Iran and Ukrainian strikes on Russian refineries boosted the largest US oil producer’s earnings.
Adjusted earnings per share for the quarter were $4.23, surpassing the average analyst expectation of $4.08 that was compiled by LSEG.
Sign up here.
Here are more details from the third quarter:
Adjusted total earnings were $17.5 billion, beating the average analyst estimate of $16.6 billion as compiled by LSEG
Adjusted upstream earnings were $7.3 billion, a 20% decline from the second quarter, as benchmark Brent crude prices were lower than in the previous three months
Fighting across the Middle East and the Russia-Ukraine war have knocked out fuel-making capacity and caused global supply shortages of diesel
Resulting higher fuel prices have led to booming profits for all the Western oil majors, including Shell and TotalEnergies, which reported higher-than-expected earnings on Thursday
Adjusted downstream earnings totaled $9 billion, a 120% surge from the previous quarter, due to higher refining margins
Exxon produced 4.5 million barrels of oil equivalent per day, roughly flat from the second quarter
Exxon earned $1.3 billion in adjusted earnings from specialty products, up 32% from the previous quarter
The company paid $4.3 billion in dividends and repurchased shares worth $5.1 billion
The company announced a 2027 share repurchase program of $20 billion, the same amount as in 2026
Company says its US Gulf Coast refineries reached the second-highest diesel production level on record and also operated at 100% crude-unit utilization
"We continued to rise to the challenge of meeting global energy needs, drawing on unmatched scale, integration and technical capabilities,” Exxon CEO Darren Woods said
Exxon has a higher percentage of production located in the Middle East compared with rivals and has been on the hunt for more oil resources in other parts of the world
Firm signed an agreement last month to explore, develop and produce shale in Azerbaijan and has held talks for a possible return to Venezuela
Reporting by Sheila Dang in Houston; Editing by Nathan Crooks and Thomas Derpinghaus
Our Standards: The Thomson Reuters Trust Principles., opens new tab
NEW YORK--(BUSINESS WIRE)--Colgate-Palmolive Company (NYSE:CL):
Net sales increased 4.6%; Organic sales* increased 3.6%, including a 0.2% negative impact from lower private label pet food sales GAAP EPS increased 3% to $0.94; Base Business EPS* increased 7% to $0.97 GAAP Gross profit margin increased 80 basis points to 60.2%; Base Business Gross profit margin* increased 90 basis points to 60.3% Net cash provided by operations was $2,913 million for the first nine months of 2026 The Company’s leadership in toothpaste continued with its global market share at 41.4% year to date The Company’s leadership in manual toothbrushes continued with its global market share at 33.1% year to date The Company narrowed its sales guidance and raised its gross profit margin and Base Business earnings per share guidance for full year 2026 Third Quarter Total Company Results (GAAP)
($ in millions except per share amounts)
2026
2025
Change
Net Sales
$5,369
$5,131
+4.6%
EPS (diluted)
$0.94
$0.91
+3%
Third Quarter Total Company Results (Base Business - Non-GAAP)*
2026
2025
Change
Organic Sales Growth
+3.6%
Base Business EPS (diluted)
$0.97
$0.91
+7%
Colgate-Palmolive Company (NYSE:CL) today reported results for third quarter 2026. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business third quarter results, “Our growth momentum continued, delivering another strong quarter of broad-based top- and bottom-line growth with net sales and organic sales increasing in all four categories and in four of five divisions. We were particularly pleased to have delivered our fourth quarter of sequential improvement in worldwide volume growth, while delivering strong pricing growth in the third quarter. As was the case last quarter, gross profit, gross profit margin, operating profit, operating profit margin, net income, earnings per share and free cash flow all increased year over year.
“We remain focused on executing our 2030 strategy, with an emphasis on driving premium, science-based innovation, and we continue to invest behind our brands globally supported by another double-digit increase in advertising this quarter.
“Despite consumer uncertainty and ongoing macroeconomic volatility, our proactive focus on driving growth while building flexibility into our P&L gives us confidence we can navigate these challenges while continuing to deliver consistent, compounded earnings per share growth and drive long-term shareholder value.”
Full Year 2026 Guidance
Based on current spot rates:
The Company now expects net sales to be up 4% to 5% (versus 2% to 6% previously), including a low-single-digit positive impact from foreign exchange. The Company now expects organic sales growth to be broadly in line with its nine-month performance (versus 1% to 4% previously). This includes the impact from our exit from the private label pet food business. On a GAAP basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales and double-digit earnings per share growth. On a non-GAAP (Base Business) basis, the Company now expects gross profit margin to be up (versus roughly flat previously) and still expects advertising to be up on both a dollar basis and as a percentage of net sales; it also now expects 5% to 7% earnings per share growth (versus mid-single-digit growth previously). Divisional Performance
See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.
Third Quarter Sales Growth By Division
(% change 3Q 2026 vs. 3Q 2025 except % of Total Company Sales)
% of Total
Company
Sales
Net
Sales
Organic
Sales*
Volume
Pricing
FX
North America(1)
17%
-1.7%
-1.6%
-3.7%
+2.2%
-0.2%
Latin America
25%
+12.5%
+6.0%
+3.9%
+2.1%
+6.5%
Europe, Middle East & Africa(1)
21%
+1.4%
+2.7%
+3.5%
-0.9%
-1.2%
Asia Pacific(1)
15%
+3.5%
+4.6%
+1.9%
+2.8%
-1.1%
Hill’s Pet Nutrition
22%
+5.6%
+5.7%
+1.8%
+3.9%
-0.1%
Total Company
100%
+4.6%
+3.6%
+1.7%
+2.0%
+1.0%
Third Quarter Operating Profit By Division
($ in millions)
3Q 2026
% Change vs
3Q 2025
% to Net
Sales
Change in basis
points vs 3Q 2025
% to Net Sales
North America(1)
$177
-11%
19.5%
-210
Latin America
$392
17%
29.6%
+100
Europe, Middle East & Africa(1)
$262
8%
23.2%
+140
Asia Pacific(1)
$211
-1%
26.4%
-110
Hill’s Pet Nutrition
$267
5%
22.2%
-20
Total Company, As Reported
$1,088
3%
20.3%
-30
Total Company, Base Business*
$1,117
5%
20.8%
+20
Prepared Materials and Webcast Information
At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding third quarter results to the Investor Center section of its website at https://investor.colgatepalmolive.com/events-and-presentations.
At 8:30 a.m. ET today, the Company will host a conference call regarding third quarter results. To access this call as a webcast, please go to Colgate-Palmolive’s website at www.colgatepalmolive.com.
About Colgate-Palmolive
Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, Ajax, Axion, Darlie, elmex, EltaMD, Fabuloso, Filorga, hello, Hill’s Prescription Diet, Hill’s Science Diet, Irish Spring, Lady Speed Stick, meridol, PCA SKIN, Prime100, Protex, Sanex, Softsoap, Sorriso, Soupline, Speed Stick, Suavitel and Tom’s of Maine. We are recognized for our leadership and innovation in promoting community wellbeing and improving children’s oral health through our Colgate Bright Smiles, Bright Futures program, which has reached approximately two billion children and their families since 1991. For more information about Colgate-Palmolive and how we make more smiles, visit www.colgatepalmolive.com. CL-E
Market Share Information
Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. Except as otherwise noted, all market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).
Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.
Cautionary Statement on Forward-Looking Statements
This press release and the related prepared materials and webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, category growth rates, the impact of foreign exchange, the impact of developments in global trade relations and tariffs, the impact of geopolitical events and tensions, wars and military conflicts, such as in Ukraine and the Middle East, cost reduction plans (including the Strategic Growth and Productivity Program), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of October 30, 2026. The Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors” and “Cautionary Statement on Forward-Looking Statements” in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at www.colgatepalmolive.com.
Non-GAAP Financial Measures
The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:
Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges related to the Strategic Growth and Productivity Program and the ERISA litigation matter and acquisition-related costs. Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments. Free cash flow before dividends: Net cash provided by operations less Capital expenditures. This press release and the related prepared materials and webcast discuss Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes” for the three and nine months ended September 30, 2026 versus 2025 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.
Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations” for the three and nine months ended September 30, 2026 and 2025 included with this release for a reconciliation of these financial measures to the related GAAP measures.
The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.
As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows” for the nine months ended September 30, 2026 and 2025 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.
(See attached tables for third quarter results.)
Table 1
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Three Months Ended September 30, 2026 and 2025
(Dollars in Millions Except Per Share Amounts) (Unaudited)
2026
2025
Net sales
$
5,369
$
5,131
Cost of sales
2,136
2,082
Gross profit
3,233
3,049
Gross profit margin
60.2
%
59.4
%
Selling, general and administrative expenses
2,111
1,971
Other (income) expense, net
34
19
Operating profit
1,088
1,059
Operating profit margin
20.3
%
20.6
%
Non-service related postretirement costs
24
21
Interest expense
62
67
Interest income
17
21
Income before income taxes
1,019
992
Provision for income taxes
240
226
Effective tax rate
23.6
%
22.8
%
Net income including noncontrolling interests
779
766
Less: Net income attributable to noncontrolling interests
28
31
Net income attributable to Colgate-Palmolive Company
$
751
$
735
Earnings per common share
Basic
$
0.94
$
0.91
Diluted
$
0.94
$
0.91
Supplemental Income Statement Information
Average common shares outstanding
Basic
796.9
807.8
Diluted
799.7
810.2
Advertising
$
775
$
674
Table 2
Colgate-Palmolive Company
Condensed Consolidated Statements of Income
For the Nine Months Ended September 30, 2026 and 2025
(Dollars in Millions Except Per Share Amounts) (Unaudited)
2026
2025
Net sales
$
16,055
$
15,152
Cost of sales
6,300
6,047
Gross profit
9,755
9,105
Gross profit margin
60.8
%
60.1
%
Selling, general and administrative expenses
6,316
5,833
Other (income) expense, net
370
58
Operating profit
3,069
3,214
Operating profit margin
19.1
%
21.2
%
Non-service related postretirement costs
70
116
Interest expense
186
203
Interest income
50
56
Income before income taxes
2,863
2,951
Provision for income taxes
682
685
Effective tax rate
23.8
%
23.2
%
Net income including noncontrolling interests
2,181
2,266
Less: Net income attributable to noncontrolling interests
91
97
Net income attributable to Colgate-Palmolive Company
$
2,090
$
2,169
Earnings per common share
Basic(1)
$
2.61
$
2.68
Diluted(1)
$
2.61
$
2.67
Supplemental Income Statement Information
Average common shares outstanding
Basic
799.5
810.0
Diluted
802.2
812.8
Advertising
$
2,286
$
2,020
Table 3
Colgate-Palmolive Company
Condensed Consolidated Balance Sheets
As of September 30, 2026, December 31, 2025 and September 30, 2025
(Dollars in Millions) (Unaudited)
September 30,
December 31,
September 30,
2026
2025
2025
Cash and cash equivalents
$
1,527
$
1,288
$
1,279
Receivables, net
1,901
1,675
1,807
Inventories
2,182
2,032
2,109
Other current assets
747
714
844
Property, plant and equipment, net
4,613
4,660
4,560
Goodwill
3,080
3,122
3,702
Other intangible assets, net
1,472
1,536
1,889
Other assets
1,220
1,303
1,323
Total assets
$
16,742
$
16,330
$
17,513
Total debt
$
7,716
$
7,988
$
8,419
Other current liabilities
6,107
5,736
5,383
Other non-current liabilities
2,279
2,241
2,473
Total liabilities
16,102
15,965
16,275
Total Colgate-Palmolive Company shareholders’ equity
288
54
856
Noncontrolling interests
352
311
382
Total liabilities and equity
$
16,742
$
16,330
$
17,513
Supplemental Balance Sheet Information
Debt less cash, cash equivalents and marketable securities(1)
$
6,104
$
6,593
$
6,947
Working capital % of sales
(6.3
)%
(7.0
)%
(4.0
)%
Table 4
Colgate-Palmolive Company
Condensed Consolidated Statements of Cash Flows
For the Nine Months Ended September 30, 2026 and 2025
(Dollars in Millions) (Unaudited)
2026
2025
Operating Activities
Net income including noncontrolling interests
$
2,181
$
2,266
Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:
Depreciation and amortization
470
457
ERISA litigation matter
—
65
Restructuring and termination benefits, net of cash
177
(15
)
Stock-based compensation expense
141
127
Deferred income taxes
54
8
Cash effects of changes in:
Receivables
(224
)
(180
)
Inventories
(104
)
9
Accounts payable and other working capital
254
30
Other non-current assets
48
48
Other non-current liabilities
(84
)
(70
)
Net cash provided by (used in) operations
2,913
2,745
Investing Activities
Capital expenditures
(400
)
(387
)
Purchases of marketable securities and investments
(163
)
(537
)
Proceeds from sale of marketable securities and investments
187
508
Payment for acquisition, net of cash acquired
—
(293
)
Other investing activities
(5
)
(5
)
Net cash provided by (used in) investing activities
(381
)
(714
)
Financing Activities
Short-term borrowing (repayment) less than 90 days, net
947
139
Principal payments on debt
(1,087
)
(655
)
Proceeds from issuance of debt
—
497
Dividends paid
(1,308
)
(1,300
)
Purchases of treasury shares
(927
)
(804
)
Proceeds from exercise of stock options
178
83
Other financing activities
(75
)
145
Net cash provided by (used in) financing activities
(2,272
)
(1,895
)
Effect of exchange rate changes on Cash and cash equivalents
(21
)
47
Net increase (decrease) in Cash and cash equivalents
239
183
Cash and cash equivalents at beginning of the period
1,288
1,096
Cash and cash equivalents at end of the period
$
1,527
$
1,279
Supplemental Cash Flow Information
Free cash flow before dividends (Net cash provided by operations less Capital expenditures)
Net cash provided by operations
$
2,913
$
2,745
Less: Capital expenditures
(400
)
(387
)
Free cash flow before dividends
$
2,513
$
2,358
Income taxes paid
$
648
$
712
Interest paid
$
205
$
235
Table 5
Colgate-Palmolive Company
Segment Information
For the Three and Nine Months Ended September 30, 2026 and 2025
(Dollars in Millions) (Unaudited)
Three Months Ended September 30,
Nine Months Ended September 30,
2026
2025
2026
2025
Net Sales
Oral, Personal and Home Care
North America(1)
$
905
$
922
$
2,684
$
2,745
Latin America
1,326
1,178
4,011
3,528
Europe, Middle East & Africa(1)
1,130
1,115
3,377
3,204
Asia Pacific(1)
802
775
2,388
2,259
Total Oral, Personal and Home Care
4,164
3,989
12,461
11,735
Hill's Pet Nutrition
1,205
1,142
3,594
3,417
Total Net Sales
$
5,369
$
5,131
$
16,055
$
15,152
Three Months Ended September 30,
Nine Months Ended September 30,
2026
2025
2026
2025
Operating Profit
Oral, Personal and Home Care
North America(1)
$
177
$
199
$
510
$
583
Latin America
392
337
1,211
1,052
Europe, Middle East & Africa(1)
262
243
791
706
Asia Pacific(1)
211
213
643
620
Total Oral, Personal and Home Care
1,042
992
3,155
2,961
Hill's Pet Nutrition
267
255
816
778
Corporate(2)
(221
)
(189
)
(902
)
(523
)
Total Operating Profit
$
1,088
$
1,059
$
3,069
$
3,214
Table 6
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Three Months Ended September 30, 2026 vs. 2025
(Unaudited)
COMPONENTS OF SALES CHANGE
Pricing
Coupons
Sales
Consumer &
Change
Organic
Trade
Foreign
Region
As Reported
Sales Change
Volume
Incentives
Exchange
Total Company
4.6
%
3.6
%
1.7
%
2.0
%
1.0
%
North America(1)
(1.7
)%
(1.6
)%
(3.7
)%
2.2
%
(0.2
)%
Latin America
12.5
%
6.0
%
3.9
%
2.1
%
6.5
%
Europe, Middle East & Africa(1)
1.4
%
2.7
%
3.5
%
(0.9
)%
(1.2
)%
Asia Pacific(1)
3.5
%
4.6
%
1.9
%
2.8
%
(1.1
)%
Total CP Products
4.4
%
3.1
%
1.6
%
1.4
%
1.3
%
Hill’s Pet Nutrition
5.6
%
5.7
%
1.8
%
3.9
%
(0.1
)%
Emerging Markets(2)
8.0
%
5.4
%
3.7
%
1.7
%
2.7
%
Developed Markets
2.0
%
2.3
%
0.1
%
2.2
%
(0.3
)%
Table 7
Colgate-Palmolive Company
Geographic Sales Analysis Percentage Changes
For the Nine Months Ended September 30, 2026 vs. 2025
(Unaudited)
COMPONENTS OF SALES CHANGE
Pricing
Coupons
Sales
Consumer &
Change
Organic
As Reported
Organic
Trade
Foreign
Region
As Reported
Sales Change
Volume(1)
Volume
Incentives
Exchange
Total Company
6.0
%
3.0
%
1.2
%
1.0
%
1.9
%
2.8
%
North America(2)
(2.2
)%
(2.3
)%
(3.6
)%
(3.6
)%
1.4
%
0.1
%
Latin America
13.7
%
5.6
%
2.8
%
2.8
%
2.7
%
8.1
%
Europe, Middle East & Africa(2)
5.4
%
2.7
%
3.0
%
3.0
%
(0.3
)%
2.8
%
Asia Pacific(2)
5.7
%
5.1
%
3.5
%
3.5
%
1.6
%
0.6
%
Total CP Products
6.2
%
2.9
%
1.5
%
1.5
%
1.4
%
3.3
%
Hill’s Pet Nutrition
5.2
%
3.3
%
0.3
%
(0.6
)%
3.9
%
1.1
%
Emerging Markets(3)
10.0
%
5.4
%
3.3
%
3.3
%
2.1
%
4.6
%
Developed Markets
2.8
%
1.0
%
(0.5
)%
(0.8
)%
1.8
%
1.4
%
Table 8
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended September 30, 2026 and 2025
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Gross Profit
2026
2025
Gross profit, GAAP
$
3,233
$
3,049
Strategic Growth and Productivity Program
5
—
Gross profit, non-GAAP
$
3,238
$
3,049
Basis Point
Gross Profit Margin
2026
2025
Change
Gross profit margin, GAAP
60.2
%
59.4
%
80
Strategic Growth and Productivity Program
0.1
%
—
%
Gross profit margin, non-GAAP
60.3
%
59.4
%
90
Selling, General and Administrative Expenses
2026
2025
Selling, general and administrative expenses, GAAP
$
2,111
$
1,971
Strategic Growth and Productivity Program
(9
)
—
Selling, general and administrative expenses, non-GAAP
$
2,102
$
1,971
Basis Point
Selling, General and Administrative Expenses as a Percentage of Net Sales
2026
2025
Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP
39.3
%
38.4
%
90
Strategic Growth and Productivity Program
(0.2
)%
—
%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP
39.1
%
38.4
%
70
Other (Income) Expense, Net
2026
2025
Other (income) expense, net, GAAP
$
34
$
19
Strategic Growth and Productivity Program
(15
)
—
Other (income) expense, net, non-GAAP
$
19
$
19
Operating Profit
2026
2025
% Change
Operating profit, GAAP
$
1,088
$
1,059
3
%
Strategic Growth and Productivity Program
29
—
Operating profit, non-GAAP
$
1,117
$
1,059
5
%
Basis Point
Operating Profit Margin
2026
2025
Change
Operating profit margin, GAAP
20.3
%
20.6
%
(30
)
Strategic Growth and Productivity Program
0.5
%
—
%
Operating profit margin, non-GAAP
20.8
%
20.6
%
20
Non-Service Related Postretirement Costs
2026
2025
Non-service related postretirement costs, GAAP
$
24
$
21
Strategic Growth and Productivity Program
(1
)
—
Non-service related postretirement costs, non-GAAP
$
23
$
21
Table 8
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Three Months Ended September 30, 2026
(Dollars in Millions Except Per Share Amounts) (Unaudited)
2026
Income
Before
Income
Taxes
Provision
For Income
Taxes(1)
Net Income
Including
Noncontrolling
Interests
Less: Income
Attributable to
Noncontrolling
Interests
Net Income
Attributable
To
Colgate-
Palmolive
Company
Effective
Income
Tax Rate(2)
Diluted
Earnings
Per Share
As Reported GAAP
$
1,019
$
240
$
779
$
28
$
751
23.6
%
$
0.94
Strategic Growth and Productivity Program
30
3
26
—
26
(0.3
)%
0.03
Non-GAAP
$
1,049
$
244
$
805
$
28
$
777
23.3
%
$
0.97
Table 9
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Nine Months Ended September 30, 2026 and 2025
(Dollars in Millions Except Per Share Amounts) (Unaudited)
Gross Profit
2026
2025
Gross profit, GAAP
$
9,755
$
9,105
Strategic Growth and Productivity Program
7
—
Gross profit, non-GAAP
$
9,762
$
9,105
Selling, General and Administrative Expenses
2026
2025
Selling, general and administrative expenses, GAAP
$
6,316
$
5,833
Strategic Growth and Productivity Program
(20
)
—
ERISA litigation matter
—
(15
)
Selling, general and administrative expenses, non-GAAP
$
6,296
$
5,817
Basis Point
Selling, General and Administrative Expenses as a Percentage of Net Sales
2026
2025
Change
Selling, general and administrative expenses as a percentage of Net sales, GAAP
39.3
%
38.5
%
80
Strategic Growth and Productivity Program
(0.1
)%
—
%
ERISA litigation matter
—
%
(0.1
)%
Selling, general and administrative expenses as a percentage of Net sales, non-GAAP
39.2
%
38.4
%
80
Other (Income) Expense, Net
2026
2025
Other (income) expense, net, GAAP
$
370
$
58
Strategic Growth and Productivity Program
(300
)
—
Acquisition-related costs
—
(9
)
Other (income) expense, net, non-GAAP
$
70
$
48
Operating Profit
2026
2025
% Change
Operating profit, GAAP
$
3,069
$
3,214
(5
)%
Strategic Growth and Productivity Program
327
—
ERISA litigation matter
—
15
Acquisition-related costs
—
9
Operating profit, non-GAAP
$
3,396
$
3,240
5
%
Basis Point
Operating Profit Margin
2026
2025
Change
Operating profit margin, GAAP
19.1
%
21.2
%
(210
)
Strategic Growth and Productivity Program
2.1
%
—
%
ERISA litigation matter
—
%
0.1
%
Acquisition-related costs
—
%
0.1
%
Operating profit margin, non-GAAP
21.2
%
21.4
%
(20
)
Non-Service Related Postretirement Costs
2026
2025
Non-service related postretirement costs, GAAP
$
70
$
116
Strategic Growth and Productivity Program
(6
)
—
ERISA litigation matter
—
(50
)
Non-service related postretirement costs, non-GAAP
$
64
$
66
Table 9
Continued
Colgate-Palmolive Company
Non-GAAP Reconciliations
For the Nine Months Ended September 30, 2026 and 2025
(Dollars in Millions Except Per Share Amounts) (Unaudited)
2026
Income
Before
Income Taxes
Provision
For
Income
Taxes(1)
Net Income
Including
Noncontrolling
Interests
Less: Income
Attributable to
Noncontrolling
Interests
Net Income
Attributable
To
Colgate-
Palmolive
Company
Effective
Income
Tax Rate(2)
Diluted
Earnings
Per Share
As Reported GAAP
$
2,863
$
682
$
2,181
$
91
$
2,090
23.8
%
$
2.61
Strategic Growth and Productivity Program
333
64
269
1
268
(0.5
)%
0.33
Non-GAAP
$
3,196
$
746
$
2,450
$
91
$
2,359
23.3
%
$
2.94
2025
Income
Before
Income Taxes
Provision
For
Income
Taxes(1)
Net Income
Including
Noncontrolling
Interests
Less: Income
Attributable to
Noncontrolling
Interests
Net Income
Attributable
To
Colgate-
Palmolive
Company
Advanced Micro Devices Inc. (NASDAQ:AMD) shares are down about 8% Friday in premarket trading as chip stocks slide in sympathy with Intel Corporation (NASDAQ:INTC), which reported earnings and issued guidance on Thursday after the market closed. Intel was down 25.51% premarket today, weighing on other semiconductor names, including ASE Technology Holding Co. Ltd. (NYSE:ASX), SK Hynix Inc. (NASDAQ:SKHY) and Astera Labs Inc. (NASDAQ:ALAB).
AMD stock is taking a hit today. What’s pressuring AMD stock? Intel Beats on Earnings and Revenue but Guides Q4 Well Below EstimatesIntel reported third-quarter earnings of 52 cents per share, beating the consensus estimate of 40 cents. It reported revenue of $16.51 billion, beating the consensus estimate of $16.47 billion. The fourth-quarter outlook is what moved the stock. Intel expects adjusted earnings per share of 25 cents, against the consensus estimate of 43 cents, and revenue of $15 billion to $16 billion, against the consensus estimate of $17.05 billion.
"Despite near-term headwinds across the PC industry, demand for our CPUs remains robust," said Lip-Bu Tan, Intel’s CEO. "Our immediate priority is to unlock additional supply to meet extraordinary demand for our Xeon family."
Why Intel’s Report Is a Read-Through for AMD and Other Chip StocksIntel and AMD compete in the same markets, PC processors and server CPUs, so Intel’s weak outlook speaks to demand and supply conditions that affect both. Intel pointed to headwinds in the PC industry and said it is working to unlock more supply, which could raise questions about PC demand and about how much chip supply is constrained across the sector. AMD sells in the same PC market and has its own client business, though its growth has recently come from data center. A drop of this size in a large chipmaker also tends to pull the group lower, as investors reduce exposure to stocks that have run up. AMD shares are up about 170% this year, according to TIKR.
AMD and Meta Advance Their Partnership as Helios Racks Run at MetaOn Oct. 27, AMD said its Helios rack-scale solutions are installed and being tested at Meta, on the path to a broader deployment in the near future. AMD EPYC processors power the computing environments behind Meta’s Muse AI agent, and AMD technologies provide Day-0 support for Meta models including Muse Spark Open and Muse Glimmer. Meta has deployed millions of EPYC processors and is a lead customer for the 6th Gen EPYC, and AMD Instinct GPUs are used in production in Meta’s training, ranking and recommendation systems. Meta will also deploy a custom AMD Instinct GPU based on the MI450 architecture. AMD will invest $1 billion in Meta’s equity offering. The partnership builds on a February agreement for Meta to deploy up to 6 gigawatts of AMD Instinct GPUs, which included a performance-based warrant for up to 160 million AMD shares.
"With Helios now running at Meta, we are taking that partnership to a new scale in the superintelligence era," said Lisa Su, AMD’s chair and CEO.
AMD Set to Report Nov. 3 Following Record-Revenue QuarterIn the second quarter, AMD reported revenue of $11.54 billion, up 50%, and data center revenue of $6.7 billion, which more than doubled. AMD reports third-quarter results after the market closes on Nov. 3. Analysts estimate earnings per share of $1.95 and revenue of $13.09 billion.
Read Next
AMD Shares SlideAMD Price Action: At the time of publication, AMD shares are trading 8.02% lower at $521.00, according to data from Benzinga Pro.
Image via Shutterstock
This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Market News and Data brought to you by Benzinga APIs
For the first time in well over half a century, Berkshire Hathaway (BRKA +0.68%)(BRKB +0.30%) entered the year in uncharted territory. Longtime CEO Warren Buffett retired at the end of last year, paving the way for his protégé, Greg Abel, to oversee the company's day-to-day operations and its closely watched $365 billion investment portfolio.
Abel wasted little time making his mark. During the first quarter, he sent 16 stocks packing! But amid this change, one investment trait remains the same: portfolio concentration. Between the Oracle of Omaha's legacy investments and the new apple of Abel's eye, four proven winners -- Apple (AAPL +1.48%), American Express (AXP +1.81%), Coca-Cola (KO +1.19%), and Alphabet (GOOGL -12.64%)(GOOG -12.29%) -- now account for 54% ($196.7 billion) of Berkshire's invested assets.
Warren Buffett and Greg Abel both favor highly concentrated portfolios. Image source: Getty Images.
Apple: $78.38 billion (21.5% of invested assets)Even though Warren Buffett sold 75% of Berkshire's Apple stake in the nine quarters leading up to his retirement, it remains the undisputed No. 1 holding. While Buffett has always appreciated customers' loyalty to the brand and Apple's otherworldly share repurchase program, totaling $879 billion since the start of 2013, it's the company's innovations that likely have Berkshire's new boss intrigued.
In addition to emphasizing its higher-margin subscription services, which can enhance customer loyalty, Apple has leaned into the evolution of artificial intelligence (AI) by rolling out its generative AI platform, Apple Intelligence, for its physical devices.
Abel sees Apple as a multidecade compounder.
AXP American Express$323.71+$5.77 (+1.81%)
NYSE · As of 4:00 PM ET 10/29/26
American Express: $47.76 billion (13.1% of invested assets)Credit-services titan American Express is another Buffett legacy investment, and the second-longest-tenured stock in Berkshire's portfolio (held continuously since 1991).
Amex's not-so-subtle secret to success is its ability to double-dip at the transaction counter. Not only is it a well-recognized payment processor that collects merchant fees, but it's also a lender generating annual fees and interest income from its cardholders.
Furthermore, Amex has historically attracted well-to-do clientele. High-income individuals are less likely to alter their spending habits or fail to pay their bills during minor economic disruptions.
Image source: Getty Images.
Coca-Cola: $37.08 billion (10.2% of invested assets)While Amex is Berkshire's second-longest holding, beverage giant Coca-Cola is No. 1 (held since 1988). Coca-Cola's 64-year streak of raising its dividend, coupled with Berkshire's ultra-low cost basis of $3.2475 per share, works out to a tidy 65% annual yield on cost!
In a world fueled by AI ambitions, Coca-Cola reminds investors that a well-known consumer brand can still deliver. With the exception of North Korea, Cuba, and Russia, it has operations in every country. This allows Coca-Cola to generate predictable cash flow in developed countries while moving the organic growth needle in faster-growing emerging markets.
Coca-Cola and Amex were labeled as "indefinite" holdings by Buffett in his 2023 letter to shareholders, so neither is going anywhere.
GOOGL Alphabet$283.82-$41.07 (-12.64%)
NASDAQ · As of 4:00 PM ET 10/29/26
Alphabet: $33.5 billion (9.1% of invested assets)Lastly, we have the stock Buffett's successor has piled into since the beginning of the year, Alphabet.
Google maintains its virtual monopoly in global internet search traffic, providing Alphabet with a boatload of operating cash flow and meaningful ad-pricing power. But it's Alphabet's AI ambitions that have Abel excited.
Since Alphabet integrated generative AI and large language model capabilities into Google Cloud, the world's No. 3 cloud infrastructure services platform, sales growth has gone parabolic. Sales for this considerably higher-margin segment soared 82% in the June-ended quarter from the previous year. There's no question about it: Alphabet is the new "Apple" of Abel's eye.
BP just posted a quarter that shattered analyst expectations, yet its stock barely flinched. With Exxon and Chevron reporting within hours and crude up sharply, find out whether the refining boom has legs or if the easy money is already…
BP (NYSE:BP | BP Price Prediction) reported on October 30, 2026 that its third-quarter underlying replacement cost profit came in at $8.5 billion. BP uses that figure as its stand-in for net profit. A year earlier it was $2.2 billion, and analysts in an LSEG consensus expected $6.2 billion. Profit nearly quadrupled: the new number is about 3.9 times the old one.
BP’s stock hardly moved. It traded at $50.56 premarket, up less than 1%. Exxon Mobil (NYSE:XOM) rose 2% to $186.97, and Chevron (NYSE:CVX) gained 2% to $235.71. Both are expected to report before the opening bell on October 30.
Refining Drove BP’s Blowout Quarter BP gave two reasons: stronger gas and marketing trading, and “significantly higher” realized refining margins. A refining margin is what a refiner earns by turning a barrel of crude into gasoline, diesel and jet fuel. BP’s indicator margin hit $46.70 a barrel, up from $29.60 in the second quarter. CEO Meg O’Neill said refining reliability was over 96%.
The cash is showing up. Operating cash flow for the first nine months reached $28.55 billion, up from $16.89 billion. Net debt fell to $13.87 billion from $26.05 billion. BP is also putting cash away for the $5.9 billion it still owes for Deepwater Horizon.
Oil prices did a lot of the work. WTI crude stood at $103.37 on October 27, up 21.3% over the trailing month, and Brent was at $123.10. CNBC reports crude is still nearly double its level a year ago.
Exxon and Chevron Have Big Refining Businesses Too Both companies run large refineries, so BP’s refining windfall is the best clue to their results. Exxon’s CFO said on the July 31 call that refining’s share of business-line earnings had gone “from about 9% to about 23% in the last 5 years.” In the second quarter, Chevron’s downstream business earned $4.87 billion, compared with $737 million a year earlier.
Size goes the other way. BP is worth about $129.68B. Exxon is worth $753.67B and Chevron $454.03B. The same margin surge has a much larger earnings base to move at each of them.
Reality Check: O’Neill Is Already Warning About Softer Margins O’Neill said BP is “seeing refining margins start to soften a bit” as the third-quarter driving season ends. She also said prices “will not always be strong.” Exxon and Chevron also lean more on oil and gas production than BP does, so one strong BP quarter doesn’t guarantee anything for them.
Much of the good news is already in the stock prices. Year to date, Exxon is up 58%, Chevron 59% and BP 51%. I own none of the three. Chevron’s 20-year deal to supply power to a Microsoft (NASDAQ:MSFT) AI data center is the kind of steady income that holds up after a price spike fades.
Will Exxon and Chevron Repeat BP’s Quarter? My view: their third-quarter refining results will look strong. The stocks will trade on what management says about the fourth quarter. BP beat the consensus by a wide margin and the stock barely moved, which tells me investors are looking past the quarter. Here’s what to check in each report:
Refining earnings (Exxon calls the segment Energy Products, Chevron calls it downstream) What management says about fourth-quarter margins Whether Exxon reaffirms its earlier $20 billion buyback target for 2026 Supply shocks and tight fuel markets are producing huge oil profits again. If Exxon or Chevron echoes O’Neill’s warning about softening margins, I expect their premarket gains on October 30 to fade by the close.
Contact [email protected] for any questions or corrections.
HOUSTON--(BUSINESS WIRE)--Chevron Corporation (NYSE: CVX) reported earnings of $9.9 billion ($5.06 per share - diluted) for third quarter 2026. Included in the quarter were a legal reserve of $160 million, an impairment of $110 million, and pension settlement costs of $24 million. Foreign currency effects decreased earnings by $143 million. Adjusted earnings were $10.4 billion ($5.28 per share - diluted) for third quarter 2026. See Attachment 4 for a reconciliation of adjusted earnings.
Earnings & Cash Flow Summary
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Total Earnings / (Loss)
$ MM
$
9,924
$
12,072
$
3,539
$
24,206
$
9,529
Upstream
$ MM
$
5,698
$
8,182
$
3,302
$
17,789
$
9,787
Downstream
$ MM
$
4,931
$
4,868
$
1,137
$
8,982
$
2,199
All Other
$ MM
$
(705
)
$
(978
)
$
(900
)
$
(2,565
)
$
(2,457
)
Earnings Per Share - Diluted
$/Share
$
5.06
$
6.11
$
1.82
$
12.26
$
5.27
Adjusted Earnings (1)
$ MM
$
10,361
$
11,977
$
3,627
$
25,131
$
10,493
Adjusted Earnings Per Share - Diluted (1)
$/Share
$
5.28
$
6.06
$
1.85
$
12.73
$
5.80
Timing Effects (1)
$ MM
$
(1,580
)
$
1,540
$
110
$
(2,980
)
$
200
Cash Flow From Operations (CFFO)
$ B
$
16.0
$
22.6
$
9.4
$
41.2
$
23.2
CFFO Excluding Working Capital (1)
$ B
$
16.6
$
19.7
$
9.9
$
43.4
$
25.8
Avg. Brent Spot Price (Source: Platts)
$/BBL
$
97
$
104
$
69
$
94
$
71
(1) See definitions in “Notice” below and non-GAAP reconciliations in the attachments
“We delivered strong operational performance and disciplined execution, while continuing to invest to grow energy supply,” said Mike Wirth, Chevron’s chairman and chief executive officer. In the United States, for third quarter 2026, upstream production exceeded 2 million barrels of oil equivalent per day for the fifth consecutive quarter, the company’s refineries achieved record crude throughput, and new production records were achieved for assets in the Eastern Mediterranean, and Australia.
“We’re reinvesting to bring more energy to a supply-constrained market,” Wirth continued. In Venezuela, Chevron’s joint ventures plan to invest $7 billion over the next five years, with the goal of unlocking low-cost, high-return, long-duration production growth. Also, in the United States, the company signed agreements to reduce Bakken midstream costs by approximately 50 percent, strengthening the asset’s competitiveness. “Building on our performance this quarter, we're focused on delivering the reliable energy the world needs today, while positioning Chevron for the future,” Wirth concluded.
Financial and Business Highlights
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Return on Capital Employed (ROCE)
%
17.7
%
21.4
%
7.6
%
14.5
%
6.7
%
Capital Expenditures (Capex)
$ B
$
4.0
$
4.5
$
4.4
$
12.6
$
12.1
Affiliate Capex
$ B
$
0.4
$
0.3
$
0.4
$
0.9
$
1.4
Free Cash Flow (FCF) (1)
$ B
$
12.0
$
18.1
$
4.9
$
28.5
$
11.1
Adjusted Free Cash Flow (1)
$ B
$
14.2
$
15.4
$
7.0
$
33.8
$
16.0
Debt-to-CFFO
Ratio
0.6x
0.8x
1.3x
0.6x
1.3x
Net debt-to-CFFO (1)
Ratio
0.4x
0.6x
1.1x
0.4x
1.1x
Net Oil-Equivalent Production
MBOED
3,980
4,070
4,086
3,970
3,614
(1) See non-GAAP measure definitions on page 5 and reconciliations in the attachments
Financial Highlights
Reported earnings increased compared to third quarter 2025 primarily due to reliable operations with higher margins on refined product sales and higher crude oil realizations, partially offset by unfavorable timing effects resulting from the rising price environment. Production in the third quarter of 2026 was lower than a year ago primarily due to lower entitlements from higher prices and impacts from the Middle East conflict, partly offset by record production at operated assets in Australia, higher production in the Gulf of America and the inclusion of one month of Venezuela production following a change to equity accounting in the quarter. U.S. refinery crude unit throughput set a new record of 1.09 million barrels per day, reflecting reliable crude unit capacity utilization of nearly 98 percent. Cash flow from operations in the third quarter of 2026 was higher than a year ago, driven by higher earnings and increased cash distributions from Tengizchevroil LLP (TCO). Adjusted free cash flow benefited from a $1 billion loan repayment from TCO and proceeds from asset sales. Capex in the third quarter of 2026 was lower than last year largely due to lower spend in the Permian Basin. Total debt was reduced by an additional $3.5 billion and net debt was down $7.8 billion in the quarter, further strengthening Chevron’s balance sheet. The company’s Board of Directors declared a quarterly dividend of one dollar and seventy-eight cents ($1.78) per share, payable December 10, 2026, to all holders of common stock as shown on the transfer records of the corporation at the close of business on November 18, 2026. Business Highlights and Milestones
Improved commercial terms and expanded acreage in Venezuela, supporting future investments and the potential to more than double production over the next five years. Announced plans to continue to strengthen the competitiveness of the company’s Bakken upstream operations by reducing midstream costs by approximately 50 percent and increasing operational flexibility. Announced an offshore crude oil and natural gas condensate discovery in Angola’s prolific Lower Congo Basin, demonstrating the potential of the company’s exploration program in sub-Saharan Africa. Signed an exploration agreement with Libya’s National Oil Corporation in the Sirte Basin, advancing Chevron’s North Africa upstream growth strategy and exploration portfolio. Started production at the new Bunge Chevron Ag Renewables LLC oilseed-processing facility in Destrehan, Louisiana, supplying additional feedstocks for transportation fuels. Completed the sale of the Cambodia downstream fuels business. Segment Highlights
Upstream
U.S. Upstream
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Earnings / (Loss)
$ MM
$
3,293
$
3,541
$
1,282
$
8,946
$
4,558
Net Oil-Equivalent Production
MBOED
2,043
2,077
2,040
2,048
1,792
Liquids Production
MBD
1,456
1,491
1,496
1,469
1,292
Natural Gas Production
MMCFD
3,522
3,520
3,265
3,474
2,997
Liquids Realization
$/BBL
$
62.72
$
70.80
$
48.12
$
61.92
$
50.12
Natural Gas Realization
$/MCF
$
1.88
$
0.91
$
1.77
$
1.74
$
1.99
U.S. upstream earnings were higher than a year ago primarily due to higher liquids realizations and lower operating expenses, including the absence of prior year severance and transaction costs related to the Hess Corporation (Hess) acquisition. Net oil-equivalent production during the quarter was up 3,000 barrels per day from the year-ago period. The increase was primarily due to higher production in the Gulf of America following project ramp-ups at Ballymore, Whale and Anchor, partly offset by lower production in the Bakken. International Upstream
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Earnings / (Loss) (1)
$ MM
$
2,405
$
4,641
$
2,020
$
8,843
$
5,229
Net Oil-Equivalent Production
MBOED
1,937
1,993
2,046
1,922
1,822
Liquids Production
MBD
1,010
1,094
1,099
1,026
925
Natural Gas Production
MMCFD
5,563
5,390
5,674
5,373
5,382
Liquids Realization
$/BBL
$
86.09
$
96.41
$
63.16
$
86.94
$
63.14
Natural Gas Realization
$/MCF
$
9.44
$
7.84
$
6.88
$
8.14
$
7.06
(1) Includes foreign currency effects
$ MM
$
(133
)
$
(77
)
$
89
$
(443
)
$
(283
)
International upstream earnings were higher than a year ago primarily due to higher realizations and higher liftings in Venezuela, partly offset by unfavorable timing effects, unfavorable taxes, unfavorable foreign currency effects, a legal reserve and an impairment charge. Net oil-equivalent production during the quarter was down 109,000 barrels per day from the year-ago period primarily due to lower entitlements from higher prices and impacts from the conflict in the Middle East, partly offset by record production at operated assets in Australia and the inclusion of one month of Venezuela production following the switch to equity accounting. Downstream
U.S. Downstream
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Earnings / (Loss)
$ MM
$
3,585
$
2,411
$
638
$
6,192
$
1,145
Refinery Crude Unit Inputs
MBD
1,093
1,070
1,064
1,072
1,043
Refined Product Sales
MBD
1,304
1,320
1,303
1,297
1,325
U.S. downstream earnings were higher than the year-ago period primarily due to higher margins on refined product sales. Refinery crude unit inputs increased 3 percent from the year-ago period as refineries operated reliably at record levels near capacity. Refined product sales were relatively flat compared to the year-ago period. International Downstream
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Earnings / (Loss) (1)
$ MM
$
1,346
$
2,457
$
499
$
2,790
$
1,054
Refinery Crude Unit Inputs
MBD
665
598
663
626
648
Refined Product Sales
MBD
1,388
1,287
1,517
1,388
1,463
(1) Includes foreign currency effects
$ MM
$
(9
)
$
31
$
42
$
30
$
(57
)
International downstream earnings were higher than the year-ago period primarily due to higher margins on refined product sales, despite unfavorable timing effects. Refinery crude unit inputs were relatively flat from the year-ago period. Refined product sales decreased 9 percent from the year-ago period due to supply disruptions from the Middle East conflict. All Other
All Other
Unit
3Q 2026
2Q 2026
3Q 2025
YTD 2026
YTD 2025
Net charges (1)
$ MM
$
(705
)
$
(978
)
$
(900
)
$
(2,565
)
$
(2,457
)
(1) Includes foreign currency effects
$ MM
$
(1
)
$
(3
)
$
16
$
(2
)
$
1
All Other consists of worldwide cash management and debt financing activities, corporate administrative functions, insurance operations, real estate activities, and technology companies. Net charges decreased compared to a year ago primarily due to favorable tax items and lower interest expense, partly offset by the absence of a prior-year favorable fair value adjustment for Hess shares. Chevron is one of the world’s leading integrated energy companies. We believe affordable, reliable and ever-cleaner energy is essential to enabling human progress. Chevron produces crude oil and natural gas; manufactures transportation fuels, lubricants, petrochemicals and additives; and develops technologies that enhance our business and the industry. We aim to grow our oil and gas business, lower the carbon intensity of operations, and grow new energies businesses. More information about Chevron is available at www.chevron.com.
NOTICE
Chevron’s discussion of third quarter 2026 earnings with security analysts will take place on Friday, October 30, 2026, at 10:00 a.m. CT. A webcast of the meeting will be available in a listen-only mode to individual investors, media, and other interested parties on Chevron’s website at www.chevron.com under the “Investors” section. Prepared remarks for today’s call, additional financial and operating information and other complementary materials will be available prior to the call at approximately 5:30 a.m. CT and located under “Events and Presentations” in the “Investors” section on the Chevron website. Chevron also publishes a “Sensitivities and Forward Guidance” document with consolidated guidance and sensitivities that is updated quarterly and posted to the Chevron website the month prior to earnings calls.
As used in this news release, the term “Chevron” and such terms as “the company,” “the corporation,” “our,” “we,” “us” and “its” may refer to Chevron Corporation, one or more of its consolidated subsidiaries, or to all of them taken as a whole. All of these terms are used for convenience only and are not intended as a precise description of any of the separate companies, each of which manages its own affairs.
Please visit Chevron’s website and Investor Relations page at www.chevron.com and www.chevron.com/investors, LinkedIn: www.linkedin.com/company/chevron, X: @Chevron, Facebook: www.facebook.com/chevron, and Instagram: www.instagram.com/chevron, where Chevron often discloses important information about the company, its business, and its results of operations.
Timing effects - Timing effects include timing mismatches in earnings recognition related to the mark‑to‑market of financial derivatives prior to the physical delivery of the associated hydrocarbons, as well as the impact of LIFO inventory accounting.
Non-GAAP Financial Measures - This news release includes adjusted earnings/(loss), which reflect earnings or losses excluding significant non-operational items including impairment charges, write-offs, decommissioning obligations from previously sold assets, severance costs, gains on asset sales, legal reserves for ceased operations, fair value adjustments for investments in equity securities, unusual tax items, effects of pension settlements and curtailments, foreign currency effects and other special items. The company believes it is useful for investors to consider this measure in comparing the underlying performance of its business across periods. The presentation of this additional information is not meant to be considered in isolation or as a substitute for net income (loss) as prepared in accordance with U.S. GAAP. A reconciliation to net income (loss) attributable to Chevron Corporation is shown in Attachment 4.
This news release also includes cash flow from operations excluding working capital, free cash flow and adjusted free cash flow. Cash flow from operations excluding working capital is defined as net cash provided by operating activities less net changes in operating working capital, and represents cash generated by operating activities excluding the timing impacts of working capital. Free cash flow is defined as net cash provided by operating activities less capital expenditures and generally represents the cash available to creditors and investors after investing in the business. Adjusted free cash flow is defined as free cash flow excluding working capital plus proceeds and deposits related to asset sales and returns of investments plus net repayment (borrowing) of loans by equity affiliates and generally represents the cash available to creditors and investors after investing in the business excluding the timing impacts of working capital. The company believes these measures are useful to monitor the financial health of the company and its performance over time. Attachment 3 shows reconciliations of cash flow from operations excluding working capital, free cash flow and adjusted free cash flow.
This news release also includes net debt ratio and net debt-to-CFFO ratio. Net debt ratio is defined as total debt less cash and cash equivalents, time deposits and marketable securities (net debt) as a percentage of net debt plus Chevron Corporation stockholders’ equity, which indicates the company’s leverage, net of its cash balances. The net debt-to-CFFO ratio is defined as net debt divided by CFFO for the trailing 12 months, which measures the company’s ability to cover its net debt using the cash it generates from operations. The company believes these measures are useful to monitor the strength of the company’s balance sheet. A reconciliation of net debt ratio and net debt-to-CFFO ratio is shown in Attachment 2.
CAUTIONARY STATEMENTS RELEVANT TO FORWARD-LOOKING INFORMATION FOR THE PURPOSE OF “SAFE HARBOR” PROVISIONS OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
This news release contains forward-looking statements relating to Chevron’s operations, assets, and strategy that are based on management’s current expectations, estimates and projections about the petroleum, chemicals and other energy-related industries. Words or phrases such as “anticipates,” “expects,” “intends,” “plans,” “targets,” “advances,” “commits,” “drives,” “aims,” “forecasts,” “projects,” “believes,” “approaches,” “seeks,” “schedules,” “estimates,” “positions,” “pursues,” “progress,” “design,” “enable,” “may,” “can,” “could,” “should,” “will,” “budgets,” “outlook,” “trends,” “guidance,” “focus,” “on track,” “trajectory,” “goals,” “objectives,” “strategies,” “opportunities,” “poised,” “potential,” “ambitions,” “future,” “aspires” and similar expressions, and variations or negatives of these words, are intended to identify such forward-looking statements, but not all forward-looking statements include such words. These statements are not guarantees of future performance and are subject to numerous risks, uncertainties and other factors, many of which are beyond the company’s control and are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in such forward-looking statements. The reader should not place undue reliance on these forward-looking statements, which speak only as of the date of this news release. Unless legally required, Chevron undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Among the important factors that could cause actual results to differ materially from those in the forward-looking statements are: changing crude oil and natural gas prices and demand for the company’s products, and production curtailments due to market conditions; crude oil production quotas or other actions that might be imposed by the Organization of Petroleum Exporting Countries and other producing countries; technological advancements; changes to government policies in the countries in which the company operates; public health crises, such as pandemics and epidemics, and any related government policies and actions; disruptions in the company’s global supply chain, including supply chain constraints and escalation of the cost of goods and services; changing economic, regulatory and political environments in the various countries in which the company operates, including Venezuela; general domestic and international economic, market and political conditions, including the conflict between Russia and Ukraine, the ongoing conflict in the Middle East and the global response to these hostilities; changing refining, marketing and chemicals margins; the amount and timing of settlements on the company’s commodity derivative contracts; actions of competitors or regulators; timing of exploration expenses; changes in projected future cash flows; timing of crude oil liftings; uncertainties about the estimated quantities of crude oil, natural gas liquids and natural gas reserves; the competitiveness of alternate-energy sources or product substitutes; pace and scale of the development of large carbon capture and storage and offset markets; the results of operations and financial condition of the company’s suppliers, vendors, partners and equity affiliates; the inability or failure of the company’s joint-venture partners to fund their share of operations and development activities; the potential failure to achieve expected net production from existing and future crude oil and natural gas development projects; potential delays in the development, construction or start-up of planned projects; the potential disruption or interruption of the company’s operations due to war, accidents, political events, civil unrest, severe weather, cyber threats, terrorist acts, or other natural or human causes beyond the company’s control; the potential liability for remedial actions or assessments under existing or future environmental regulations and litigation; significant operational, investment or product changes undertaken or required by existing or future environmental statutes and regulations, including international agreements and national or regional legislation and regulatory measures related to greenhouse gas emissions and climate change; the potential liability resulting from pending or future litigation; the company’s ability to achieve the anticipated benefits from the acquisition of Hess Corporation; potential litigation relating to the transaction with Hess Midstream LP that could be instituted against the company or its respective directors; the possibility that any of the anticipated benefits of the transaction with Hess Midstream LP will not be realized or will not be realized within the expected time period; the company’s future acquisitions or dispositions of assets or shares or the delay or failure of such transactions to close based on required closing conditions; the potential for gains and losses from asset dispositions or impairments; government mandated sales, divestitures, recapitalizations, taxes and tax audits, tariffs, sanctions, changes in fiscal terms or restrictions on scope of company operations; foreign currency movements compared with the U.S. dollar; higher inflation and related impacts; material reductions in corporate liquidity and access to debt markets; changes to the company’s capital allocation strategies; the effects of changed accounting rules under generally accepted accounting principles promulgated by rule-setting bodies; the company’s ability to identify and mitigate the risks and hazards inherent in operating in the global energy industry; and the factors set forth under the heading “Risk Factors” on pages 21 through 27 of the company’s 2025 Annual Report on Form 10-K, and as updated in the future. Other unpredictable or unknown factors not discussed in this news release could also have material adverse effects on forward-looking statements.
Attachment 1
CHEVRON CORPORATION - FINANCIAL REVIEW
(Millions of Dollars, Except Per-Share Amounts)
(unaudited)
CONSOLIDATED STATEMENT OF INCOME
Three Months Ended
September 30,
Nine Months Ended
September 30,
REVENUES AND OTHER INCOME
2026
2025
2026
2025
Sales and other operating revenues
$
65,237
$
48,169
$
179,992
$
138,645
Income (loss) from equity affiliates
2,097
981
4,967
2,337
Other income (loss)
464
576
1,501
1,176
Total Revenues and Other Income
67,798
49,726
186,460
142,158
COSTS AND OTHER DEDUCTIONS
Purchased crude oil and products
36,534
27,398
101,406
82,866
Operating expenses (1)
9,494
9,128
27,079
24,414
Exploration expenses
259
288
720
727
Depreciation, depletion and amortization
6,272
5,781
18,162
14,248
Taxes other than on income
1,310
1,347
3,837
3,903
Interest and debt expense
304
370
1,001
856
Total Costs and Other Deductions
54,173
44,312
152,205
127,014
Income (Loss) Before Income Tax Expense
13,625
5,414
34,255
15,144
Income tax expense (benefit)
3,577
1,801
9,700
5,504
Net Income (Loss)
10,048
3,613
24,555
9,640
Less: Net income (loss) attributable to noncontrolling interests
124
74
349
111
NET INCOME (LOSS) ATTRIBUTABLE TO CHEVRON CORPORATION
$
9,924
$
3,539
$
24,206
$
9,529
(1) Includes operating expense, selling, general and administrative expense, and other components of net periodic benefit costs.
PER SHARE OF COMMON STOCK
Net Income (Loss) Attributable to Chevron Corporation
- Basic
$
5.07
$
1.83
$
12.29
$
5.29
- Diluted
$
5.06
$
1.82
$
12.26
$
5.27
Weighted Average Number of Shares Outstanding (000's)
- Basic
1,956,743
1,938,922
1,968,833
1,801,623
- Diluted
1,962,905
1,946,035
1,974,547
1,808,004
Note: Shares outstanding (excluding 14 million associated with Chevron’s Benefit Plan Trust) were 1,951 million and 1,980 million at September 30, 2026, and December 31, 2025, respectively.
EARNINGS BY MAJOR OPERATING AREA
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Upstream
United States
$
3,293
$
1,282
$
8,946
$
4,558
International
2,405
2,020
8,843
5,229
Total Upstream
5,698
3,302
17,789
9,787
Downstream
United States
3,585
638
6,192
1,145
International
1,346
499
2,790
1,054
Total Downstream
4,931
1,137
8,982
2,199
All Other
(705
)
(900
)
(2,565
)
(2,457
)
NET INCOME (LOSS) ATTRIBUTABLE TO CHEVRON CORPORATION
$
9,924
$
3,539
$
24,206
$
9,529
Attachment 2
CHEVRON CORPORATION - FINANCIAL REVIEW
(Millions of Dollars)
(unaudited)
SELECTED BALANCE SHEET ACCOUNT DATA (Preliminary)
September 30,
2026
December 31,
2025
Cash and cash equivalents
$
12,804
$
6,293
Time deposits
$
—
$
4
Total assets
$
333,786
$
324,012
Total debt
$
33,534
$
40,758
Total Chevron Corporation stockholders’ equity
$
194,327
$
186,450
Noncontrolling interests
$
5,650
$
5,726
SELECTED FINANCIAL RATIOS
Total debt plus total stockholders’ equity
$
227,861
$
227,208
Debt ratio (Total debt / Total debt plus stockholders’ equity)
14.7
%
17.9
%
Net debt (Total debt less cash and cash equivalents, time deposits and marketable securities)
$
20,730
$
34,461
Net debt plus total stockholders’ equity
$
215,057
$
220,911
Net debt ratio (Net debt / Net debt plus total stockholders’ equity)
9.6
%
15.6
%
Cash flow from operations (CFFO) (1)
$
51,950
$
33,939
Debt-to-CFFO ratio (1)
0.6x
1.2x
Net debt-to-CFFO ratio (1)
0.4x
1.0x
(1) CFFO is presented on a trailing 12-month basis.
RETURN ON CAPITAL EMPLOYED (ROCE)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026
2025
2026
2025
Total reported earnings
$
9,924
$
3,539
$
24,206
$
9,529
Noncontrolling interest
124
74
349
111
Interest expense (A/T)
244
329
872
771
ROCE earnings
10,292
3,942
25,427
10,411
Annualized ROCE earnings
41,168
15,768
33,903
13,881
Average capital employed (1)
233,072
206,935
233,223
207,421
ROCE
17.7
%
7.6
%
14.5
%
6.7
%
(1) Capital employed is the sum of Chevron Corporation stockholders’ equity, total debt and noncontrolling interest. Average capital employed is computed by averaging the sum of capital employed at the beginning and the end of the period.
Three Months Ended
September 30,
Nine Months Ended
September 30,
CAPEX BY SEGMENT
2026
2025
2026
2025
United States
Upstream
$
1,667
$
2,383
$
6,046
$
7,209
Downstream
250
133
490
442
Other
95
112
244
286
Total United States
2,012
2,628
6,780
7,937
International
Upstream
1,920
1,732
5,632
3,967
Downstream
64
72
163
139
Other
15
12
37
40
Total International
1,999
1,816
5,832
4,146
CAPEX
$
4,011
$
4,444
$
12,612
$
12,083
AFFILIATE CAPEX (not included above)
Upstream
$
155
$
214
$
381
$
593
Downstream
205
215
537
766
AFFILIATE CAPEX
$
360
$
429
$
918
$
1,359
Attachment 3
CHEVRON CORPORATION - FINANCIAL REVIEW
(Millions of Dollars)
(unaudited)
SUMMARIZED STATEMENT OF CASH FLOWS (Preliminary)
Three Months Ended
September 30,
Nine Months Ended
September 30,
OPERATING ACTIVITIES
2026
2025
2026
2025
Net Income (Loss)
$
10,048
$
3,613
$
24,555
$
9,640
Adjustments
Depreciation, depletion and amortization
6,272
5,781
18,162
14,248
Distributions more (less) than income from equity affiliates
323
626
797
1,802
Loss (gain) on asset retirements and sales
(129
)
(3
)
(361
)
(302
)
Net foreign currency effects
99
(26
)
267
444
Deferred income tax provision
136
200
170
709
Net decrease (increase) in operating working capital
(538
)
(555
)
(2,218
)
(2,685
)
Other operating activity
(197
)
(251
)
(211
)
(706
)
Net Cash Provided by Operating Activities (CFFO)
$
16,014
$
9,385
$
41,161
$
23,150
INVESTING ACTIVITIES
Acquisition of businesses, net of cash acquired
—
1,056
—
1,056
Acquisition of Hess Corporation common stock
—
—
—
(2,225
)
Capital expenditures (Capex)
(4,011
)
(4,444
)
(12,612
)
(12,083
)
Proceeds and deposits related to asset sales and returns of investment
710
483
1,065
1,473
Net repayment (borrowing) of loans by equity affiliates
992
974
1,971
798
Other investing activity
2
2
3
2
Net Cash Provided by (Used for) Investing Activities
$
(2,307
)
$
(1,929
)
$
(9,573
)
$
(10,979
)
FINANCING ACTIVITIES
Net change in debt
(3,530
)
2,059
(7,294
)
6,790
Cash dividends — common stock
(3,482
)
(3,429
)
(10,512
)
(9,347
)
Shares issued for share-based compensation
274
84
1,483
313
Shares repurchased (1)
(2,502
)
(2,566
)
(8,191
)
(9,227
)
Distributions to noncontrolling interests
(148
)
(190
)
(417
)
(220
)
Net Cash Provided by (Used for) Financing Activities
$
(9,388
)
$
(4,042
)
$
(24,931
)
$
(11,691
)
EFFECT OF EXCHANGE RATE CHANGES ON CASH, CASH EQUIVALENTS AND RESTRICTED CASH
18
(6
)
(23
)
41
NET CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
$
4,337
$
3,408
$
6,634
$
521
RECONCILIATION OF NON-GAAP MEASURES
Net Cash Provided by Operating Activities
$
16,014
$
9,385
$
41,161
$
23,150
Less: Net decrease (increase) in operating working capital
(538
)
(555
)
(2,218
)
(2,685
)
Cash Flow from Operations Excluding Working Capital
$
16,552
$
9,940
$
43,379
$
25,835
Net Cash Provided by Operating Activities
$
16,014
$
9,385
$
41,161
$
23,150
Less: Capital expenditures
4,011
4,444
12,612
12,083
Free Cash Flow
$
12,003
$
4,941
$
28,549
$
11,067
Less: Net decrease (increase) in operating working capital
(538
)
(555
)
(2,218
)
(2,685
)
Plus: Proceeds and deposits related to asset sales and returns of capital
710
483
1,065
1,473
Plus: Net repayment (borrowing) of loans by equity affiliates
992
974
1,971
798
Adjusted Free Cash Flow
$
14,243
$
6,953
$
33,803
$
16,023
(1) Includes $114 million and $146 million for the nine months ended September 30, 2026 and 2025, respectively, related to excise tax payments for prior year repurchases.
Attachment 4
CHEVRON CORPORATION - FINANCIAL REVIEW
(Millions of Dollars)
(unaudited)
RECONCILIATION OF NON-GAAP MEASURES
Three Months Ended
September 30, 2026
Three Months Ended
September 30, 2025
Nine Months Ended
September 30, 2026
Nine Months Ended
September 30, 2025
REPORTED EARNINGS
Pre-Tax
Income Tax
After-Tax
Pre-Tax
Income Tax
After-Tax
Pre-Tax
Income Tax
After-Tax
Pre-Tax
Income Tax
After-Tax
U.S. Upstream
$
3,293
$
1,282
$
8,946
$
4,558
Int'l Upstream
2,405
2,020
8,843
5,229
U.S. Downstream
3,585
638
6,192
1,145
Int'l Downstream
1,346
499
2,790
1,054
All Other
(705
)
(900
)
(2,565
)
(2,457
)
Net Income (Loss) Attributable to Chevron Corporation
FILE PHOTO: The logo of Dow Jones Industrial Average stock market index listed company Chevron (CVX) is seen in Los Angeles, California, United States, April 12, 2016. REUTERS/Lucy... Purchase Licensing Rights, opens new tab Read more
CompaniesHOUSTON, Oct 30 (Reuters) - Chevron's (CVX.N), opens new tab third-quarter earnings surpassed analyst estimates on Friday as refining margins soared amid the US-Israeli war on Iran and the Russia-Ukraine conflict.
Adjusted earnings were $10.4 billion, or $5.28 per share, a 185% increase from the prior-year quarter. The per-share figure also topped the consensus Wall Street estimate of $4.89 per share according to LSEG data.
Sign up here.
Here are more details from Chevron's third quarter:
Upstream earnings were $5.7 billion, down 30% from the previous three months due in part to lower oil prices.
Downstream earnings totaled $4.9 billion, slightly higher than the second quarter
Chevron refineries achieved record US crude throughput of over 1 million barrels per day during the quarter and diesel and jet fuel yields rose by more than 10%
The quarter included one month of Venezuela production after Chevron switched to equity accounting for its operations there, following improved fiscal terms
Output from Venezuela is free cash flow positive and has total costs of less than $20 per barrel, the company said
Chevron produced 3.98 million barrels of oil equivalent per day, down 2% from the previous quarter
Adjusted free cash flow was $14.2 billion, twice the level of the same period last year
The company paid $3.5 billion in dividends and repurchased $2.5 billion worth of shares during the third quarter
Net debt at the end of the third quarter was $20.7 billion, down from $34.5 billion at the end of 2025
Reporting by Sheila Dang in Houston; Editing by Nathan Crooks and Christian Schmollinger
Our Standards: The Thomson Reuters Trust Principles., opens new tab
Chevron and Exxon Mobil on Friday reported profits that surged in the third quarter, as their U.S. refineries ran at full capacity to take advantage of high diesel fuel prices.
Chevron's net income surged nearly 200% to $9.9 billion, or $5.06 a share, compared to $3.5 billion, or $1.82 a share, in the same period last year. When adjusted for one-time items, it reported earnings of $5.28 per share, soundly beating Wall Street's expectations of $4.89.
Diesel prices have surged globally as Ukraine and Iran have bombed refineries in Russia and the Middle East. U.S. refiners have ramped up production to fill the supply gap.
Exxon Mobil's profits doubled to $15.4 billion, or $3.72 a share, compared to $7.5 billion, or $1.76 a share, in the same period in 2025. When adjusted for one-time items, it posted earnings of $4.23 a share, beating the Street's expectations.
Chevron shares are up about 2% in premarket trading, while Exxon is trading about 1.5% higher.
Here's how Chevron and Exxon did, compared with estimates from analysts polled by LSEG:
Chevron's earnings per share: $5.28 adjusted, vs. $4.89 expectedChevron's revenue: $67.8 billion, vs. $61.6 billion expectedExxon's earnings per share: $4.23 adjusted, vs. $4.08 expectedExxon's revenue: $113.2 billion, vs. $103.1 billion expectedChevron's U.S. refineries processed record amounts of crude oil at just above 1 million barrels per day, as the facilities ran at 98% capacity. Diesel and jet fuel yields rose more than 10%, the company said.
Exxon said its Gulf Coast refineries operated at 100% utilization with the second-high diesel production on record at those facilities.
Profits from Chevron's refining division surged more than 300% to $4.9 billion compared to $1.1 billion in the same period in 2025.
Profits from Chevron's oil and gas production rose about 70% to $5.7 billion compared to $3.3 billion in the year-ago period. Its output actually declined slightly to 3.9 million bpd compared to about 4 million bpd in the same period last year. The decline was in its international segment due in part to the conflict in the Middle East, while output was largely flat in the U.S. year over year.
FILE PHOTO: Exxon Mobil logo and stock graph are seen through a magnifier displayed in this illustration taken September 4, 2022. REUTERS/Dado Ruvic/Illustration/File Photo/File Photo Purchase Licensing Rights, opens new tab
SummaryCompaniesExxon earns more from refining than from upstream in Q3Chevron's Q3 downstream earnings reach highest point in at least six yearsBoth companies use excess cash to pay down debtHOUSTON, Oct 30 (Reuters) - US oil majors ExxonMobil (XOM.N), opens new tab and Chevron (CVX.N), opens new tab both beat analyst expectations for quarterly profit on Friday, as soaring refining margins increased earnings from their fuel-making businesses - which typically have smaller profits - to rival the upstream segments.
The US-Israeli war with Iran and the conflict between Russia and Ukraine have disrupted global energy markets and sent gasoline and diesel prices higher. The effective closure of the Strait of Hormuz and recent attacks on refineries in Saudi Arabia and Russia have knocked out fuel-making capacity, lifting margins for Exxon and Chevron as they ran their US refineries near full rates.
Sign up here.
Exxon, the largest US oil producer by market capitalization, is now earning more money from refining than from upstream for the first time in at least the past six years. Chevron's third-quarter downstream earnings also reached their highest point over the same time frame.
Shares of Exxon rose 2% in pre-market trading, while Chevron was up 1%.
Exxon is continuing to invest more in its refineries, including at its Baytown complex in Texas, to increase fuel production and has leaned on its trading team to direct supplies to where they are needed globally, Chief Financial Officer Neil Hansen said in an interview.
"It's important to acknowledge that these higher fuel prices put real pressure on families and businesses," he said. "The most meaningful response ... that we can offer as a company is to pull every lever that's available to us to increase supply."
Distillate production in the US will grow by another 100,000 barrels per day through the refinery investments, the company said in prepared remarks ahead of the earnings call, without giving a timeline.
High fuel prices have become a political flashpoint ahead of Tuesday’s US midterm elections, with diesel and gasoline costs adding to voter frustration.
The industry has so far avoided some of the toughest measures floated in Washington, including a possible diesel export ban that US President Donald Trump had considered in September before saying in early October he would not impose it.
Chevron has opportunities to increase efficiency at its US Gulf refineries and could grow capacity by 7% at its Pascagoula refinery in Mississippi by the end of the decade, Chief Financial Officer Eimear Bonner told Reuters in an interview.
Exxon reported third-quarter adjusted earnings per share of $4.23, while Chevron earned $5.28 in adjusted per-share profit.
PAYING DOWN DEBTThe two US oil majors are using the cash windfall to pay down debt and strengthen their balance sheets instead of increasing dividends or buying back more shares.
Exxon reduced debt by $8 billion during the third quarter, Hansen said, adding it planned to stick to its approach of maintaining a sustainable and growing dividend over the long term.
Chevron has cut net debt by nearly $14 billion when compared with the end of 2025.
"We think in decades, not quarters," Bonner said. "We need that (strong) balance sheet through high prices and low prices."
Bonner said the spot price of benchmark Brent crude swung from as low as $68 per barrel to a high of $132 during the third quarter, underscoring the volatility of the energy market.
Exxon said it would repurchase $20 billion worth of shares in 2027, the same level as in the previous two years.
During the earnings calls with analysts later on Friday, executives from both firms could face questions about when they might increase distributions to shareholders or their plans to invest higher profits into new or existing projects.
Reporting by Sheila Dang in Houston; Editing by Nathan Crooks, Thomas Derpinghaus and Tomasz Janowski
Our Standards: The Thomson Reuters Trust Principles., opens new tab
FILE PHOTO: The logo of Dow Jones Industrial Average stock market index listed company Chevron (CVX) is seen in Los Angeles, California, United States, April 12, 2016. REUTERS/Lucy... Purchase Licensing Rights, opens new tab Read more
CompaniesOct 30 (Reuters) - US oil major Chevron (CVX.N), opens new tab said on Friday turnaround and downtime were expected to reduce its upstream production by 175,000 to 225,000 barrels of oil equivalent per day (boepd) in the fourth quarter.
The company also said disruptions during the fourth quarter were expected to weigh on downstream earnings by $400 million to $500 million.
SummaryCaterpillar (CAT) fell sharply post-earnings despite strong Q3 results, reflecting investor concerns over guidance and valuation.CAT's Power & Energy division, driven by data center demand, now outpaces Construction Industries, with a record $78B backlog up 96% YoY.Sequential backlog growth is decelerating as manufacturing capacity expands, and Q4 guidance remains unchanged, disappointing bullish expectations.I view CAT as fairly priced near $650, but my buy zone starts at a lower level, which I explain in the article.Looking for a helping hand in the market? Members of iREIT®+HOYA Capital get exclusive ideas and guidance to navigate any climate. Learn More »8.79K Followers
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
We initiated a position in 908 Devices, a maker of portable chemical detection instruments used by hazmat teams, law enforcement, firefighters, and the military. We initiated a position in Bowhead Specialty Holdings, a specialty insurer founded in 2020 by industry veteran Stephen Sills. We exited Coastal Financial in July. Our thesis rested on its role as a banking partner to fintech companies and the operating leverage those partnerships were expected to deliver this year.
Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesDigital Realty Trust NYSE: DLR reported third-quarter results that exceeded its expectations, supported by record leasing activity, rising occupancy and continued demand for data-center capacity tied to artificial intelligence, cloud computing and enterprise workloads.
The company raised its 2026 Core FFO per-share guidance, excluding net promoting income, by $0.15 to a range of $8.30 to $8.35. The midpoint would represent nearly 13% growth from 2025, according to Chief Financial Officer Matt Mercier. Third-quarter Core FFO was $2.10 per share, up 11% year over year.
Get Digital Realty Trust alerts:
3 Stocks Built for Higher Rates—And 2 That Could Break“Digital Realty delivered an outstanding quarter, highlighted by strong execution across our global platform, robust financial results, record leasing activity, and continued progress against our long-term growth strategy,” President and CEO Andy Power said.
Record Leasing and Backlog Total leasing bookings reached approximately $855 million during the quarter, or $627 million at Digital Realty’s share. The total exceeded the company’s previous leasing record by 20%, Mercier said.
Why the Landlord of the AI Boom Could Outlast the ChipmakersBookings in the company’s 0 to 1 megawatt-plus-interconnection category totaled $165 million, or $151.8 million at Digital Realty’s share, up 40% from the prior quarter’s record. Interconnection bookings were $23.9 million, or $22.2 million at the company’s share, also a record.
Power said the results reflect the growing need for connected data-center environments as AI infrastructure becomes more distributed. The company cited demand from enterprises, cloud providers, network operators and AI customers, including an AI platform deploying inference and low-latency edge hubs in 15 metros.
“AI workloads increasingly depend on a broader digital infrastructure architecture that connects compute and storage with cloud platforms, networks, customers, and inference locations,” Power said.
Hyperscale leasing, defined as deployments greater than 1 MW, reached $689 million, or $474 million at Digital Realty’s share. The activity included two previously disclosed leases in Northern Virginia and record signings in Asia-Pacific, including Seoul, Chennai and Sydney.
The company’s backlog rose nearly 30% sequentially to a record $2.5 billion, or $1.8 billion at Digital Realty’s share. Booked but not billed backlog represented almost 40% of in-place rental revenue, Mercier said. Management said the backlog provides visibility into 2027 and beyond.
Operating Metrics and Development Activity Same-capital portfolio cash net operating income increased about 6% year over year in the third quarter. Stabilized occupancy increased nearly 90 basis points sequentially to 93.4%, while churn fell to a record low of 0.7%.
Cash re-leasing spreads approached 12% during the quarter, while the company signed $261 million in renewals at an average 11.8% cash re-leasing spread. Renewals for deployments above 1 MW delivered a 26.3% cash mark-to-market, led by multiple hyperscale renewals in Northern Virginia.
Digital Realty commenced $207 million of annualized GAAP rents during the quarter. Mercier said commencements are expected to accelerate over the following two quarters, supported by newly signed smaller-scale leases and more than 250 MW of upcoming pre-leased deliveries.
The company invested $1.5 billion in development capital expenditures during the quarter and $3.3 billion year to date, net of partner share. It delivered 50 MW of new IT capacity that was 95% pre-leased and began development on 112 MW across projects in APAC, EMEA and the Americas.
Its development pipeline reached 1.5 gigawatts under construction, with an expected total cost of $22 billion. The pipeline was 63% pre-leased and carried an average expected stabilized yield of 11.6%.
Land, International Expansion and Capital Digital Realty acquired sites for future development across seven U.S. and European locations, investing more than $700 million. The investments included a 1 GW development in the greater Indianapolis area. The company also entered Türkiye, its 65th global metro, through a development joint venture that plans an initial 22 MW project in Ankara before pursuing expansion into Istanbul.
In discussing recent land purchases, Power said the company is targeting markets with robust and diverse demand from enterprise customers, cloud computing and AI workloads. Chief Investment Officer Greg Wright said Indianapolis has drawn more than $25 billion of hyperscale investment over the past three years and benefits from lower power costs and proximity to major population centers.
The company also continued to expand its private-capital platform. During the quarter, Digital Realty closed its acquisition of Columbia Capital, a digital-infrastructure-focused investment platform. Subsequent to quarter-end, it secured more than $1.4 billion in initial cornerstone equity commitments for a perpetual-capital strategy focused on stabilized hyperscale data centers in North America.
Mercier said Digital Realty raised approximately $3.5 billion across its capital stack in recent weeks, including $450 million of common equity through its at-the-market program and $1.7 billion of debt proceeds from euro and Swiss franc bond offerings at a blended average coupon of 4%.
At quarter-end, headline leverage was 5.2 times, or 4.9 times on a pro forma basis for the expected stabilization of three fully leased Northern Virginia developments acquired at the end of the previous quarter. Moody’s upgraded the company’s long-term issuer rating to Baa1 in September.
Updated Outlook Along with its Core FFO guidance increase, Digital Realty lifted its forecast for constant-currency same-capital cash NOI growth to 5.25% to 5.75%. It expects cash renewal spreads of 10% to 12% and maintained its capital-expenditure forecast, net of partner contributions, at $4.25 billion to $4.75 billion.
The company raised capital-recycling guidance by $500 million to a range of $1.5 billion to $2 billion, citing progress with its perpetual private-capital strategy. Management said continued strength in smaller-scale colocation and interconnection leasing, the record backlog and its development pipeline support confidence in extending double-digit Core FFO per-share growth into 2027 and beyond.
About Digital Realty Trust (NYSE:DLR)Digital Realty Trust, Inc is a real estate investment trust that owns, operates and develops data center facilities for businesses, cloud service providers, information technology companies and telecommunications organizations. The company provides the physical infrastructure needed to support data storage, networking, cloud computing and other digital operations.
Its services include data center colocation, interconnection and private connectivity solutions. Digital Realty also offers access to cloud and network providers through its PlatformDIGITAL platform, which is designed to help customers deploy, connect and manage their digital infrastructure across multiple locations.
Founded in 2001, Digital Realty serves customers through a global portfolio of data centers and related facilities across North America, Europe, Asia-Pacific and Latin America.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Digital Realty Trust Right Now?Before you consider Digital Realty Trust, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Digital Realty Trust wasn't on the list.
While Digital Realty Trust currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Nejnovější výsledky společností Amazon a Intel ukázaly, že samotný růst už trhu nestačí, pokud je vykoupen rekordními investicemi a zhoršujícím se cash flow.
Článek se odemkne 30.10.2026 12:58
Pokračování článku je dostupné jen klientům placených služeb Patria Plus / Investor Plus případně uživatelům platformy Patria Direct. Pokud jste klientem těchto služeb, potom je nutné se Přihlásit.
V rámci placeného informačního servisu získáte přístup ke kompletnímu zpravodajství www.patria.cz bez jakýchkoliv omezení. Veškeré zprávy, komentáře a horké zprávy jsou zobrazovány terminálovou metodou (bez nutnosti obnovovat stránku) bez zpoždění a v plné verzi.
Nejen zpravodajství, ale i další služby získáte v Patria Plus / Investor Plus - sms a e-mailové zpravodajství, data z finančních trhů v reálném čase, kompletní analytický servis, rozsáhlé databáze časových řad ke stažení, prognózy vývoje a valuace, ekonomické fundamenty, nástroje a kalkulátory... více
HOUSTON and LONDON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (NYSE: LYB) today announced it has entered into an agreement to sell its former Houston Refinery site and related assets to Valero Refining-Texas, L.P., a wholly owned subsidiary of Valero Energy Corporation (NYSE: VLO, "Valero"). The transaction represents another step in the company’s ongoing portfolio transformation, sharpening its focus on businesses and assets that offer the strongest strategic fit and long-term value creation potential while strengthening its ability to allocate capital in line with its company strategy.
“This transaction reflects the disciplined approach we are taking to transform our portfolio and create long-term value,” said LYB CEO Peter Vanacker. “It provides an opportunity to realize value from a non-core asset while positioning the site, its infrastructure and employees with an owner whose core business is refining. We are pleased that the agreement provides continued employment for the site’s workforce and look forward to working with Valero on an orderly transition.”
Following the decision to cease refining operations, LYB evaluated a range of options for the site and determined that the sale offered the most compelling opportunity to advance the company’s strategic priorities.
The total purchase price for the transaction is $320.5 million. Valero is assuming responsibility for ongoing site operations, environmental liabilities, pension costs and related employee obligations. The transaction is expected to close in the fourth quarter of 2026, subject to regulatory approvals and other customary closing conditions.
About LyondellBasell
We are LyondellBasell (NYSE: LYB), a global leader in the chemical industry. We develop, manufacture and market innovative products for applications ranging from transportation and infrastructure to food safety, clean water and quality healthcare.
We hold leading positions in polyolefins, oxyfuels, propylene oxide and acetyls. Our focus on safe and reliable operations, proprietary technologies and strong portfolio positions us for success. Through disciplined investments, we strengthen our core businesses, and build profitable circular and low-carbon solutions that create long-term value for our customers, investors and other stakeholders.
Our commitment to an inclusive global workplace enables employees to do their best work as they create solutions for everyday sustainable living. For more information, please visit www.lyb.com or follow @LyondellBasell on LinkedIn.
Cautionary Note Regarding Forward-looking Statements
The statements in this press release relating to matters that are not historical facts are forward-looking statements. These forward-looking statements are based upon assumptions of management which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. Actual results could differ materially from the anticipated results, or other expectations expressed in this press release, including, but not limited to, receipt of required regulatory approvals or the expiration of applicable waiting periods; the satisfaction of closing conditions; and our ability to complete the transaction described herein within the time period included herein. While these statements are made in good faith, LyondellBasell and its management cannot guarantee that anticipated future results will be achieved.
Net income: $758 million, $828 million excluding identified items1Diluted earnings per share: $2.32 per share, $2.54 per share excluding identified itemsEBITDA: $1.4 billion, $1.5 billion excluding identified itemsContinued strong EBITDA margin reflecting the resilience of our global, cost-advantaged portfolio, ongoing execution of our Value Enhancement Program and diversified end market exposureDemonstrated operational excellence through improved asset reliability and completion of the Clinton turnaround on time and under budgetIncreased cash by approximately $600 million during the quarter including planned €500 million debt repaymentProgressed our Cash Improvement Plan including reducing global structural fixed costs HOUSTON and LONDON, Oct. 30, 2026 (GLOBE NEWSWIRE) -- LyondellBasell Industries (NYSE: LYB) (the "company") today announced results for the third quarter 2026. Comparisons with the prior quarter and third quarter 2025 are available in the following table:
Table 1 - Earnings Summary
Millions of U.S. dollars (except share data)
Three Months EndedNine Months Ended September 30, 2026 June 30, 2026 September 30, 2025September 30, 2026 September 30, 2025Sales and other operating revenues $8,499 $9,177 $7,727 $24,873 $23,062 Net income (loss) 758 559 (890) 1,442 (598)Diluted earnings (loss) per share 2.32 1.71 (2.77) 4.42 (1.89)Weighted average diluted share count 323 323 322 323 322 EBITDA1 1,420 1,252 (480) 3,240 781
Excluding Identified Items1
Net income excluding identified items $828 $1,401 $330 $2,392 $642 Diluted earnings per share excluding identified items 2.54 4.30 1.01 7.34 1.96 Loss on sale of business, pre-tax — 734 6 734 6 Asset write-downs, pre-tax — 74 1,202 89 1,234 Cash Improvement Plan costs, pre-tax 2 31 7 33 27 Site closure costs, pre-tax 77 30 — 111 117 European transaction costs, net of transition service agreement income, pre-tax (9) (11) 17 (10) 27 (Income) loss from discontinued operations, pre-tax 22 17 83 57 (66)EBITDA excluding identified items 1,512 2,127 835 4,254 2,126 (1) See “Information Related to Financial Measures” for a discussion of the company’s use of non-GAAP financial measures and Tables 2-4 for reconciliations or calculations of these financial measures. “Identified items” include adjustments for lower of cost or market ("LCM"), gain/loss on sale of business, asset write-downs in excess of $10 million in aggregate for the period, Cash Improvement Plan costs, site closure costs, European transaction costs, net of transition service agreement income, and discontinued operations.
“In an evolving macroeconomic environment, we delivered another quarter of strong earnings and robust cash conversion through disciplined execution underscored by the strength of our global, cost-advantaged portfolio,” said Peter Vanacker, LYB chief executive officer. “We are leveraging the flexibility and resilience of our leaner structure by optimizing feedstocks, directing products to the most attractive markets and aligning operating rates with demand. The strength of our oxyfuels business and materially higher Intermediates and Derivatives profitability highlight the benefits of our diversified portfolio. We continue to prioritize safety, reliability and cost discipline, to maximize margins, generate cash and deliver sustainable value for our shareholders.”
THIRD QUARTER 2026 RESULTS
The company reported net income for the third quarter 2026 of $758 million, or $2.32 per diluted share. During the quarter, the company recognized $70 million of identified items, net of tax. These items, which impacted third quarter earnings by $0.22 per diluted share, included closure costs for a European propylene oxide (PO) joint venture. Third quarter 2026 EBITDA was $1.4 billion, or $1.5 billion excluding identified items.
Market conditions remained dynamic throughout the third quarter, as ongoing geopolitical uncertainty led to diverging impacts in our key markets. Compared with the second quarter, profitability fell in the Olefins and Polyolefins (O&P) – Americas segment, driven by lower prices for polymers and olefin products. However, the industry's integrated polyethylene margins ended the third quarter at approximately 50% above 2025 levels, supported by positive polyethylene price momentum in September. The company completed the planned turnaround at Clinton on time and under budget, reflecting the ongoing focus on operational excellence. In the O&P – Europe, Asia and International segment, polymer prices fell which pressured margins. Volumes in the third quarter were also lower sequentially, reflecting the sale of certain European assets in May 2026.
Intermediates and Derivatives (I&D) delivered materially higher quarterly profitability, largely driven by oxyfuels. Through the Value Enhancement Program, LYB increased utilization of the Channelview PO/TBA asset to approximately 110%. Bayport PO/TBA operated at full rates after a successful restart in June, leveraging strong customer demand and providing additional support to earnings. Global supply disruptions led to higher crack spreads, and favorable gasoline blend economics boosted octane values. These factors significantly expanded Europe and U.S. oxyfuel margins. Acetyls also benefited from improved reliability at La Porte.
LYB generated $1.7 billion in cash from operating activities during the third quarter, including a release of working capital. Capital allocation was balanced between capital expenditures of $303 million and $224 million of shareholder returns through dividends. The company also repaid its €500 million note maturity in September as planned. At the end of the quarter, LYB held $3.2 billion in cash and cash equivalents and $7.7 billion in available liquidity.
OUTLOOK
Conditions in the Middle East are likely to remain fluid and a potential return to pre-conflict conditions is likely to be non-linear and take longer than anticipated. Customer buying patterns have been impacted by inventory levels and price volatility, however polyethylene domestic and export demand is strong and polymer pricing improved through the end of the third quarter. Additionally, oxyfuels margins and demand remain strong. As markets continue to adjust, reliable supply and operational flexibility are expected to remain important differentiators. The company's cost-advantaged assets and exposure to diverse end markets are well positioned to underpin future earnings and cash flow.
In the fourth quarter, we expect normal seasonal demand patterns along with ongoing supply uncertainty. The company has a planned maintenance project in a North American polypropylene asset. To align with global demand and the company's planned maintenance, LYB expects fourth quarter operating rates of 85% for North American O&P assets, 60% for European O&P assets and 75% for I&D assets. The fourth quarter is expected to deliver a seasonal release of working capital.
LYB remains focused on commercial and operational agility in this dynamic market while continuing to execute the Cash Improvement Plan. The company's capital allocation priorities remain unchanged: safely operate and maintain assets, strengthen the balance sheet through disciplined deleveraging, maintain an attractive dividend and invest selectively in opportunities that enhance long-term shareholder value.
CONFERENCE CALL
LYB will host a conference call Oct. 30 at 11 a.m. EDT. Participants on the call will include CEO Peter Vanacker, Executive Vice President (EVP) and Chief Financial Officer Agustin Izquierdo, EVP of Global O&P Kim Foley, EVP of I&D Aaron Ledet, EVP of Advanced Polymer Solutions Torkel Rhenman and Head of Investor Relations David Dennison. For event access, the toll-free dial-in number is 1-877-407-8029, international dial-in number is 201-689-8029 or click the CallMe link. The slides and webcast that accompany the call will be available at investors.lyondellbasell.com/earnings. A replay of the call will be available from 1 p.m. EDT Oct. 30 until Nov. 30, 2026. The replay toll-free dial-in numbers are 1-877-660-6853 and 201-612-7415. The access ID for each is 13746219.
ABOUT LYONDELLBASELL
We are LyondellBasell (NYSE: LYB), a global leader in the chemical industry. We develop, manufacture and market innovative products for applications ranging from transportation and infrastructure to food safety, clean water and quality healthcare.
We hold leading positions in polyolefins, oxyfuels, propylene oxide and acetyls. Our focus on safe and reliable operations, proprietary technologies and strong portfolio positions us for success. Through disciplined investments, we strengthen our core businesses, and build profitable circular and low-carbon solutions that create long-term value for our customers, investors and other stakeholders.
Our commitment to an inclusive global workplace enables employees to do their best work as they create solutions for everyday sustainable living. For more information, please visit https://lyondellbasell.com or follow @LyondellBasell on LinkedIn.
FORWARD-LOOKING STATEMENTS
The statements in this release relating to matters that are not historical facts are forward-looking statements. These forward-looking statements are based upon assumptions of management of LyondellBasell which are believed to be reasonable at the time made and are subject to significant risks and uncertainties. When used in this release, the words “estimate,” “believe,” “continue,” “could,” “intend,” “may,” “plan,” “potential,” “predict,” “should,” “will,” “expect,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. Actual results could differ materially based on factors including, but not limited to, market conditions, including the prolonged industry downturn, the business cyclicality of the chemical and polymers industries; the availability, cost and price volatility of raw materials and utilities, particularly the cost of oil, natural gas, and associated natural gas liquids; our ability to successfully implement initiatives identified pursuant to our Value Enhancement Program and generate anticipated earnings; competitive product and pricing pressures; labor conditions; our ability to attract and retain key personnel; operating interruptions (including leaks, explosions, fires, weather-related incidents, mechanical failure, unscheduled downtime, supplier disruptions, labor shortages, strikes, work stoppages or other labor difficulties, transportation interruptions, spills and releases and other environmental risks); the supply/demand balances for our and our joint ventures’ products; industry production capacities, operating rates, and the pace of global capacity rationalizations; the impacts and scope of the global supply disruption resulting from the conflict in Ukraine and the Middle East; our ability to manage costs; future financial and operating results; our ability to complete capital projects on time and on budget and successfully operate the asset; our ability to align our assets and grow and upgrade our core; our ability to reduce our fixed costs and increase cash flow; legal and environmental proceedings; tax rulings and related consequences or proceedings; the impacts of tariffs and trade disruptions; technological developments, and our ability to develop new products and process technologies; our ability to meet our sustainability goals, including the ability to operate safely, increase production of recycled and renewable-based polymers to meet our targets and forecasts, and reduce our emissions and achieve net zero emissions by the time set in our goals; our ability to procure energy from renewable sources; our ability to build a profitable Circular & Low Carbon Solutions business; our ability to improve the business performance of our Advanced Polymer Solutions segment and its ability to secure new customers; potential governmental regulatory actions; political unrest and terrorist acts; risks and uncertainties posed by international operations, including foreign currency fluctuations; our ability to maintain our investment-grade credit rating and execute our capital allocation strategy, including our ability to pay dividends; and our ability to comply with debt covenants and to repay our debt. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the “Risk Factors” section of our Form 10-K for the year ended December 31, 2025, which can be found at www.LyondellBasell.com on the Investors page and on the Securities and Exchange Commission’s website at www.sec.gov. There is no assurance that any of the actions, events or results of the forward-looking statements will occur, or if any of them do, what impact they will have on our results of operations or financial condition. Forward-looking statements speak only as of the date they were made and are based on the estimates and opinions of management of LyondellBasell at the time the statements are made. LyondellBasell does not assume any obligation to update forward-looking statements should circumstances or management’s estimates or opinions change, except as required by law.
INFORMATION RELATED TO FINANCIAL MEASURES
This release makes reference to certain non-GAAP financial measures as defined in Regulation G of the U.S. Securities Exchange Act of 1934, as amended.
We report our financial results in accordance with U.S. generally accepted accounting principles ("GAAP"), but believe that certain non-GAAP financial measures, such as EBITDA, and EBITDA, net income and diluted EPS exclusive of identified items provide useful supplemental information to investors regarding the underlying business trends and performance of the company's ongoing operations and are useful for period-over-period comparisons of such operations. Non-GAAP financial measures should be considered as a supplement to, and not as a substitute for, or superior to, the financial measures prepared in accordance with GAAP.
We calculate EBITDA as net income (loss) plus interest expense, net, provision for (benefit from) income taxes, and depreciation and amortization. EBITDA should not be considered an alternative to profit or operating profit for any period as an indicator of our performance, or as an alternative to operating cash flows as a measure of our liquidity. We also present EBITDA, net income and diluted EPS exclusive of identified items. Identified items include adjustments for lower of cost or market (“LCM”), gain/loss on sale of business, asset write-downs in excess of $10 million in aggregate for the period, Cash Improvement Plan costs, site closure costs, European transaction costs, net of transition service agreement income, and discontinued operations. Asset write-downs include impairments of goodwill and impairments of long-lived assets. Our inventories are stated at the lower of cost or market. Cost is determined using the last-in, first-out (“LIFO”) inventory valuation methodology, which means that the most recently incurred costs are charged to cost of sales and inventories are valued at the earliest acquisition costs. Fluctuation in the prices of crude oil, natural gas and correlated products from period to period may result in the recognition of charges to adjust the value of inventory to the lower of cost or market in periods of falling prices and the reversal of those charges in subsequent interim periods, within the same fiscal year as the charge, as market prices recover. A gain/loss on sale of a business is calculated as the consideration received from the sale less its carrying value. We evaluate property, plant and equipment and definite-lived intangible assets whenever impairment indicators are present. If it is determined that an asset or asset group’s undiscounted future cash flows will not be sufficient to recover the carrying amount, an impairment charge is recognized to write the asset down to its estimated fair value. Goodwill is tested for impairment annually in the fourth quarter or whenever events or changes in circumstances indicate that the fair value of a reporting unit with goodwill is below its carrying amount. If it is determined that the carrying value of the reporting unit including goodwill exceeds its fair value, an impairment charge is recognized. We assess our equity investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment may not be recoverable. If the decline in value is considered to be other-than-temporary, the investment is written down to its estimated fair value. In June 2025, we announced the divestiture of select olefins and polyolefins assets and the associated businesses in Europe, in May 2026 we completed the divestiture. In connection with the divestiture we recognized selling expenses, separation costs and employee-related charges (collectively referred to as "European transaction costs"), income from the transition service agreement and loss on sale of business. In April 2025, the company announced the Cash Improvement Plan, focused on strengthening financial performance, which resulted in employee-related charges across all segments. In March 2025, we announced the permanent closure of our Dutch PO joint venture asset, resulting in the recognition of shutdown-related charges in our Intermediates & Derivatives ("I&D") segment. Additionally, we recognized shutdown and employee-related charges related to sites in our Advanced Polymer Solutions ("APS") and Olefins & Polyolefins – Europe, Asia, International ("O&P-EAI") segments. In February 2025, we ceased business operations at our Houston refinery. Accordingly, our refining business, previously disclosed as the Refining segment, is reported as a discontinued operation.
These non-GAAP financial measures as presented herein, may not be comparable to similarly titled measures reported by other companies due to differences in the way the measures are calculated. In addition, we include calculations for certain other financial measures to facilitate understanding. This release contains time sensitive information that is accurate only as of the time hereof. Information contained in this release is unaudited and subject to change.
LyondellBasell undertakes no obligation to update the information presented herein except to the extent required by law.
Additional operating and financial information may be found on our website at investors.lyondellbasell.com.
Source: LyondellBasell Industries
Investor Contact: David Dennison +1 713-309-4987
Media Contact: Barrie Lee +1 713-309-4791
Table 2 - Reconciliations of Net Income (Loss) to Net Income Excluding Identified Items and to EBITDA Including and Excluding Identified Items Three Months Ended Nine Months EndedMillions of U.S. dollars September 30, 2026 June 30, 2026 September 30, 2025 September 30, 2026 September 30, 2025Net income (loss) $758 $559 $(890) $1,442 $(598)Identified items add: Loss on sale of business, pre-tax(a) — 734 6 734 6 add: Asset write-downs, pre-tax(b) — 74 1,202 89 1,234 add: Cash Improvement Plan costs, pre-tax(c) 2 31 7 33 27 add: Site closure costs, pre-tax(d) 77 30 — 111 117 add: European transaction costs, net of transition service agreement income, pre-tax(e) (9) (11) 17 (10) 27 less: (Income) loss from discontinued operations, pre-tax 22 17 83 57 (66)less: Benefit from income taxes related to identified items (22) (33) (95) (64) (105)Net income excluding identified items $828 $1,401 $330 $2,392 $642 Net income (loss) $758 $559 $(890) $1,442 $(598)Provision for (benefit from) income taxes 183 232 (49) 409 91 Depreciation and amortization 370 347 350 1,059 1,005 Interest expense, net 109 114 109 330 283 EBITDA 1,420 1,252 (480) 3,240 781 Identified items add: Loss on sale of business(a) — 734 6 734 6 add: Asset write-downs(b) — 74 1,202 89 1,234 add: Cash Improvement Plan costs(c) 2 31 7 33 27 add: Site closure costs(d) 77 30 — 111 117 add: European transaction costs, net of transition service agreement income(e) (9) (11) 17 (10) 27 less: EBITDA from discontinued operations 22 17 83 57 (66)EBITDA excluding identified items $1,512 $2,127 $835 $4,254 $2,126 (a) In May 2026, we disposed of select European O&P assets and the associated businesses, resulting in the recognition of a loss in our O&P-EAI segment. In September 2025, we sold our U.S. specialty powders business, resulting in the recognition of a loss in our APS segment.
(b) Includes asset write-downs in excess of $10 million in aggregate for the period. For the nine months ended September 30, 2026, we recognized non-cash asset write-downs of $89 million, including a $74 million impairment charge recognized in the second quarter related to a plastic waste sorting facility in Houston, Texas, within our Olefins & Polyolefins – Americas segment and $15 million related to property, plant and equipment ("PP&E") in the O&P-EAI segment. For the nine months ended September 30, 2025, we recognized non-cash asset write-downs of $1,234 million, which included non-cash goodwill impairment charges of $400 million in our O&P-EAI segment and $572 million in our APS segment, non-cash impairment charges of $111 million for intangible assets and $99 million for PP&E in our APS segment, and non-cash impairment charges of $43 million for PP&E related to the European assets classified as held for sale within our O&P-EAI segment.
(c) In April 2025, the company announced the Cash Improvement Plan, focused on strengthening financial performance, which resulted in employee-related charges across all segments.
(d) In March 2025, we announced the permanent closure of our Dutch PO joint venture asset, resulting in shutdown-related charges of $76 million and $117 million for the nine months ended September 30, 2026 and 2025, respectively, within our I&D segment. Additionally, for the nine months ended September 30, 2026, we recognized $31 million of employee-related charges related to the planned closure of our polypropylene asset in Brindisi, Italy, within our O&P-EAI segment.
(e) In June 2025, we announced plans to sell select European O&P assets and the associated businesses, resulting in selling expenses, separation costs and employee-related charges in our O&P-EAI segment. Transition service agreement income was $10 million and $18 million, for the three and nine months ended September 30, 2026, respectively.
Table 3 - Reconciliation of Diluted EPS to Diluted EPS Excluding Identified Items Three Months Ended Nine Months Ended September 30,
2026 June 30,
2026 September 30,
2025 September 30,
2026 September 30,
2025Diluted earnings (loss) per share $2.32 $1.71 $(2.77) $4.42 $(1.89)Identified items add: Loss on sale of business — 2.27 0.02 2.27 0.02 add: Asset write-downs(a) — 0.18 3.51 0.21 3.58 add: Cash Improvement Plan costs 0.01 0.07 0.01 0.08 0.06 add: Site closure costs 0.17 0.06 — 0.24 0.27 add: European transaction costs, net of transition service agreement income (0.02) (0.03) 0.05 (0.02) 0.08 less: (Income) loss from discontinued operations 0.06 0.04 0.19 0.14 (0.16)Diluted earnings per share excluding identified items $2.54 $4.30 $1.01 $7.34 $1.96 (a) Includes asset write-downs in excess of $10 million in aggregate for the period.
Table 4 - Calculation of Cash and Liquid Investments and Total Liquidity Millions of U.S. dollars September 30,
2026
Cash and cash equivalents $3,227 Restricted cash 8 Short-term investments — Cash and liquid investments 3,235 add: Availability under Senior Revolving Credit Facility 3,750 Availability under U.S. Receivables Facility 700 Total liquidity $7,685
3 Surging Stocks That Don’t Need the AI Boom to Keep WinningDaVita NYSE: DVA reported third-quarter adjusted operating income of $561 million, adjusted earnings per share of $3.82 and free cash flow of $276 million, while narrowing its full-year 2026 outlook. The kidney-care provider said its Integrated Kidney Care business outperformed expectations, though higher technology spending continued to weigh on U.S. dialysis results.
Chief Executive Officer Javier Rodriguez said the company’s investments in clinical programs, technology and new dialysis treatments were intended to improve patient outcomes while supporting longer-term volume growth. “Our maturing Integrated Kidney Care business is a prime example, as it continues to deliver clinical performance for our patients while starting to demonstrate its economic potential,” Rodriguez said.
Get DaVita alerts:
U.S. Dialysis Volume and Cost Trends How Berkshire Hathaway Performed During Buffett's Final QuarterU.S. dialysis treatment volume rose 1.2% from the third quarter of 2025, while treatments per normalized day increased about 65 basis points year over year. Chief Financial Officer Joel Ackerman said higher patient census, driven primarily by improving mortality, supported the growth. However, an uptick in missed treatments limited the quarterly benefit.
The company expects an approximately 1% headwind to treatment volume in the fourth quarter from year-over-year day mix. Ackerman said DaVita’s fourth-quarter assumptions include missed-treatment trends returning to a more normal pattern and continued benefits from census growth.
Buffett's Latest Portfolio Moves, and Another Secret StockRevenue per treatment increased approximately 1.1% from a year earlier and was roughly flat sequentially. Normal rate increases were partly offset by lower commercial mix and lower phosphate-binder reimbursement. Management said the impact from the expiration of enhanced Affordable Care Act premium tax credits remained in line with expectations and that it continues to anticipate a $40 million year-over-year headwind in 2026.
Patient-care costs per treatment increased 2.4% year over year. While phosphate-binder expenses declined, labor costs rose, and medical supply and professional liability costs were higher than expected. Ackerman said those latter expenses are expected to return to more typical levels over time.
U.S. dialysis general and administrative costs, excluding non-GAAP-adjusted cyber expenses in the prior-year period, rose less than 2%. Technology spending, however, grew more than 20% year over year during the quarter. Rodriguez said DaVita has invested more than $1 billion over recent years to modernize its technology platform, with benefits in areas including mortality, revenue operations, labor productivity, care management and pharmacy costs. The company expects technology investment growth to decelerate, though Ackerman said spending itself is not expected to decline in 2027.
Expanded HD Dialyzer Rollout DaVita said it will begin a national rollout of expanded hemodialysis dialyzers in the following week and expects to transition the vast majority of eligible patients during November. The new dialyzers are compatible with the company’s existing dialysis machines.
The company completed pilot programs at 150 centers involving more than 10,000 patients. Rodriguez said roughly 75% of DaVita’s total patient census is clinically eligible for the therapy, excluding home and acute-care dialysis patients, pediatric patients and patients with acute kidney injury. More than 90% of eligible patients in the pilot adopted the treatment, according to the company.
DaVita said more than 95% of its clinical teammates nationally have been trained on expanded HD. Management does not expect the rollout to have a material net impact on adjusted operating income in 2026 or 2027. It expects the benefit of lower mortality and higher treatment volume growth to begin in the second half of 2028 and increase over time, supporting its goal of returning to volume growth of 2% or more by 2029.
Rodriguez also highlighted fluid-management initiatives, which he said have helped drive mortality improvement. The company reported a 10% improvement in treatments achieving optimal fluid removal, a 5% improvement in patients’ management of weight gain between treatments, and nearly a 5-pound reduction in the average patient’s weight.
Integrated Kidney Care Outperforms Plan DaVita raised its outlook for Integrated Kidney Care, or IKC, and now expects the business to generate at least $65 million in adjusted operating income in 2026. That represents a $45 million improvement from 2025 and at least a $25 million increase from the company’s previous guidance.
Ackerman attributed the outperformance largely to a higher shared-savings rate in the Medicare fee-for-service Comprehensive Kidney Care Contracting program and in value-based contracts with Medicare Advantage insurers. Higher physician payouts tied to shared savings and the launch of a chronic kidney disease program with Humana partly offset those gains.
Rodriguez said DaVita is seeking additional growth opportunities for the business as its clinical, actuarial and technology capabilities mature. The recently announced Humana partnership is expected to expand upstream care to approximately 10,000 chronic kidney disease patients.
Guidance, International Results and Policy Updates DaVita narrowed its full-year 2026 adjusted operating income guidance to $2.175 billion to $2.25 billion and its adjusted EPS outlook to $14.30 to $15.20. The company maintained its free-cash-flow forecast of $1 billion to $1.25 billion.
International adjusted operating income totaled $46 million in the third quarter, up $20 million from a year earlier, primarily due to growth and improved performance in Latin America. The company continues to expect approximately $135 million of international adjusted operating income for the full year.
DaVita repurchased approximately 600,000 shares during the third quarter and another 500,000 shares after quarter-end, including shares from Berkshire Hathaway. Its leverage ratio was 3.38 times consolidated EBITDA at the end of September, roughly unchanged from the preceding quarter.
On policy, management said the Centers for Medicare & Medicaid Services’ final ESRD rule permanently incorporates phosphate binders into the dialysis payment bundle. Ackerman estimated the net full-year 2027 impact to DaVita at approximately 1.5% to 2%, noting that the headline 3.5% increase for large dialysis organizations applies to the first quarter and will be subject to quarterly adjustments thereafter.
Rodriguez said DaVita supports goals in the Department of Health and Human Services’ Kidney Care National Plan, including earlier intervention, disease prevention, transplant access and innovation. He also said the company expects to work with policymakers as the plan’s provisions are developed.
About DaVita (NYSE:DVA)DaVita Inc NYSE: DVA is a health care services company focused on kidney care. Through its DaVita Kidney Care business, the company provides outpatient dialysis treatments for people with chronic kidney failure, including in-center hemodialysis, home dialysis and related clinical support services.
DaVita also offers integrated kidney care programs intended to support patients across the stages of chronic kidney disease. Its services may include care coordination, disease management, education, transplant support and other services designed to improve clinical outcomes and help manage the needs of patients with complex kidney conditions.
The company operates a network of dialysis centers and related facilities in the United States and serves patients in select international markets.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in DaVita Right Now?Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
By You're currently following this author! Click to unsubscribe from email alerts.
Halloween was the busiest single day for ride-hailing companies in 2025, according to Gridwise. Robert Gauthier/Los Angeles Times via Getty Images The busiest day of the year for Uber and Lyft drivers is almost here.
While you might guess that New Year's Eve or St. Patrick's Day would draw the most rider demand as people go out partying, Halloween actually wins the prize for ride-hailing drivers in the US, according to ride volume data and comments from executives.
The culmination of spooky season is likely to be big again this year, with Halloween falling on a Saturday, giving people more time to party — and creating more demand for rides.
Last year, the most ride-hailing trips occurred on October 31, according to Gridwise, a data analytics company. Ride volumes were 23% higher than median rideshare volume for the year, adjusted for day of the week and quarterly seasonal variation, Gridwise said.
The next-busiest days were November 1 and July 3, the day before Independence Day. Ride-hailing volumes were about 20% above the median on each day, Gridwise said. The day after Halloween may be big because rides run late into the night.
How Uber uses AI to charge you more
Halloween kicks off the busiest season of the year for Uber and Lyft. Besides getting a ride home from Halloween parties, riders also request trips to the airport for flights home around Thanksgiving and Christmas.
Earlier this month, Uber offered some drivers hundreds of dollars in bonuses for driving more — a potential sign that the company needs more drivers working as ride demand ramps up.
For Lyft, Halloween 2025 was "our biggest day" and "our biggest week, and not by a little bit," CEO David Risher said a few days after Halloween 2025 on an earnings call last November.
A company spokesperson declined to say how many trips Lyft drivers completed on Halloween but said that it amounted to "millions of rides."
Uber, meanwhile, "hit a new record over Halloween weekend" in 2025, with about 130 million ride-hailing and delivery trips worth $2 billion, CEO Dara Khosrowshahi said on an earnings call last November.
While lucrative, working on Halloween also comes with risks for drivers.
Raymundo Rodriguez, who drives for Uber on the island of Oahu in Hawaii, said he started driving for the app around Halloween two years ago.
There were plenty of riders, he said, but some trips involved dealing with rowdy or drunk passengers. Costumes can also pose risks: One rider dressed as a stripper left glitter on the black leather seats of his car after she got out — a mess that Rodriguez said he had to clean up himself.
This year, Rodriguez said, he's planning to skip driving for the app and take his kids trick-or-treating.
"I don't want nobody throwing up in my car," he said.
Do you have a story idea about Uber? Contact this reporter at [email protected] or via encrypted messaging app Signal at 808-854-4501. Use a personal email address, a nonwork WiFi network, and a nonwork device; here's our guide to sharing information securely.
Read next
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Business Insider tells the innovative stories you want to know
Alex Bitter You're currently following this author! Click to unsubscribe from email alerts.
Alex Bitter is a senior retail reporter covering Uber, Lyft, DoorDash, Instacart, and related companies. His coverage ranges from the experiences of gig workers to what's happening inside the world's biggest ride-hailing and delivery companies.Alex has also written about the retail and food industries. Convenience store chain Sheetz ended its "smile policy" after his reporting. Alex lives in the Washington, DC, area, where you can find him studying ancient coins or searching for Civil War artifacts with his metal detector in his free time.Got a tip? Reach out at [email protected] or via encrypted messaging app Signal at +1 (808) 854-4501.
Third quarter 2026 revenues increased 36% to $5.1 billion versus third quarter 2025Dupixent® global net sales (recorded by Sanofi) increased 35% to $6.5 billionEYLEA HD® U.S. net sales increased 62% to $699 millionLibtayo® global net sales increased 51% to $550 millionGAAP EPS increased 35% to $18.45; non-GAAP EPS(a) increased 70% to $20.07Expanded collaboration with Sanofi, adding multiple next-generation, long-acting immunology antibodies; $1.0 billion up-front to be recognized as collaboration revenue in fourth quarter 2026 with potential to receive up to an additional $7.0 billion in future milestonesPasatru™ (garetosmab) approved by FDA for fibrodysplasia ossificans progressiva (FOP) TARRYTOWN, N.Y., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) today announced financial results for the third quarter of 2026 and provided a business update.
"This was an outstanding quarter for Regeneron, with Dupixent, EYLEA HD, and Libtayo each achieving record net sales," said Leonard S. Schleifer, M.D., Ph.D., Board co-Chair, President and Chief Executive Officer of Regeneron. "Our pipeline of about 50 product candidates is rapidly advancing. We expect an FDA decision for cemdisiran in generalized myasthenia gravis next month; our Phase 3 programs in multiple myeloma, lymphoma, anticoagulation, and obesity continue to advance; and we have generated encouraging early data in MASH, POTS, and ovarian cancer. Finally, we expanded our alliance with Sanofi to include four Regeneron-invented, next-generation, long-acting antibodies designed to build on the success of Dupixent."
Financial Highlights
($ in millions, except per share data) Q3 2026
Q3 2025
% ChangeTotal revenues $5,116 $3,754 36% GAAP net income $1,949 $1,460 33% GAAP net income per share - diluted $18.45 $13.62 35% Non-GAAP net income(a) $2,150 $1,287 67% Non-GAAP net income per share - diluted(a) $20.07 $11.83 70% "We are pleased with our third quarter financial results, which marked our third consecutive quarter of double-digit growth in both revenue and non-GAAP EPS," said Christopher Fenimore, Executive Vice President, Finance and Chief Financial Officer of Regeneron. "Strong commercial execution across our portfolio, together with the anticipated step-up in Sanofi collaboration revenue in the first full quarter following repayment of the Development Balance, drove a 36% increase in total revenues and a 70% increase in non-GAAP EPS, positioning us to deliver one of our strongest years ever."
Business Highlights
Key Pipeline Progress
Regeneron has approximately 50 product candidates in clinical development, including a number of marketed products for which it is investigating additional indications. Updates from the clinical pipeline include:
Libtayo (cemiplimab)
In August 2026, the Ministry of Health, Labour and Welfare (MHLW) in Japan approved Libtayo as an adjuvant treatment for cutaneous squamous cell carcinoma (CSCC) and for the treatment of metastatic or locally advanced CSCC. These indications are already approved in the United States and European Union (EU).In October 2026, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending the approval of an alternative dosing schedule for Libtayo across all approved indications. The positive opinion supports reducing Libtayo dosing frequency from every three weeks to every six weeks after the first 12 weeks of treatment. The European Commission (EC) is expected to make a final decision in the coming months. There is also a supplemental Biologics License Application (sBLA) under review by the U.S. Food and Drug Administration (FDA), which has a target action date in March 2027.In October 2026, the Company announced longer-term data which showed increasing and clinically meaningful overall survival benefit for Libtayo as an adjuvant treatment for patients with CSCC. The results were presented at the European Society for Medical Oncology (ESMO) 2026 Meeting. Other Oncology Programs
The FDA accepted for review the resubmission of the BLA for Ordspono™ (odronextamab) in relapsed or refractory diffuse large B-cell lymphoma (DLBCL), which has a target action date in February 2027.The Company announced that ubamatamab (MUC16 and CD3 bispecific antibody) showed a high rate of durable responses in an initial study in patients with advanced low-grade serous ovarian cancer (LGSOC). The data are from an ongoing Phase 1/2 trial and were presented at the International Gynecologic Cancer Society (IGCS) 2026 Annual Global Meeting. Based on these preliminary trial results, the Company has been enrolling a single-arm, potentially registrational LGSOC trial and is planning to initiate a confirmatory Phase 3 trial in this setting. Pasatru (garetosmab)
In August 2026, the FDA approved Pasatru to reduce formation of new heterotopic ossification lesions and clinician-assessed flare-ups in adults with FOP. A regulatory application is also under review in the EU.The Company announced positive 84-week results from the Phase 3 trial for Pasatru in adults with FOP. These longer-term findings demonstrated sustained efficacy in halting new, rogue bone growth and in significantly reducing disease flare-ups, and were presented at the American Society for Bone and Mineral Research (ASBMR) Annual Meeting. Other Programs
A three-arm, placebo-controlled Phase 3 study was initiated to evaluate cenvacibart (an antibody to Factor XI (catalytic domain)), and amrecibart (an antibody to Factor XI (A2 domain)), individually, for the prevention of venous thromboembolism in patients with a peripherally inserted central catheter (PICC).The Company has an ongoing Phase 1/2 study for its RNAi therapy targeting CIDEB. Interim results from this randomized, placebo-controlled, first-in-human trial in adults with metabolic dysfunction-associated steatotic liver disease (MASLD) showed that a single dose was generally well tolerated and reduced liver fat by approximately 70% on average from baseline at 12 weeks, with effects sustained through 24 weeks of follow-up. The Company plans to present interim results at the American Association for the Study of Liver Diseases (AASLD) Meeting in November 2026 and to initiate a Phase 3 study in metabolic dysfunction-associated steatohepatitis (MASH)/MASLD in the fourth quarter of 2026.The Company plans to report results from the Phase 2 study for baloncibart (NPR1 antagonist antibody) in postural orthostatic tachycardia syndrome (POTS) at the American Autonomic Society (AAS) Meeting in November 2026. Additionally, the Company plans to initiate a Phase 3 study in POTS in the first half of 2027, pending regulatory feedback.The Company announced new results from the Phase 2 COURAGE trial evaluating trevogrumab (myostatin antibody) for its potential to prevent lean mass and muscle loss during GLP-1 receptor agonist-induced weight loss in people living with obesity. The results of the trial were presented at the European Association for the Study of Diabetes (EASD) Annual Meeting.A second Phase 3 study was initiated for REGN1908-1909, an investigational treatment for cat allergy. Corporate Updates
In October 2026, the Company and Sanofi amended their antibody collaboration, adding multiple next-generation, long-acting Regeneron-invented antibodies to the alliance. Under the terms of the agreement, the Company received an up-front payment of $1.0 billion, and is entitled to receive up to an additional $7.0 billion in the aggregate upon the achievement of certain development, regulatory, and sales-based milestones. The companies will equally share development and commercialization costs for the new programs, and, if commercialized, share any future profits equally on a global basis.In October 2026, the Company announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) to provide additional supply of Inmazeb® for U.S. preparedness against Ebola disease. Under the terms of the agreement, the Company expects to deliver a pre-specified number of treatment doses of Inmazeb each year to the U.S. government beginning in 2027 through 2031. Third Quarter 2026 Financial Results
Revenues
($ in millions) Q3 2026
Q3 2025
% ChangeNet product sales: EYLEA HD - U.S. $699 $431 62% EYLEA® - U.S. 400 681 (41%)Total EYLEA HD and EYLEA - U.S. 1,099 1,112 (1%)Libtayo - U.S. 396 219 81% Libtayo - ROW* 154 146 5% Total Libtayo - Global 550 365 51% Praluent® - U.S. 81 67 21% Evkeeza® - U.S. 55 43 28% Lynozyfic® - Global 19 1 ** Other products - Global 1 — ** Total net product sales 1,805 1,588 14% Collaboration revenue: Sanofi 2,724 1,617 68% Bayer 267 345 (23%)Other 10 6 67% Other revenue 310 198 57% Total revenues $5,116 $3,754 36% * Rest of world (ROW)** Percentage not meaningful or greater than 100% EYLEA HD U.S. net product sales increased in the third quarter of 2026, compared to the third quarter of 2025, primarily due to higher sales volumes driven by increased demand, partly offset by a lower net selling price.
EYLEA U.S. net product sales decreased in the third quarter of 2026, compared to the third quarter of 2025, primarily due to lower sales volumes as a result of continued competitive pressures and the continued transition of patients to EYLEA HD.
Libtayo U.S. net product sales increased in the third quarter of 2026, compared to the third quarter of 2025, primarily due to higher sales volumes driven by increased demand.
Sanofi collaboration revenue increased in the third quarter of 2026, compared to the third quarter of 2025, due to an increase in the Company's share of profits from the commercialization of antibodies, which were $2.575 billion and $1.456 billion in the third quarter of 2026 and 2025, respectively. The increase in the Company's share of profits from the commercialization of antibodies was driven by higher profits primarily associated with an increase in Dupixent sales. In addition, the Sanofi Development Balance was fully repaid as of the end of the second quarter of 2026 and no longer reduced Sanofi collaboration revenue beginning in the third quarter of 2026.
Refer to Table 4 for a summary of collaboration revenue.
Operating Expenses
GAAP %
Change Non-GAAP(a) %
Change($ in millions) Q3 2026 Q3 2025 Q3 2026 Q3 2025 Research and development (R&D) $1,795 $1,475 22% $1,654 $1,350 23% Acquired in-process research and development (IPR&D) $22 $83 (73%) * * * Selling, general, and administrative (SG&A) $678 $658 3% $588 $541 9% Cost of goods sold (COGS) $322 $281 15% $246 $227 8% Gross margin on net product sales(b) 82% 82% 86% 86% Cost of collaboration and contract manufacturing (COCM)(c) $252 $241 5% * * * Other operating (income) expense, net $— $(10) (100%) * * * * GAAP and non-GAAP amounts are equivalent as no non-GAAP adjustments have been recorded GAAP and non-GAAP R&D expenses increased in the third quarter of 2026, compared to the third quarter of 2025, driven by the advancement of the Company's clinical pipeline and increased manufacturing activity associated with the Company's product candidates.
Other Financial Information
GAAP other income (expense), net decreased in the third quarter of 2026, compared to the third quarter of 2025, primarily due to lower net gains on marketable and other securities.
In the third quarter of 2026, the Company's GAAP effective tax rate (ETR) was 14.7%, compared to 17.2% in the third quarter of 2025. The GAAP ETR for the third quarter of 2025 was negatively impacted by the enactment of the "One Big Beautiful Bill Act" or "OBBBA," including a $45 million charge related to the re-measurement of the Company's U.S. net deferred tax assets. In the third quarter of 2026, the non-GAAP ETR was 15.0%, compared to 13.1% in the third quarter of 2025.
A reconciliation of the Company's GAAP to non-GAAP results is included in Table 3 of this press release.
Capital Allocation
During the nine months ended September 30, 2026, the Company repurchased $2.3 billion of its common stock. As of September 30, 2026, $2.2 billion remained available for share repurchases under the Company's share repurchase programs.
In October 2026, the Company declared a cash dividend of $0.94 per share on the Company's common stock and Class A stock, payable on December 3, 2026 to shareholders of record as of November 20, 2026.
2026 Financial Guidance*
The Company's full year 2026 financial guidance consists of the following components:
2026 Guidance Prior UpdatedGAAP R&D $6.500–$6.635 billion $6.600–$6.735 billionNon-GAAP R&D(a) $5.950–$6.050 billion $6.050–$6.150 billionGAAP SG&A $2.830–$2.960 billion $2.730–$2.860 billionNon-GAAP SG&A(a) $2.500–$2.600 billion $2.400–$2.500 billionGAAP gross margin on net product sales 78%–79% Approximately 80%Non-GAAP gross margin on net product sales(a) 84%–85% Approximately 86%GAAP COCM $985 million–$1.035 billion UnchangedNon-GAAP COCM(a) $970 million–$1.020 billion UnchangedCapital expenditures $1.030–$1.100 billion $1.050–$1.100 billionGAAP effective tax rate 13%–14% Approximately 14%Non-GAAP effective tax rate(a) 14%–15% Approximately 15% * The Company's 2026 financial guidance does not assume the completion of any business development transactions not completed as of the date of this press release A reconciliation of full year 2026 GAAP to non-GAAP financial guidance is included below:
Projected Range($ in millions) Low HighGAAP R&D $6,600 $6,735 Stock-based compensation expense (550) (580)Other — (5)Non-GAAP R&D(a) $6,050 $6,150 GAAP SG&A $2,730 $2,860 Stock-based compensation expense (325) (350)Other* (5) (10)Non-GAAP SG&A(a) $2,400 $2,500 GAAP gross margin on net product sales 80% 80% Stock-based compensation expense 1% 1% Other** 5% 5% Non-GAAP gross margin on net product sales(a) 86% 86% GAAP COCM $985 $1,035 Temporary manufacturing interruption-related costs (15) (15)Non-GAAP COCM(a) $970 $1,020 GAAP ETR 14% 14% Income tax effect of GAAP to non-GAAP reconciling items 1% 1% Income tax expense: Shortfall from stock-based compensation (<1%) (<1%)Non-GAAP ETR(a) 15% 15% * Includes litigation settlements and other costs** Includes intangible asset amortization and temporary manufacturing interruption-related costs (a)This press release uses non-GAAP R&D, non-GAAP SG&A, non-GAAP COGS, non-GAAP gross margin on net product sales, non-GAAP COCM, non-GAAP other income (expense), net, non-GAAP ETR, non-GAAP net income, non-GAAP net income per share, and free cash flow, which are financial measures that are not calculated in accordance with U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures are computed by excluding certain non-cash and/or other items from the related GAAP financial measure. The Company also includes a non-GAAP adjustment for the estimated income tax effect of reconciling items. A reconciliation of the Company's GAAP to non-GAAP results is included in Table 3 of this press release.The Company makes such adjustments for items the Company does not view as useful in evaluating its operating performance. For example, adjustments may be made for items that fluctuate from period to period based on factors that are not within the Company's control (such as the Company's stock price on the dates share-based grants are issued or changes in the fair value of the Company's investments in equity securities) or items that are not associated with normal, recurring operations (such as acquisition and integration costs). Management uses these non-GAAP measures for planning, budgeting, forecasting, assessing historical performance, and making financial and operational decisions, and also provides forecasts to investors on this basis. With respect to free cash flow, the Company believes that this non-GAAP measure provides a further measure of the Company's ability to generate cash flows from its operations. Additionally, the non-GAAP measures presented are intended to provide investors with an enhanced understanding of the financial performance of the Company's core business operations. However, there are limitations in the use of these and other non-GAAP financial measures as they exclude certain expenses that are recurring in nature. Furthermore, the Company's non-GAAP financial measures may not be comparable with non-GAAP information provided by other companies. Any non-GAAP financial measure presented by the Company should be considered supplemental to, and not a substitute for, measures of financial performance prepared in accordance with GAAP.
(b)Gross margin on net product sales represents gross profit expressed as a percentage of total net product sales recorded by the Company. Gross profit is calculated as net product sales less cost of goods sold. (c)Corresponding reimbursements from collaborators and others for manufacturing product is recorded within revenues. Conference Call Information
Regeneron will host a conference call and simultaneous webcast to discuss its third quarter 2026 financial and operating results on Friday, October 30, 2026, at 8:30 AM Eastern Time. Participants may access the conference call live via webcast, or register in advance and participate via telephone, on the "Investors and Media" page of Regeneron's website at www.regeneron.com. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can be used to access the call. A replay and transcript of the conference call and webcast will be archived on the Company's website for at least 30 days.
About Regeneron
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, Regeneron's unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in Regeneron's laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.
Regeneron pushes the boundaries of scientific discovery and accelerates drug development using its proprietary technologies, such as VelociSuite®, which produces optimized fully human antibodies and new classes of bispecific antibodies. Regeneron is shaping the next frontier of medicine with data-powered insights from the Regeneron Genetics Center® and pioneering genetic medicine platforms, enabling Regeneron to identify innovative targets and complementary approaches to potentially treat or cure diseases.
For more information, please visit www.regeneron.com or follow Regeneron on LinkedIn, Instagram, Facebook, or X.
Forward-Looking Statements and Use of Digital Media
This press release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company"), and actual events or results may differ materially from these forward-looking statements. Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words. These statements concern, and these risks and uncertainties include, among others, competing products and product candidates (including biosimilar products) that may be superior to, or more cost effective than, products marketed or otherwise commercialized by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Products") and product candidates being developed by Regeneron and/or its collaborators or licensees (collectively, "Regeneron's Product Candidates"); uncertainty of the utilization, market acceptance, and commercial success of Regeneron's Products and Regeneron's Product Candidates and the impact of studies (whether conducted by Regeneron or others and whether mandated or voluntary) or recommendations and guidelines from governmental authorities and other third parties or other factors beyond Regeneron's control on the commercial success of Regeneron's Products and Regeneron's Product Candidates; the nature, timing, and possible success and therapeutic applications of Regeneron's Products and Regeneron's Product Candidates and research and clinical programs now underway or planned, including without limitation EYLEA HD® (aflibercept) Injection 8 mg, EYLEA® (aflibercept) Injection, Dupixent® (dupilumab), Libtayo® (cemiplimab), Praluent® (alirocumab), Kevzara® (sarilumab), Evkeeza® (evinacumab), Veopoz® (pozelimab), Ordspono™ (odronextamab), Lynozyfic® (linvoseltamab), Otarmeni® (lunsotogene parvec), Pasatru™ (garetosmab), other clinical programs discussed in this press release, Regeneron's and its collaborators' earlier-stage programs, and the use of human genetics in Regeneron's research programs; the likelihood and timing of achieving any of the anticipated milestones described in this press release; safety issues resulting from the administration of Regeneron's Products and Regeneron's Product Candidates in patients, including serious complications or side effects in connection with the use of Regeneron’s Products and Regeneron's Product Candidates in clinical trials; the likelihood, timing, and scope of possible regulatory approval and commercial launch of Regeneron's Product Candidates and new indications for Regeneron's Products, including those listed above and/or otherwise discussed in this press release; the extent to which the results from the research and development programs conducted by Regeneron and/or its collaborators may be replicated in other studies and/or lead to advancement of product candidates to clinical trials, therapeutic applications, or regulatory approval; ongoing regulatory obligations and oversight impacting Regeneron's Products, research and clinical programs, and business, including those relating to patient privacy; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's Products and Regeneron's Product Candidates; the ability of Regeneron to manufacture and manage supply chains for multiple products and product candidates and risks associated with tariffs and other trade restrictions; the ability of Regeneron’s collaborators, suppliers, or other third parties (as applicable) to perform manufacturing, filling, finishing, packaging, labeling, distribution, and other steps related to Regeneron’s Products and Regeneron's Product Candidates; the availability and extent of reimbursement or copay assistance for Regeneron’s Products from third-party payors and other third parties, including private payor healthcare and insurance programs, health maintenance organizations, pharmacy benefit management companies, and government programs such as Medicare and Medicaid; coverage and reimbursement determinations by such payors and other third parties and new policies and procedures adopted by such payors and other third parties; changes to drug pricing regulations and requirements and Regeneron's drug pricing strategy, including in connection with Regeneron's April 2026 agreements with the U.S. government; other changes in laws, regulations, and policies affecting the healthcare industry; unanticipated expenses; the costs of developing, producing, and selling products; the ability of Regeneron to meet any of its financial projections or guidance and changes to the assumptions underlying those projections or guidance, including GAAP and non-GAAP R&D, GAAP and non-GAAP SG&A, GAAP and non-GAAP gross margin on net product sales, GAAP and non-GAAP COCM, capital expenditures, and GAAP and non-GAAP ETR; the potential for any license or collaboration agreement, including Regeneron's agreements with Sanofi and Bayer (or their respective affiliated companies, as applicable), to be cancelled or terminated; the impact of public health outbreaks, epidemics, or pandemics on Regeneron's business; and risks associated with litigation and other proceedings and government investigations relating to the Company and/or its operations (including the pending civil proceedings initiated or joined by the U.S. Department of Justice and the U.S. Attorney's Office for the District of Massachusetts), risks associated with intellectual property of the Company or other parties and pending or future litigation or patent office proceedings relating thereto (including without limitation patent litigation and other related proceedings relating to Regeneron's Products), the ultimate outcome of any such proceedings and investigations, and the impact any of the foregoing may have on Regeneron’s business, prospects, operating results, and financial condition. A more complete description of these and other material risks can be found in Regeneron's filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the fiscal year ended December 31, 2025 and its Form 10-Q for the quarterly period ended September 30, 2026. Any forward-looking statements are made based on management's current beliefs and judgment, and the reader is cautioned not to rely on any forward-looking statements made by Regeneron. Regeneron does not undertake any obligation to update (publicly or otherwise) any forward-looking statement, including without limitation any financial projection or guidance, whether as a result of new information, future events, or otherwise.
Regeneron uses its media and investor relations website and social media outlets to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Regeneron is routinely posted and is accessible on Regeneron's media and investor relations website (https://investor.regeneron.com) and its LinkedIn page (https://www.linkedin.com/company/regeneron-pharmaceuticals).
Non-GAAP Financial Measures
This press release and/or the financial results attached to this press release include amounts that are considered "non-GAAP financial measures" under SEC rules. As required, Regeneron has provided reconciliations of such non-GAAP financial measures.
Contact Information: Ryan Crowe Christina Chan Investor Relations Corporate Affairs 914-847-8790 914-847-8827 [email protected][email protected]
TABLE 1
REGENERON PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions)
September 30,
December 31,
2026
2025
Assets: Cash and marketable securities $18,858.5 $18,865.8 Accounts receivable, net 7,578.6 5,741.1 Inventories 2,894.6 3,200.8 Property, plant, and equipment, net 5,727.5 5,120.4 Intangible assets, net 1,315.5 1,257.4 Deferred tax assets 4,535.6 4,077.2 Other assets 3,494.9 2,296.0 Total assets $44,405.2 $40,558.7 Liabilities and stockholders' equity: Accounts payable, accrued expenses, and other liabilities $7,229.7 $5,834.2 Finance lease liabilities 720.0 720.0 Deferred revenue 970.0 761.7 Long-term debt 1,987.0 1,985.9 Stockholders' equity 33,498.5 31,256.9 Total liabilities and stockholders' equity $44,405.2 $40,558.7
TABLE 2
REGENERON PHARMACEUTICALS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except per share data)
Three Months Ended
September 30, Nine Months Ended
September 30, 2026 2025 2026 2025Revenues: Net product sales $1,805.3 $1,587.7 $4,982.2 $4,634.3 Collaboration revenue 3,000.5 1,968.4 7,355.2 5,360.3 Other revenue 310.0 198.2 674.5 464.0 5,115.8 3,754.3 13,011.9 10,458.6 Expenses: Research and development 1,794.7 1,475.0 4,969.8 4,224.1 Acquired in-process research and development 21.5 83.1 250.4 105.4 Selling, general, and administrative 677.8 657.8 1,987.6 1,925.0 Cost of goods sold 321.7 281.0 1,055.8 822.1 Cost of collaboration and contract manufacturing 251.9 240.6 763.7 694.0 Other operating (income) expense, net — (10.0) — (10.0) 3,067.6 2,727.5 9,027.3 7,760.6 Income from operations 2,048.2 1,026.8 3,984.6 2,698.0 Other income (expense): Other income (expense), net 246.5 755.8 693.0 1,520.6 Interest expense (10.6) (19.3) (34.5) (31.6) 235.9 736.5 658.5 1,489.0 Income before income taxes 2,284.1 1,763.3 4,643.1 4,187.0 Income tax expense 335.4 303.3 670.3 526.7 Net income $1,948.7 $1,460.0 $3,972.8 $3,660.3 Net income per share - basic $19.16 $14.09 $38.65 $34.83 Net income per share - diluted $18.45 $13.62 $37.37 $33.61 Weighted average shares outstanding - basic 101.7 103.6 102.8 105.1 Weighted average shares outstanding - diluted 105.6 107.2 106.3 108.9
TABLE 3
REGENERON PHARMACEUTICALS, INC.
RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (Unaudited)
(In millions, except per share data) Three Months Ended
September 30, Nine Months Ended
September 30, 2026 2025 2026 2025GAAP R&D $1,794.7 $1,475.0 $4,969.8 $4,224.1 Stock-based compensation expense (140.3) (125.1) (406.2) (405.1)Other costs (0.6) — (1.2) — Non-GAAP R&D $1,653.8 $1,349.9 $4,562.4 $3,819.0 GAAP SG&A $677.8 $657.8 $1,987.6 $1,925.0 Stock-based compensation expense (86.6) (92.0) (261.3) (279.0)Litigation settlements — (25.0) 5.0 (25.0)Other costs (2.9) — (8.8) (0.8)Non-GAAP SG&A $588.3 $540.8 $1,722.5 $1,620.2 GAAP COGS $321.7 $281.0 $1,055.8 $822.1 Stock-based compensation expense (28.9) (19.9) (88.7) (60.3)Intangible asset amortization expense (47.1) (33.7) (130.3) (94.8)Temporary manufacturing interruption-related costs — — (161.3) — Non-GAAP COGS $245.7 $227.4 $675.5 $667.0 GAAP COCM $251.9 $240.6 $763.7 $694.0 Temporary manufacturing interruption-related costs — — (14.8) — Non-GAAP COCM $251.9 $240.6 $748.9 $694.0 GAAP other income (expense), net $235.9 $736.5 $658.5 $1,489.0 Gains on marketable and other securities, net (60.3) (577.7) (147.2) (967.6)Non-GAAP other income (expense), net $175.6 $158.8 $511.3 $521.4 GAAP net income $1,948.7 $1,460.0 $3,972.8 $3,660.3 Total of GAAP to non-GAAP reconciling items above 246.1 (282.0) 920.4 (102.6)Income tax effect of GAAP to non-GAAP reconciling items (48.8) 64.7 (170.6) 37.0 Income tax expense: Shortfall from stock-based compensation 4.0 — 10.1 — Income tax expense: Charge related to enactment of OBBBA — 44.5 — 44.5 Non-GAAP net income $2,150.0 $1,287.2 $4,732.7 $3,639.2 Non-GAAP net income per share - basic $21.14 $12.42 $46.04 $34.63 Non-GAAP net income per share - diluted $20.07 $11.83 $43.70 $32.87 Shares used in calculating: Non-GAAP net income per share - basic 101.7 103.6 102.8 105.1 Non-GAAP net income per share - diluted 107.1 108.8 108.3 110.7 RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL INFORMATION (Unaudited) (continued)
Three Months Ended
September 30, Nine Months Ended
September 30, 2026 2025 2026 2025Effective tax rate reconciliation: GAAP ETR 14.7% 17.2% 14.4% 12.6% Income tax effect of GAAP to non-GAAP reconciling items 0.4% (2.4%) 0.6% (0.8%)Income tax expense: Shortfall from stock-based compensation (0.1%) —% (0.1%) —% Income tax expense: Charge related to enactment of OBBBA —% (1.7%) —% (0.9%)Non-GAAP ETR 15.0% 13.1% 14.9% 10.9% Gross margin on net product sales reconciliation: GAAP gross margin on net product sales 82% 82% 79% 82% Stock-based compensation expense 2% 2% 2% 2% Intangible asset amortization expense 2% 2% 2% 2% Temporary manufacturing interruption-related costs —% —% 3% —% Non-GAAP gross margin on net product sales 86% 86% 86% 86% Nine Months Ended
September 30, 2026 2025 Free cash flow reconciliation: Net cash provided by operating activities $3,675.3 $3,808.2 Capital expenditures (771.0) (649.7) Free cash flow $2,904.3 $3,158.5
TABLE 4
REGENERON PHARMACEUTICALS, INC.
COLLABORATION REVENUE (Unaudited)
(In millions)
Three Months Ended
September 30,
Nine Months Ended
September 30,
2026 2025 2026 2025Sanofi collaboration revenue: Regeneron's share of profits in connection with commercialization of antibodies $2,574.9 $1,455.5 $6,058.3 $3,755.7 Reimbursement for manufacturing of commercial supplies 149.1 161.5 445.1 488.1 Total Sanofi collaboration revenue 2,724.0 1,617.0 6,503.4 4,243.8 Bayer collaboration revenue: Regeneron's share of profits in connection with commercialization of EYLEA 8 mg and EYLEA outside the United States 211.5 311.9 678.8 1,012.6 Reimbursement for manufacturing of commercial supplies 55.3 32.9 151.5 91.1 Total Bayer collaboration revenue 266.8 344.8 830.3 1,103.7 Other collaboration revenue 9.7 6.6 21.5 12.8 Total collaboration revenue $3,000.5 $1,968.4 $7,355.2 $5,360.3
TABLE 5
REGENERON PHARMACEUTICALS, INC.
NET PRODUCT SALES OF REGENERON-DISCOVERED PRODUCTS (Unaudited)
(In millions) Three Months Ended
September 30, 2026 2025 % Change U.S. ROW Total U.S. ROW Total (Total Sales)Dupixent(a) $5,064.1 $1,476.4 $6,540.5 $3,618.8 $1,238.2 $4,857.0 35% EYLEA HD(b) $698.8 $384.0 $1,082.8 $430.6 $232.4 $663.0 63% EYLEA(b) $399.7 $258.7 $658.4 $680.6 $621.4 $1,302.0 (49%)Total EYLEA HD and EYLEA $1,098.5 $642.7 $1,741.2 $1,111.2 $853.8 $1,965.0 (11%)Libtayo(c) $395.8 $154.2 $550.0 $219.1 $146.1 $365.2 51% Praluent(d) $81.5 $179.4 $260.9 $67.7 $148.0 $215.7 21% Kevzara(a) $192.7 $62.9 $255.6 $102.9 $51.1 $154.0 66% Lynozyfic $18.6 $0.4 $19.0 $0.8 $— $0.8 * Other products(e) $56.2 $35.1 $91.3 $43.1 $28.0 $71.1 28% Nine Months Ended
September 30, 2026 2025 % Change U.S. ROW Total U.S. ROW Total (Total Sales)Dupixent(a) $13,183.6 $4,235.2 $17,418.8 $9,453.2 $3,414.0 $12,867.2 35% EYLEA HD(b) $1,763.5 $1,082.8 $2,846.3 $1,130.6 $620.5 $1,751.1 63% EYLEA(b) $1,285.0 $955.1 $2,240.1 $2,170.9 $2,068.8 $4,239.7 (47%)Total EYLEA HD and EYLEA $3,048.5 $2,037.9 $5,086.4 $3,301.5 $2,689.3 $5,990.8 (15%)Libtayo(c) $1,024.5 $453.1 $1,477.6 $659.4 $367.4 $1,026.8 44% Praluent(d) $222.8 $549.4 $772.2 $190.3 $440.7 $631.0 22% Kevzara(a) $436.6 $169.7 $606.3 $271.4 $151.2 $422.6 43% Lynozyfic $45.5 $1.2 $46.7 $0.8 $— $0.8 * Other products(e) $187.3 $95.0 $282.3 $116.3 $81.5 $197.8 43% Note: The table above includes net product sales of Regeneron-discovered products. Such net product sales are recorded by the Company or others, as further described in the footnotes below.* Percentage not meaningful or greater than 100%(a) Sanofi records global net product sales of Dupixent and Kevzara, and the Company records its share of profits in connection with global sales of such products within Collaboration revenue(b) The Company records net product sales of EYLEA HD and EYLEA in the United States, and Bayer records net product sales outside the United States. The Company records its share of profits in connection with sales outside the United States within Collaboration revenue.(c) The Company records global net product sales of Libtayo and pays Sanofi a royalty on such sales(d) The Company records net product sales of Praluent in the United States. Sanofi records net product sales of Praluent outside the United States and pays the Company a royalty on such sales, which is recorded within Other revenue.(e) Included in this line item are products which are sold by the Company and others. Refer to "Third Quarter 2026 Financial Results" section above for a listing of net product sales recorded by the Company. Not included in this line item are net product sales of ARCALYST®, which are recorded by Kiniksa.
Eli Lilly delivered standout 3Q26 results, with 39% revenue growth to $24.4B, driven by Mounjaro and Zepbound franchises. LLY's growth story is increasingly diversified, with Foundayo, Retatrutide, and the Medicare Bridge program offering additional revenue expansion paths. Management raised FY26 revenue guidance by $5.5B, but valuation remains demanding at 37.4x forward earnings and 13.5x forward sales.
It's easy to point to Lockheed Martin's (LMT +2.20%) soaring order backlog, up to $292 billion in the third quarter from $194 billion at the start of the year, and lazily conclude that the stock is worth buying. However, the number only tells part of the story because it's improving not only in quantity but also in quality. Here's why both factors support buying the stock.
The following table shows each Lockheed Martin segment and how backlog has increased in each one through 2026. The first point to note is that Lockheed's backlog is increasing in its highest margin segment: missiles and fire control (MFC). This implies the company's profit margin will improve as its backlog turns into revenue.
Segment
Backlog End of 2025
Backlog End of September 2026
Backlog Increase
Operating Profit 2025
Operating Margin 2025
Aeronautics
$59,435 million
$57,331 million
($2,104) million
$2,086 million
6.9%
Missiles and Fire Control
$46,650 million
$142,517 million
$95,867 million
$1,989 million
13.8%
Rotary and Mission Systems
$47,715 million
$49,435 million
$1,720 million
$1,323 million
7.6%
Space
$39,822 million
$42,701 million
$2,879 million
$1,345 million
10.3%
Data source: Lockheed Martin presentations.
Reducing execution risk
The increase in the MFC backlog also implies a reduction in overall risk. To understand why, you first have to appreciate the many issues that defense companies, including Lockheed Martin, Boeing, and RTX, have had in recent years in delivering on complex fixed-price development programs for the Department of Defense. In a nutshell, many of these contracts have caused multibillion-dollar charges and losses at defense companies, as well as friction exemplified by the presidential executive order issued in January that instructed the Secretary of War to "identify any defense contractors for critical weapons, supplies, and equipment that are underperforming on their contracts" and take action that could result in restricting share buybacks or dividends.
LMT Lockheed Martin$643.59+$13.84 (+2.20%)
NYSE · As of 4:00 PM ET 10/29/26
As such, defense contractors would ideally prefer to:
Increase their backlogs in relatively less complex contracts that tend to involve producing tried and tested technologies rather than highly complex programs that require significant research and development risk.
Improve the conditions on which they do agree on more complex contracts.
The evidence from the third quarter is that Lockheed did both, and the recent update went a long way to placate fears over the risk in its government contracts.
First, as Chief Financial Officer Evan Scott noted on the earnings call: "The largest contributor in the quarter was the PAC-3 seven-year contract, which brings that multiyear contract to a total value of up to $58.6 billion." The Patriot Advanced Capability (PAC-3) is a missile defense system. It's a mature technology, so producing it carries little development risk. Too be sure, there are significant execution risks around it, not least in ensuring its supply chain is healthy. Still, it's nowhere near the overall risk of a brand new development program.
Improving defense contract conditions
Second, it appears that defense companies and the DoD are refining their contractual relationships toward a more mutually beneficial model centered on long-term agreements that enable defense contractors and their suppliers to invest with greater confidence. Chief Executive Officer Jim Taiclet said that key provisions include long-term duration (the PAC-3 deal is more than seven years), fixed-price escalators (including an inflation escalator adjusted for "the industry that we're in"), cash flow neutrality (government provides up-front payments to cover Lockheed's expansion costs before it delivers defense products), and cancellation protections (a recovery mechanism to protect Lockheed from a future administration reducing orders).
Image source: Getty Images.
Where next for Lockheed Martin
The backlog is soaring; the profit margin in it is likely rising too, and the risk in its backlog and overall business is falling. Meanwhile, defense contractors and the DoD appear to be building a more mutually beneficial relationship. Although there are still execution risks to overcome, there are clear improvements in Lockheed's prospects, with the company trading at 22 times earnings and 18.6 times free cash flow expectations for 2026. Lockheed looks like a good value for defense-focused investors.
Medical device maker Stryker (NYSE:SYK | SYK Price Prediction) shares fell about 10% before the open Friday to $279.98, compared with Thursday's close of $311.75. The quarter missed expectations on both lines.
Republic Services, Inc. (RSG) Q3 2026 Earnings Call October 29, 2026 5:00 PM EDT
Company Participants
John Weeks - Vice President of Investor Relations
Jon Vander Ark - President, CEO & Director
Brian Delghiaccio - Executive VP & CFO
Conference Call Participants
Sabahat Khan - RBC Capital Markets, Research Division
Bryan Burgmeier - Citigroup Inc., Research Division
Noah Kaye - Oppenheimer & Co. Inc., Research Division
Yehuda Silverman - Morgan Stanley, Research Division
Jerry Revich - Wells Fargo Securities, LLC, Research Division
Adam Bubes - Goldman Sachs Group, Inc., Research Division
Trevor Romeo - William Blair & Company L.L.C., Research Division
Tami Zakaria - JPMorgan Chase & Co, Research Division
Seth Weber - BNP Paribas, Research Division
Shlomo Rosenbaum - Stifel, Nicolaus & Company, Incorporated, Research Division
Stephanie Benjamin Moore - Jefferies LLC, Research Division
Kevin Chiang - CIBC Capital Markets, Research Division
Tobey Sommer - Truist Securities, Inc., Research Division
Presentation
Operator
Good afternoon, and welcome to the Republic Services Third Quarter 2026 Investor Conference Call. Republic Services is traded on the New York Stock Exchange under the symbol RSG.
[Operator Instructions]
Please note this event is being recorded.
I would now like to turn the conference over to John Weeks, Vice President of Investor Relations. Please go ahead.
John Weeks
Vice President of Investor Relations
Good afternoon. I would like to welcome everyone to Republic Services Third Quarter 2026 Conference Call. Jon Vander Ark, our CEO; and Brian DelGhiaccio, our CFO, are on the call today to discuss our performance.
I'd like to take a moment to remind everyone that some information we discuss on today's call contains forward-looking statements, including forward-looking financial information, which involve risks and uncertainties and may be materially different from actual results. Our SEC filings discuss factors that could cause actual results to differ materially from expectations. The material that we discuss today is time sensitive. If in the future, you
When it comes to artificial intelligence (AI) stocks, investors tend to think of chip giants like Nvidia or Micron Technology. But AI is starting to create value for many companies, even those not operating at the industry's frontier, and that spells an opportunity for investors.
Spotify (SPOT +3.50%) runs the world's largest music streaming platform, and it's betting big on AI to enhance the listening experience, which is boosting engagement and, therefore, revenue. The company reported a strong set of operating results for the third quarter of 2026 (ended Sept. 30) last week, which sent its stock soaring by more than 11%.
But the stock is still down 26% from last year's record high as I write this on Oct. 27, so should investors take this opportunity to buy the dip, or will the recent recovery run out of steam?
Image source: Getty Images.
Artificial intelligence is transforming Spotify
Most music streaming services offer the same content catalog, because a small handful of record labels control most of the industry's rights, and they want their artists to reach as many listeners as possible. That means the primary way Spotify can differentiate its platform from the competition is by delivering a better user experience, and AI is central to its strategy.
AI is embedded in Spotify's recommendation algorithm, where it learns what type of music each user likes, so it can feed them more of it. AI also powers a growing number of features, like Prompted Playlist which will curate a basket of songs based on a description provided by the user. But management is aiming to turn Spotify into the world's first agentic media platform, which will introduce a range of unique capabilities, and some of them are already live.
For example, users can ask Spotify to analyze their listening history dating all the way back to 2008, and surface their favorite songs. It can also ask the platform to mix tracks together to create the perfect playlist, organized by factors like beats per minute. It can also recap an audiobook the user is listening to, up until the point they previously stopped.
Spotify can integrate with third-party agentic systems like OpenAI's Dots and Meta Platforms' Muse, enabling users to control their audio environment while completing other tasks. For example, users can ask Muse to build a playlist through Spotify, tailored to a specific road-trip destination.
SPOT Spotify Technology$557.24+$18.84 (+3.50%)
NYSE · As of 4:00 PM ET 10/29/26
Spotify's profits could soar from here
Spotify had 306 million Premium subscribers at the end of the third quarter, in addition to 499 million free users who were monetized through advertising. The company generated $5.5 billion in revenue from both categories during the third quarter, a 16% increase from the year-ago period.
However, Premium subscribers accounted for over 90% of that total revenue, so converting free users into paying members is a top priority. Developing new AI-powered features that are only available to subscribers is one way Spotify is doing that, but this strategy requires significant investment. As a result, the company's total operating costs increased by 25% to $1.1 billion during the third quarter, with research and development spending alone climbing by 35%.
Spotify still managed to turn a profit of $578 million during the quarter, but that was down 42% from the year-ago period. Fortunately, management says operating expense growth has likely peaked and will moderate from the fourth quarter onwards, so profits could grow materially from here.
Spotify stock might be a solid long-term buy
Based on Spotify's trailing 12-month revenue of $21 billion and its market capitalization of $117 billion, its stock is trading at a price-to-sales (P/S) ratio of 5.5, making it cheaper than the technology-heavy Nasdaq-100 index which has a P/S ratio of 6.5. Moreover, Wall Street's average estimate (provided by Yahoo! Finance) suggests the company could grow its revenue to $25 billion in 2027, placing its stock at a forward P/S ratio of 4.7.
SPOT PS Ratio data by YCharts
However, Spotify is more expensive than the Nasdaq-100 based on the more traditional price-to-earnings (P/E) ratio, which values a company based on its profits. The Nasdaq-100 has a trailing P/E of 29.5, whereas Spotify has a trailing P/E of 39.5, and a forward P/E of 33.2 (based on Wall Street's 2027 earnings forecast). With that said, depending how quickly the company's costs moderate from here, it could deliver better earnings than expected which would make its stock cheaper than it currently appears on a forward basis.
Longer term, Spotify could generate significant growth at the top and bottom lines. Co-chief executive Alex Norström says the platform could add "hundreds of millions" more paying members in emerging markets alone, which include regions like Asia, Latin America, and the Middle East. In fact, he has previously outlined a goal to convert 10% to 15% of the entire world's population into paying members, representing significant potential growth from the current level of under 4%.
As a result, I think Spotify stock could be a great buy while it's still trading below its record high, but investors should aim to hold it for at least five years to maximize their chances of earning strong returns.
SummaryAres Capital Corp is rated HOLD, reflecting a balance of mixed fundamentals and fair valuation near $18.61.NII and Core EPS fell to $0.46, failing to cover the $0.48 dividend, while NAV declined for a fourth consecutive quarter.ARCC trades at 0.96× book (below the historical mean) but at a 10.1× NII multiple, indicating premium pricing on earnings.The MFIC acquisition may add ~$0.40 per share to NAV but introduces execution risk and will not impact results before 2027.Looking for more investing ideas like this one? Get them exclusively at iREIT®+HOYA Capital. Learn More » Richard Drury/DigitalVision via Getty Images
Investment Thesis and Recommendation This is my third Ares Capital Corp (ARCC) note in six months (I own it, and I follow it as the bellwether). I upgraded to BUY on May
5.83K Followers
Analyst’s Disclosure: I/we have a beneficial long position in the shares of ARCC, BXSL, HTGC, TSLX, MSDL, RWAYI, NCDL either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
The content of this article reflects my personal views and is provided for informational and educational purposes only. It does not constitute investment advice, financial advice, or a recommendation to buy or sell any securities or financial instruments. While I strive for accuracy, the information presented may contain errors or omissions or be based on sources believed to be reliable but not independently verified. I make no representations or warranties as to the completeness, accuracy, or timeliness of any information presented. This article is not intended to provide, and should not be relied upon for, investment, legal, tax, or accounting advice. The securities and strategies discussed may not be suitable for all investors. Past performance is not indicative of future results. All investments involve risk, including the potential loss of principal. I may hold, or have held, positions in the securities mentioned. I do not receive compensation for writing this article, nor do I intend to influence the price or trading volume of any security discussed. All opinions are subject to change without notice. This content is written strictly in a personal capacity and does not reflect the views of any employer, organization, or associated entity. Readers are strongly encouraged to conduct their own independent research and to consult with a licensed financial advisor before making any investment.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
The USD/NOK exchange rate fell all through October. The Norwegian krone got stronger, largely following higher oil prices. These prices climbed due to Middle East supply issues and bigger energy revenues
Oil alone is unlikely to keep the krone strong. Norges Bank's high rates, currently at 4.50% along with a healthy risk appetite, also play a big role.
Things could turn around if oil prices drop sharply should tensions ease, or if the US dollar strengthens as interest rates diverge.
The USD/NOK exchange rate took a big dive in October. It started the month around 9.62–9.65 but ended closer to 9.22–9.28. This boost for the Norwegian krone (NOK) mostly followed what was happening in the crude oil market.
The link looks obvious, since Norway is a major energy exporter, but is oil really carrying the krone alone?
Oil Is Not the Whole Story
Sure, Norway is a huge energy exporter, so oil prices definitely connect to the krone. But that’s not the only thing moving the exchange rate. Higher crude oil prices mean more valuable Norwegian exports, bringing in bigger revenues for energy companies and the government.
These companies often convert their foreign currency earnings into kroner for domestic tax payments, which keeps demand for NOK steady.
Still, the US dollar has stayed pretty strong. The Federal Reserve raised interest rates in September and held them between 3.75% and 4.00% at its October 28 meeting. A close vote there hinted that another hike had some backing. Normally, a strong dollar would send USD/NOK higher.
Norges Bank, Norway’s central bank, also helped boost the krone. It lifted its policy rate to 4.50% on September 23, with the next decision set for November 5. Unlike some European central banks that began easing monetary policy earlier, Norway’s pretty high baseline interest rate helps narrow the yield gap compared to the US Federal Reserve. This makes carry trades, which bet against the Krone, less attractive.
What Could Disrupt the Momentum?
A few things could throw off this trend. Oil prices, for instance, might not keep the krone strong forever. For instance, if a diplomatic agreement between the US and Iran reopens shipping through the Strait of Hormuz, it could cause oil prices to drop significantly.
How the market feels about riskier assets also plays a part in USD/NOK. The krone generally follows overall risk appetite. If equity markets drop sharply, investors might start buying dollars, even if oil prices hold steady. We saw this happen when weak tech earnings sent investors looking for safer assets.
Being a smaller currency with less liquidity, the krone’s also prone to weakening during broad market sell-offs. In those times, institutional investors often shift money into perceived safe-haven assets like the US dollar.
How Likely Is a Near-Term Reversal?
A short-term rebound for USD/NOK seems moderately likely. That’s partly because technical indicators point to oversold conditions after October’s significant 4% drop.
Supportive factors might keep things going for a few weeks, but the krone is very sensitive to energy prices. This means any sustained drop in crude oil would likely send USD/NOK climbing quickly. For instance, the currency could weaken rapidly if global oil supply picks up significantly.
Still, a lasting reversal of the trend above 9.60 seems unlikely before the year’s end, unless global energy prices collapse or Norges Bank unexpectedly cuts interest rates soon.
Why has USD/NOK fallen throughout October?
The Norwegian krone strengthened, pulling the pair lower. This largely reflected elevated oil prices, which boosted Norway’s export revenues and increased demand for NOK. Supportive interest rates also played a role.
Can oil prices alone sustain a stronger krone?
Oil is a major driver, but it is not strong enough to do it alone. Interest-rate differences, risk appetite, and relative fiscal stability also influence the currency’s path over time.
What is the biggest risk to the current krone strength?
A significant drop in oil prices, perhaps from geopolitical de-escalation, would likely remove the krone’s key support. USD/NOK would then probably rebound quickly.
Micron (MU -4.98%) has dazzled investors by more than tripling this year, but picking next year's winners may require shifting away from current leaders. The memory chip maker has already become a centerpiece of the artificial intelligence (AI) boom, but smaller companies may present a higher potential upside.
If you missed the boat with Micron this year, these three stocks are worth following.
Image source: Getty Images.
Penguin Solutions
Penguin Solutions (PENG -3.31%) specializes in memory products. While the company hasn't gained as much ground as Micron, Penguin Solutions is making meaningful progress.
PENG Penguin Solutions$58.79-$2.01 (-3.31%)
NASDAQ · As of 4:00 PM ET 10/29/26
The company's CXL memory products are essentially memory banks that any AI chips in the server can access. That way, if an AI chip runs out of memory, it can tap into this pool of memory instead of slowing down the entire system. Penguin Solutions' CXL products are each deployed to a single rack, which leads to higher revenue as AI data centers scale up their racks.
Racks inside AI data centers each contains eight to 72 graphics processing units (GPUs), although eight to 32 GPUs is the norm. It's a major long-term opportunity as companies continue to accumulate chips, and that growth already shows up in Penguin Solutions' financial results.
Penguin Solutions reported 68% year-over-year net sales growth in its fiscal 2026 fourth quarter (ended Aug. 28), highlighted by 158% year-over-year growth in its integrated memory segment. That's the main driver for Penguin Solutions' share gain of more than 190% this year, and as it makes up a larger percentage of total revenue, Penguin Solutions should see its overall numbers surge.
Sandisk
Sandisk (SNDK -5.32%) is another key part of the memory sector. It specializes in NAND flash memory products and is growing at a faster rate than Micron. Not only is Sandisk outgrowing the large memory chip maker, but it also has a lower market cap and a compelling valuation.
SNDK Sandisk$1,330.05-$74.72 (-5.32%)
NASDAQ · As of 4:00 PM ET 10/29/26
Sandisk trades at a forward price-to-earnings (P/E) ratio of less than 6, and its financial performance is supported by multiyear strategic partnerships with key customers. Those long-term deals have eased worries about the cyclical nature of memory chips. Even though boom-and-bust cycles have been the norm, the AI infrastructure build-out is still in its early stages, much to the benefit of Sandisk.
Even with the recent downward pressure on AI stocks, Sandisk is up by more than 450% this year. If its revenue and net income growth rates continue to outpace Micron's, the company has a real shot at continuing its outperformance of the bigger chipmaker. Sandisk's $14 billion in additional authorized stock buybacks in its fiscal 2026 fourth quarter serves as the cherry on top.
Fortinet
Fortinet (FTNT -20.09%) is a cybersecurity stock that is benefiting from AI. As more businesses use AI agents and other products, they increase the number of vulnerabilities within their systems.
That's one of the trade-offs with using AI, especially as hackers use this technology to infiltrate databases. However, enterprises are simply investing in safeguards instead of giving up on the most innovative technology of our era.
Fortinet shares have gained about 70% this year as its cybersecurity platform gains more traction. It also trades at a lower valuation than most of its cybersecurity peers, with its 65 P/E ratio. That's still an elevated valuation compared to most tech stocks, but it's trading at a more affordable level than the majority of cybersecurity companies.
Fortinet anticipates a $172 billion total addressable market for the AI security industry. While it's not the only player in the business, Fortinet has established itself as a cybersecurity leader, positioning it to gain a large portion of total market share. Fortinet also incorporates annual recurring revenue in its business, which makes it easier for the company to scale over time.
SASKATOON, Saskatchewan--(BUSINESS WIRE)--Cameco (TSX: CCO; NYSE: CCJ) today reported its consolidated financial and operating results for the third quarter ended September 30, 2026.
Mortgage Rates Squeeze FHA Buyers: 3 Housing Stocks to WatchInvitation Homes NYSE: INVH reported third-quarter results marked by stronger renewal rent growth, continued share repurchases funded in part by home sales, and an increase in its full-year Core FFO guidance.
President and Chief Executive Officer Dallas Tanner said same-store blended rent growth reached 3% in the third quarter, the company’s strongest result of 2026 to date. Renewal rent growth was 4.3%, while Core FFO per share rose 2.4% year over year to $0.48.
Get Invitation Homes alerts:
Tanner said the company sees continued demand for single-family rentals, citing John Burns data indicating that, weighted across Invitation Homes’ markets, leasing a home was more than $1,000 per month less expensive than owning one as of September. He said the company’s average resident stays more than 41 months, which he said could translate to more than $42,000 in savings relative to homeownership costs.
Leasing Trends Show Strong Renewals, Seasonal New-Lease Moderation Chief Operating Officer Tim Lobner said same-store net operating income increased 1.1% year over year in the third quarter. Core revenue grew 1.6%, while core operating expenses rose 2.5%.
Blended rent growth improved sequentially from 1.6% in the first quarter and 2.7% in the second quarter. The result was driven primarily by renewals, while new-lease rent growth declined 0.2% during the quarter. Lobner said the new-lease figure was 50 basis points better than the prior year but reflected typical seasonal patterns after the peak moving season.
Average monthly rent increased 1.8% year over year. Turnover declined 10 basis points to 6.2%. Average occupancy was 96.4% in the third quarter. October blended rent growth was 2.2%, with renewal growth of 4.2% and new-lease growth of negative 2.2%. October occupancy averaged 96.1%, nearly unchanged from a year earlier. Lobner said the company expects to balance occupancy and pricing through the winter months in an effort to enter the new year from a stronger position. He noted that approximately 55% of lease expirations occur in the first half of the year and 45% in the second half.
On supply, Lobner said listings from large single-family rental operators were down 13% year over year in August, according to John Burns data, including declines in Atlanta, Tampa and Phoenix. He also said build-to-rent deliveries peaked in 2024 and are expected to slow through 2027 and 2028. However, management said it continues to monitor potential supply from homebuilders, accidental landlords and smaller “mom-and-pop” landlords.
Dispositions Fund Continued Share Repurchases Invitation Homes continued to sell homes and redeploy proceeds into stock repurchases. During the third quarter, the company sold 658 wholly owned homes for approximately $318 million in gross proceeds, or about $484,000 per home on average. After acquiring 216 wholly owned homes, primarily builder-partner deliveries, net disposition proceeds totaled roughly $245 million.
Chief Financial Officer Jon Olsen said those proceeds were used toward the repurchase of approximately 8.9 million shares for $250 million during the quarter. Since December through the Tuesday before the call, the company had repurchased about 37 million shares for $989 million at an average price of $26.78 per share. The repurchases represented 6% of shares outstanding.
Tanner contrasted the company’s home sale values with the implied value of its shares. Since December, the average gross sales price for homes sold was about $460,000, he said, while the market was valuing the company’s homes at approximately $280,000 each through its share price.
The board authorized a new $500 million share-repurchase program. Olsen said future repurchase activity will remain subject to the company’s leverage targets, market conditions and tax capacity associated with asset sales.
The company raised the midpoint of its 2026 wholly owned disposition guidance by $100 million, to a range of $900 million to $1 billion. Through September, it had completed $833 million of dispositions.
Balance Sheet and Guidance Invitation Homes ended the quarter with $1.3 billion of available liquidity. Approximately 90% of its debt was unsecured, 90% was fixed-rate or swapped to fixed-rate, and about 90% of wholly owned homes were unencumbered. Net debt to adjusted EBITDA was 5.5 times, within the company’s stated 5.5-times to 6-times target range.
Olsen said the company issued $500 million of five-year bonds in July with a 4.95% coupon and used proceeds to prepay roughly half of its IH 2017-1 securitization. The remaining $500 million of that securitization matures in June 2027, and the company has no other debt maturities before then.
The company increased its full-year 2026 Core FFO per-share guidance by $0.01 at the midpoint, setting a range of $1.94 to $1.98. It also narrowed its same-store revenue growth range, reduced its same-store expense growth outlook by 30 basis points, largely because of anticipated lower property taxes, and raised the midpoint of same-store NOI growth guidance to 1.2%.
Property tax expense declined slightly year over year in the third quarter. Olsen said final tax bills received so far, including in Florida and Georgia, have been more favorable than originally expected. Higher repair and utility costs associated with extreme summer heat partly offset those gains, according to Lobner.
Policy and Pathway Homes Update Tanner said the company’s preliminary assessment of Treasury’s proposed regulations under the 21st Century ROAD to Housing Act was that the framework was generally workable and aligned with congressional intent. He said Invitation Homes intends to remain involved during the public comment process and may seek clarification or changes to certain provisions.
Management also discussed the consolidation of Pathway Homes assets. Olsen said the portfolio comprises roughly 800 to 900 homes and had previously generated management-fee income before consolidation. Tanner said Invitation Homes had operated the homes for years and that the consolidation did not represent new supply entering its portfolio.
Tanner said the company remains interested in rent-to-own programs as a potential option for consumers, though fewer than 10 customers in the particular Pathway venture had purchased homes to date. He said Invitation Homes will continue honoring existing contracts and evaluating whether such programs could make sense over time.
About Invitation Homes (NYSE:INVH)Invitation Homes Inc NYSE: INVH is a real estate investment trust that owns, leases and operates single-family homes in the United States. The company provides professionally managed rental housing for individuals and families, with properties generally located in suburban communities and metropolitan areas.
The company’s services include home leasing, property management, resident support, maintenance and renovations. Invitation Homes uses technology and centralized operating systems to market homes, manage lease agreements, collect rent and coordinate property care.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Invitation Homes Right Now?Before you consider Invitation Homes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Invitation Homes wasn't on the list.
While Invitation Homes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Rithm Capital is rated Buy, while Dynex Capital is rated Hold, reflecting stronger dividend coverage and valuation for Rithm. RITM trades at 0.74x book with a 2.2x covered dividend, while DX trades at book value but pays out more than it earns. RITM's borrower-side exposure is more resilient in a rate-hiking environment; DX's bondholder model is vulnerable to spread widening and insufficient distributable earnings.
Analyst’s Disclosure: I/we have a beneficial long position in the shares of AMAT either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
Rate-Resilient vs. Rate-Exposed: Why Homebuilder Stocks Are DivergingD.R. Horton NYSE: DHI reported fourth-quarter fiscal 2026 net income of $741.8 million, or $2.67 per diluted share, on consolidated revenue of $9.4 billion, as higher mortgage rates and cautious consumer sentiment weighed on housing demand late in the quarter.
For the full fiscal year, the homebuilder generated net income of $2.9 billion, or $10.11 per diluted share, on revenue of $33 billion. Consolidated pre-tax income totaled $3.9 billion for the year, representing an 11.8% pre-tax profit margin.
Get D.R. Horton alerts:
Why 3 Struggling Stocks Are Suddenly Spending Big on BuybacksPresident and CEO Paul Romanowski said D.R. Horton completed its 25th consecutive year as the nation’s largest builder by volume. The company’s homebuilding and rental operations provided homes to more than 89,000 families during the year, including approximately 43,500 first-time homebuyers.
Demand Weakens as Rates Rise Fourth-quarter home sales revenue totaled $8.4 billion from 22,915 homes closed. The average closing price was $365,600, up 1% sequentially and unchanged from a year earlier. Romanowski said the company’s average closing price was about $135,000, or 27%, below the average new-home price in the U.S.
Lennar’s Earnings Miss May Be Sending a Bigger Warning About U.S. HousingNet sales orders declined 7% year over year to 18,619 homes, while order value fell 9% to $6.6 billion. The average net order price was $356,600, down 2% both sequentially and from the prior-year period. The cancellation rate rose to 23%, compared with 20% in both the preceding quarter and the year-earlier quarter.
Romanowski said demand “came under increased pressure” as mortgage rates rose sharply during the quarter. While the company continued to see prospective buyers visiting sales offices, management described those customers as more cautious and tentative in their decision-making.
The company said it increased the mortgage rates offered through rate buydowns as market rates moved higher, while generally maintaining a buydown rate about 1.5 percentage points below market rates. Management said buyers using D.R. Horton’s mortgage company continued to use rate buydowns at a high rate, with high-80% to low-90% of those buyers receiving one.
Margins Face Pressure From Incentives and Costs Home sales gross margin was 19.5% in the fourth quarter, down 120 basis points from the June quarter and below the company’s expectations. Jessica Hansen, senior vice president of communications, said 80 basis points of the sequential decline reflected more difficult market conditions that limited D.R. Horton’s ability to offset higher costs through pricing. Above-normal litigation costs accounted for the remainder.
The company said its typical warranty and litigation expense affects gross margin by roughly 40 to 50 basis points, compared with an 80-basis-point impact in the fourth quarter. Stick-and-brick costs and home sales revenue per square foot each increased 1% sequentially, while lot costs rose 4%.
D.R. Horton expects first-quarter fiscal 2027 home sales gross margin of 18% to 18.5%, reflecting lower average sales prices and higher incentive costs. Management expects incentives to remain elevated in fiscal 2027, although Romanowski said the first-quarter margin outlook was indicative of current conditions rather than a longer-term normalized margin level.
The company plans to manage pricing, incentives and sales pace at the community level. Romanowski said the mix of incentives may include mortgage-rate buydowns, included home features or price reductions depending on local market conditions.
Inventory and Lot Strategy D.R. Horton reduced starts to 13,100 homes in the September quarter, down 45% sequentially and 10% year over year, in an effort to better align inventory with demand. Total inventory at Sept. 30 was 28,200 homes, down 26% sequentially and 5% from a year earlier. The company had 17,700 unsold homes, including 8,800 completed homes.
The company ended the year with a lot position of 571,000 lots, including 23% owned and 77% controlled through purchase contracts. Its owned lot position declined 11% from a year earlier to 131,000 lots, representing roughly a one-and-a-half-year supply.
Management said 70% of fourth-quarter closings occurred on lots developed by Forestar or third parties, up from 65% a year earlier. Romanowski said the company expects land and lot pricing to adjust slowly, but anticipates future development activity could occur at better pricing as land residuals reset to current market conditions.
Rental Impairment and Fiscal 2027 Outlook The rental operations segment reported a fourth-quarter pre-tax loss of $25.3 million, including $91.4 million of inventory impairment charges on nine completed multifamily projects. Romanowski said the charges reflected lower expected sales prices following the recent increase in interest rates.
For fiscal 2027, D.R. Horton expects rental inventory to remain at or below its current level. The company said its single-family rental business has shifted to a forward-sale model, with an investor generally in place before a project begins, and it expects returns in that portion of the rental operation to improve over time.
For fiscal 2027, D.R. Horton forecast consolidated revenue of approximately $30 billion to $32 billion and homebuilding closings of 79,000 to 84,000 homes. For the first quarter ending Dec. 31, the company expects revenue of $5.9 billion to $6.4 billion, homebuilding closings of 15,500 to 16,500 homes, and a consolidated pre-tax profit margin of 7% to 8%.
The company expects to generate about $3.5 billion of operating cash flow in fiscal 2027 and plans to repurchase approximately $3 billion of common stock while paying about $500 million in dividends. Its board raised the quarterly dividend 11% to $0.50 per share.
During fiscal 2026, D.R. Horton generated $3.5 billion of operating cash flow and returned $4.1 billion to shareholders through $3.6 billion of stock repurchases and $513 million of dividends. The company ended the year with $7.2 billion of consolidated liquidity and $6.1 billion of debt.
About D.R. Horton (NYSE:DHI)D.R. Horton, Inc is a residential construction company that builds and sells single-family detached and attached homes in the United States. Its offerings include entry-level, move-up, luxury and active-adult housing, serving a range of homebuyers through brands such as D.R. Horton, Express Homes, Emerald Homes and Freedom Homes.
The company's operations also include land acquisition and development, home financing and title services. Through subsidiaries and affiliated businesses, D.R.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in D.R. Horton Right Now?Before you consider D.R. Horton, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and D.R. Horton wasn't on the list.
While D.R. Horton currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for higher dividend income in 2027? Discover seven high-yield dividend stocks with attractive payouts, proven dividend histories and growth potential.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Not financial or tax advice. PANews content is strictly educational and informational and is not investment advice, financial advice, tax advice, legal advice, or a solicitation to buy or sell any digital asset, security, or financial product. Do your own research and consult qualified advisers.
Disclosure. PANews may publish sponsored content, partner content, advertisements, affiliate links, event promotions, and market commentary involving Web3 projects, service providers, or financial products. PANews personnel, contributors, or affiliates may hold digital assets or other interests related to covered topics. See our Terms of Service.
He Yi: The 60 million USDT collateralized on AAVE is not covered by the full freeze; hackers actually only siphoned off $46 million worth of ETH.
He Yi released a statement addressing the status of AAVE-related collateral funds, clarifying: The 60 million USDT collateralized in AAVE is not fully frozen; hackers only stole approximately $46 million worth of ETH. Once these assets are unfrozen through law enforcement processes, an additional roughly $14 million in assets will be recoverable.
3 minutes ago
Mistral open-sourced the trillion-parameter Large 4 model weights, reporting that its programming test scores rose by 13 percentage points while per-question costs dropped by 63%.
Beating AI News Flash: French AI company Mistral has officially open-sourced the weights of its flagship model Large 4 (codenamed Le Chonk). The model has a total of 1.05 trillion parameters, with approximately 49 billion activated per inference. After opening API previews on October 6, Mistral conducted three additional weeks of reinforcement learning training, and the version released now is an improved iteration. Mistral reported its Terminal-Bench 4.0 programming score rose from 28% to 41%; FrontierCode 2.0 scored 19.7%, ranking first among open-source models. In Artificial Analysis' programming agent index, Large 4 scored 48%, close to GLM-5.3's 49%, while consuming 47% fewer tokens per average question. However, Artificial Analysis only recorded a 25% score for Terminal-Bench 4.0 under its own test configuration, failing to replicate the official 41% result. In other tests, financial table task Finch's score increased from 67.4% to 73.3%; the agent's success rate in resisting prompt injection attacks rose from 93.3% to 97.1%. Its cybersecurity index stands at 51%, still lower than DeepSeek V4.1 Flash's 57%, with more modest overall capability improvements. Artificial Analysis has just upgraded its intelligence index to v5. On the same metric, Large 4's score rose from 25 in the preview version to 26, below GLM-5.3 and DeepSeek V4.1 Flash's 32 points. But inference efficiency improved significantly: output tokens per question dropped by 39%, and hallucination rate fell from 41% to 28%. API prices were also nearly halved. Based on October 29 evaluation pricing and usage estimates, per-question cost fell from $5.54 to $2.06, a 63% reduction. The model weights have been uploaded to Hugging Face, offering FP8 and NVFP4 versions, supporting self-deployment, fine-tuning, and general commercial use. Separate authorization from Mistral is required to operate a commercial model hosting service.
3 minutes ago
A whale added $10 million worth of short positions on US stock indices ahead of US pre-market trading.
According to TradingBeats monitoring, a whale has concentrated on adding short positions in US stock index futures over the past half hour. The combined notional value of new short positions opened in Nasdaq 100 and S&P 500 contracts totals approximately $9.51 million, with the S&P 500 position switching from long to short. The account currently holds around $7.29 million in XYZ100 short positions at an average price of $28,796.94, plus roughly $2.4 million in S&P 500 short positions at an average price of $7,646.54, bringing the total value of the two short positions to about $9.7 million.
3 minutes ago
Intel suffers another sharp pre-market drop, profit whales add $4.5 million in short positions
According to TradingBeats' monitoring, a whale has been steadily adding short positions on Intel (INTC) today, lifting its short position count from around 79,900 contracts to 146,000, an 82.7% increase. Since the start of today, the account has added a net total of roughly 66,100 INTC short positions, with a net sell turnover of approximately $4.58 million. During US pre-market trading hours, the whale further net sold around $2.37 million at an average execution price of $68.07, a 31.3% rise. The account currently holds about 146,000 INTC short positions, valued at roughly $10.058 million, with an average entry price of $79.52, generating an unrealized profit of around $1.549 million. Over the same period, INTC contracts trade at $68.91, some 13.3% lower than the position's overall holding cost. The position uses 10x isolated margin leverage, with a liquidation price of approximately $82.46.
3 minutes ago
OpenRouter upgrades its inference routing: it costs 6% more, with response speed improving by approximately 17%.
Beating AI Express News: OpenRouter has announced an upgrade to its default inference routing algorithm. Previously, the platform primarily selected inference providers based solely on price; now, it will comprehensively consider speed, stability, and actual call costs, no longer blindly choosing the cheapest service provider. The company tested over 24 million requests, with results showing a 16.9% reduction in first-token response time, a 19% cut in full request latency, and a drop in rate-limiting error requests from 7.1% to 3.8%. The tradeoff is a roughly 6% increase in cost per 1,000 requests. The new algorithm is now live, and users do not need to adjust any configurations. This optimization targets the selection of inference providers behind the same model, rather than the model’s own capabilities.
3 minutes ago
Changxin Technology plans to repurchase its shares with an amount ranging from 1 billion to 2 billion yuan, and its net profit for the first three quarters reached 132.04 billion yuan.
Changxin Technology announced that it plans to repurchase its own shares through centralized bidding transactions, with a repurchase amount ranging from 1 billion to 2 billion yuan, a maximum repurchase price of 72.69 yuan per share, and the funds will be sourced from its own or self-raised capital. Additionally, the company achieved a net profit of 132.04 billion yuan in the first three quarters of 2026, turning around from a net loss in the same period last year.
He Yi: The 60 million USDT collateralized on AAVE is not covered by the full freeze; hackers actually only siphoned off $46 million worth of ETH.
He Yi released a statement addressing the status of AAVE-related collateral funds, clarifying: The 60 million USDT collateralized in AAVE is not fully frozen; hackers only stole approximately $46 million worth of ETH. Once these assets are unfrozen through law enforcement processes, an additional roughly $14 million in assets will be recoverable.
3 minutes ago
Mistral open-sourced the trillion-parameter Large 4 model weights, reporting that its programming test scores rose by 13 percentage points while per-question costs dropped by 63%.
Beating AI News Flash: French AI company Mistral has officially open-sourced the weights of its flagship model Large 4 (codenamed Le Chonk). The model has a total of 1.05 trillion parameters, with approximately 49 billion activated per inference. After opening API previews on October 6, Mistral conducted three additional weeks of reinforcement learning training, and the version released now is an improved iteration.
Mistral reported its Terminal-Bench 4.0 programming score rose from 28% to 41%; FrontierCode 2.0 scored 19.7%, ranking first among open-source models. In Artificial Analysis' programming agent index, Large 4 scored 48%, close to GLM-5.3's 49%, while consuming 47% fewer tokens per average question. However, Artificial Analysis only recorded a 25% score for Terminal-Bench 4.0 under its own test configuration, failing to replicate the official 41% result.
In other tests, financial table task Finch's score increased from 67.4% to 73.3%; the agent's success rate in resisting prompt injection attacks rose from 93.3% to 97.1%. Its cybersecurity index stands at 51%, still lower than DeepSeek V4.1 Flash's 57%, with more modest overall capability improvements.
Artificial Analysis has just upgraded its intelligence index to v5. On the same metric, Large 4's score rose from 25 in the preview version to 26, below GLM-5.3 and DeepSeek V4.1 Flash's 32 points. But inference efficiency improved significantly: output tokens per question dropped by 39%, and hallucination rate fell from 41% to 28%.
API prices were also nearly halved. Based on October 29 evaluation pricing and usage estimates, per-question cost fell from $5.54 to $2.06, a 63% reduction. The model weights have been uploaded to Hugging Face, offering FP8 and NVFP4 versions, supporting self-deployment, fine-tuning, and general commercial use. Separate authorization from Mistral is required to operate a commercial model hosting service.
3 minutes ago
A whale added $10 million worth of short positions on US stock indices ahead of US pre-market trading.
According to TradingBeats monitoring, a whale has concentrated on adding short positions in US stock index futures over the past half hour. The combined notional value of new short positions opened in Nasdaq 100 and S&P 500 contracts totals approximately $9.51 million, with the S&P 500 position switching from long to short. The account currently holds around $7.29 million in XYZ100 short positions at an average price of $28,796.94, plus roughly $2.4 million in S&P 500 short positions at an average price of $7,646.54, bringing the total value of the two short positions to about $9.7 million.
3 minutes ago
Intel suffers another sharp pre-market drop, profit whales add $4.5 million in short positions
According to TradingBeats' monitoring, a whale has been steadily adding short positions on Intel (INTC) today, lifting its short position count from around 79,900 contracts to 146,000, an 82.7% increase. Since the start of today, the account has added a net total of roughly 66,100 INTC short positions, with a net sell turnover of approximately $4.58 million. During US pre-market trading hours, the whale further net sold around $2.37 million at an average execution price of $68.07, a 31.3% rise. The account currently holds about 146,000 INTC short positions, valued at roughly $10.058 million, with an average entry price of $79.52, generating an unrealized profit of around $1.549 million. Over the same period, INTC contracts trade at $68.91, some 13.3% lower than the position's overall holding cost. The position uses 10x isolated margin leverage, with a liquidation price of approximately $82.46.
3 minutes ago
OpenRouter upgrades its inference routing: it costs 6% more, with response speed improving by approximately 17%.
Beating AI Express News: OpenRouter has announced an upgrade to its default inference routing algorithm. Previously, the platform primarily selected inference providers based solely on price; now, it will comprehensively consider speed, stability, and actual call costs, no longer blindly choosing the cheapest service provider. The company tested over 24 million requests, with results showing a 16.9% reduction in first-token response time, a 19% cut in full request latency, and a drop in rate-limiting error requests from 7.1% to 3.8%. The tradeoff is a roughly 6% increase in cost per 1,000 requests. The new algorithm is now live, and users do not need to adjust any configurations. This optimization targets the selection of inference providers behind the same model, rather than the model’s own capabilities.
3 minutes ago
Changxin Technology plans to repurchase its shares with an amount ranging from 1 billion to 2 billion yuan, and its net profit for the first three quarters reached 132.04 billion yuan.
Changxin Technology announced that it plans to repurchase its own shares through centralized bidding transactions, with a repurchase amount ranging from 1 billion to 2 billion yuan, a maximum repurchase price of 72.69 yuan per share, and the funds will be sourced from its own or self-raised capital. Additionally, the company achieved a net profit of 132.04 billion yuan in the first three quarters of 2026, turning around from a net loss in the same period last year.
He Yi: The 60 million USDT collateralized on AAVE is not covered by the full freeze; hackers actually only siphoned off $46 million worth of ETH.
He Yi released a statement addressing the status of AAVE-related collateral funds, clarifying: The 60 million USDT collateralized in AAVE is not fully frozen; hackers only stole approximately $46 million worth of ETH. Once these assets are unfrozen through law enforcement processes, an additional roughly $14 million in assets will be recoverable.
3 minutes ago
Mistral open-sourced the trillion-parameter Large 4 model weights, reporting that its programming test scores rose by 13 percentage points while per-question costs dropped by 63%.
Beating AI News Flash: French AI company Mistral has officially open-sourced the weights of its flagship model Large 4 (codenamed Le Chonk). The model has a total of 1.05 trillion parameters, with approximately 49 billion activated per inference. After opening API previews on October 6, Mistral conducted three additional weeks of reinforcement learning training, and the version released now is an improved iteration.
Mistral reported its Terminal-Bench 4.0 programming score rose from 28% to 41%; FrontierCode 2.0 scored 19.7%, ranking first among open-source models. In Artificial Analysis' programming agent index, Large 4 scored 48%, close to GLM-5.3's 49%, while consuming 47% fewer tokens per average question. However, Artificial Analysis only recorded a 25% score for Terminal-Bench 4.0 under its own test configuration, failing to replicate the official 41% result.
In other tests, financial table task Finch's score increased from 67.4% to 73.3%; the agent's success rate in resisting prompt injection attacks rose from 93.3% to 97.1%. Its cybersecurity index stands at 51%, still lower than DeepSeek V4.1 Flash's 57%, with more modest overall capability improvements.
Artificial Analysis has just upgraded its intelligence index to v5. On the same metric, Large 4's score rose from 25 in the preview version to 26, below GLM-5.3 and DeepSeek V4.1 Flash's 32 points. But inference efficiency improved significantly: output tokens per question dropped by 39%, and hallucination rate fell from 41% to 28%.
API prices were also nearly halved. Based on October 29 evaluation pricing and usage estimates, per-question cost fell from $5.54 to $2.06, a 63% reduction. The model weights have been uploaded to Hugging Face, offering FP8 and NVFP4 versions, supporting self-deployment, fine-tuning, and general commercial use. Separate authorization from Mistral is required to operate a commercial model hosting service.
3 minutes ago
A whale added $10 million worth of short positions on US stock indices ahead of US pre-market trading.
According to TradingBeats monitoring, a whale has concentrated on adding short positions in US stock index futures over the past half hour. The combined notional value of new short positions opened in Nasdaq 100 and S&P 500 contracts totals approximately $9.51 million, with the S&P 500 position switching from long to short. The account currently holds around $7.29 million in XYZ100 short positions at an average price of $28,796.94, plus roughly $2.4 million in S&P 500 short positions at an average price of $7,646.54, bringing the total value of the two short positions to about $9.7 million.
3 minutes ago
Intel suffers another sharp pre-market drop, profit whales add $4.5 million in short positions
According to TradingBeats' monitoring, a whale has been steadily adding short positions on Intel (INTC) today, lifting its short position count from around 79,900 contracts to 146,000, an 82.7% increase. Since the start of today, the account has added a net total of roughly 66,100 INTC short positions, with a net sell turnover of approximately $4.58 million. During US pre-market trading hours, the whale further net sold around $2.37 million at an average execution price of $68.07, a 31.3% rise. The account currently holds about 146,000 INTC short positions, valued at roughly $10.058 million, with an average entry price of $79.52, generating an unrealized profit of around $1.549 million. Over the same period, INTC contracts trade at $68.91, some 13.3% lower than the position's overall holding cost. The position uses 10x isolated margin leverage, with a liquidation price of approximately $82.46.
3 minutes ago
OpenRouter upgrades its inference routing: it costs 6% more, with response speed improving by approximately 17%.
Beating AI Express News: OpenRouter has announced an upgrade to its default inference routing algorithm. Previously, the platform primarily selected inference providers based solely on price; now, it will comprehensively consider speed, stability, and actual call costs, no longer blindly choosing the cheapest service provider. The company tested over 24 million requests, with results showing a 16.9% reduction in first-token response time, a 19% cut in full request latency, and a drop in rate-limiting error requests from 7.1% to 3.8%. The tradeoff is a roughly 6% increase in cost per 1,000 requests. The new algorithm is now live, and users do not need to adjust any configurations. This optimization targets the selection of inference providers behind the same model, rather than the model’s own capabilities.
3 minutes ago
Changxin Technology plans to repurchase its shares with an amount ranging from 1 billion to 2 billion yuan, and its net profit for the first three quarters reached 132.04 billion yuan.
Changxin Technology announced that it plans to repurchase its own shares through centralized bidding transactions, with a repurchase amount ranging from 1 billion to 2 billion yuan, a maximum repurchase price of 72.69 yuan per share, and the funds will be sourced from its own or self-raised capital. Additionally, the company achieved a net profit of 132.04 billion yuan in the first three quarters of 2026, turning around from a net loss in the same period last year.
Rocket Lab (RKLB +0.85%) has fallen a long way. It touched $151 in the spring. However, it churned steadily lower before tanking to under $60 in October after announcing it had pushed the highly anticipated first launch of its Neutron rocket to 2027.
It's unfortunate, but Rocket Lab is a growing company, operating in a space industry that's only just getting started. At the same time, Rocket Lab's setback doesn't necessarily doom the company to permanent failure.
Here's why Rocket Lab stock's steep slide could actually be the buying opportunity long-term investors have been waiting for.
The delay isn't the worst-case scenario Despite the stock tanking on the news, I don't believe many would deny that there are worse things. The company delayed Neutron due to a defect in its propellant dome that posed a risk of catastrophic failure on the launch pad. Clearly, a delay is preferable to a rocket exploding on launch.
Image source: The Motley Fool.
Remember, this stuff is literally rocket science. Rocket Lab is going through the pains and learning process of developing rocket technology, much like Space Exploration Technologies (SpaceX) did with its Falcon rocket, and continues to experience as it develops Starship.
The demand is clearly there to make Rocket Lab a winner Neutron would be capable of heavier loads than Rocket Lab's existing Electron rocket. Essentially, Neutron would enable Rocket Lab to compete more directly with SpaceX for medium-lift payloads, which are crucial for satellite deployments and government contracts. It seems fair to say there's a ton riding on getting Neutron into orbit.
Rocket Lab's backlog grew to $2.36 billion as of second-quarter 2026, up 137% from the prior year. It now includes over 90 launches across Electron, Neutron, and HASTE vehicles. Management anticipates recognizing approximately 45% of its backlog as revenue within the next year.
The company signed its largest commercial Electron deal ever in September, a deal with Synspective for 20 launches. If Rocket Lab can get Neutron off the ground, bookings growth could potentially accelerate.
RKLB Rocket Lab$59.10+$0.50 (+0.85%)
NASDAQ · As of 4:00 PM ET 10/29/26
Lower entry price, lower investment risk Rocket Lab's sharp decline is a great example of how a stock's story and share price often move in different directions. Neutron's delay wasn't ideal, but it doesn't erase the company's backlog or meaningfully hinder its opportunity to compete with SpaceX over the long term.
Rocket Lab has a market cap of about $35 billion at its current price, valuing the stock at roughly 27 times Wall Street's revenue estimates for next year, which are approximately $1.3 billion.
That's not a jaw-droppingly low valuation, but it is the most attractive entry point Rocket Lab's stock has offered investors in months. It seems like a solid opportunity for long-term investors who have been waiting to smash that buy button.
Medical Properties Trust remains a 'strong buy' despite a 38.8% decline since August, with shares trading at deep value multiples. Q3 2026 results showed revenue growth but missed analyst expectations, while bottom-line gains were driven by asset sales and debt refinancing. Tenant health and rent coverage ratios have deteriorated, and MPW's net leverage ratio remains elevated versus peers, justifying the market discount.
New York, New York--(Newsfile Corp. - October 30, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against DICK's Sporting Goods, Inc. ("Dick's Sporting Goods" or the "Company") (NYSE: DKS) on behalf of investors that purchased or otherwise acquired Dick's Sporting Goods common stock between September 8, 2025 and August 24, 2026 (the "Class Period").
CLICK HERE TO JOIN THE CASE
If you are an investor in Dick's Sporting Goods and have suffered losses, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing [email protected] or by calling (646) 315-9003.
DEADLINE REMINDER: If you are a member of the proposed Class, you may move the court no later than November 3, 2026 for an opportunity to be lead plaintiff for the purported class. If you have losses we encourage you to contact us to learn more about the lead plaintiff process. You need not seek to become a lead plaintiff in order to share in any possible recovery.
On September 8, 2025, the first day of the Class Period, Dick's Sporting Goods announced the completion of its acquisition of Foot Locker, Inc. ("Foot Locker") for approximately $2.5 billion in cash and stock.
The complaint alleges that throughout the Class Period, Defendants misled investors regarding the Company's acquisition of Foot Locker, touting the acquisition as a strategic opportunity to drive growth and profitability while assuring investors that Foot Locker's longstanding inventory and promotional challenges had been resolved. In reality, according to the complaint, those problems persisted, as Foot Locker remained heavily dependent on legacy footwear products that were exposed to intensifying promotional pressures across the athletic footwear industry.
The truth was allegedly revealed to investors before markets opened on August 25, 2026, when Dick's Sporting Goods reported disappointing second-quarter 2026 results, which included revenue of $1.73 billion from Foot Locker that fell well short of analysts' estimates of $1.81 billion. Dick's Sporting Goods also reduced its net sales guidance for full-year 2026 and disclosed that it expected Foot Locker's proforma comparable sales to yield a range of negative 2.0% to 0.0% for the year-down from Dick's prior forecast of 1.5% to 3% growth.
On this news, the price of Dick's Sporting Goods stock fell $55.02 per share, or 30.68%, to close at $124.31 per share on August 25, 2026.
CLICK HERE TO LEARN MORE
WHY CONTACT KAPLAN FOX?
Kaplan Fox & Kilsheimer LLP is a nationally recognized law firm focused on complex litigation, with offices in New York, Oakland, Los Angeles, Chicago, and New Jersey. Founded in 1956, the firm has spent more than 50 years prosecuting securities, antitrust, and consumer protection actions in federal and state courts nationwide, recovering more than $10 billion for clients and the classes it has represented.
Kaplan Fox is widely regarded as one of the nation's premier plaintiffs' securities litigation firms and has received recognition from Chambers and Partners, Benchmark Litigation, Super Lawyers, and Lawdragon. Serving as lead or co-lead counsel in many landmark cases, the firm has secured some of the largest recoveries in the history of securities litigation, including a $2.425 billion recovery on behalf of Bank of America shareholders in In re Bank of America—the largest recovery ever obtained for claims under Section 14(a) of the Securities Exchange Act—$800 million recovered for the Arkansas Teacher Retirement System and other pension funds in ATRS v. Allianz Global Investors, and a $475 million settlement in In re Merrill Lynch.
For decades, Kaplan Fox has represented public pension funds, institutional investors, businesses, and individuals in high-stakes litigation. Through its successful advocacy and precedent-setting victories, the firm has helped shape important areas of securities and corporate law while advancing accountability and protecting investor interests.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. Past results do not guarantee future outcomes.
If you have any questions about this Notice, your rights, or your interests, please contact:
Contacting or submitting information to Kaplan Fox & Kilsheimer LLP does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client.
3Q 2026 Diluted EPS of $1.603Q 2026 C&I adjusted diluted EPS of $1.51 3Q 2026 Managed receivables of $28.1 billion Declared quarterly dividend of $1.05 per share, /PRNewswire/ -- OneMain Holdings, Inc. (NYSE: OMF), the leader in offering nonprime consumers responsible access to credit, today reported pretax income of $233 million and net income of $185 million for the third quarter of 2026, compared to $263 million and $199 million, respectively, in the prior year quarter. Earnings per diluted share were $1.60 in the third quarter of 2026, compared to $1.67 in the prior year quarter.
On October 30, 2026, OneMain declared a quarterly dividend of $1.05 per share, payable on November 13, 2026, to record holders of the Company's common stock as of the close of business on November 9, 2026.
During the quarter, the Company repurchased approximately 538 thousand shares of common stock for $34 million.
"We delivered another strong quarter, building on the positive momentum across our business and demonstrating our ability to drive growth while maintaining rigorous credit discipline," said Doug Shulman, Chairman and CEO of OneMain. "We are confident in our ability to deliver attractive returns for shareholders well into the future."
The following segment results are reported on a non-GAAP basis. Refer to the required reconciliations of non-GAAP to comparable GAAP measures at the end of this press release.
Consumer and Insurance Segment ("C&I")
C&I adjusted pretax income was $232 million and adjusted net income was $174 million for the third quarter of 2026, compared to $303 million and $227 million, respectively, in the prior year quarter. Adjusted earnings per diluted share were $1.51 for the third quarter of 2026, compared to $1.90 in the prior year quarter.
Management runs the business based on capital generation, which it defines as C&I adjusted net income excluding the after-tax change in C&I allowance for finance receivable losses while still considering the current period C&I net charge-offs. Capital generation was $284 million for the third quarter of 2026, compared to $272 million the prior year quarter. The increase was driven by receivables growth, partially offset by higher net charge-offs in the current quarter compared to the prior year period.
Managed receivables, which includes loans serviced for our whole loan sale partners and auto finance loans originated by third parties, were $28.1 billion at September 30, 2026, up 9% from $25.9 billion at September 30, 2025.
Consumer loan originations totaled $4.5 billion in the third quarter of 2026, up 17% from $3.9 billion in the prior year quarter.
Total revenue, comprising interest income and total other revenue, was $1.7 billion in the third quarter of 2026, up 7% from $1.6 billion in the prior year quarter. Interest income in the third quarter of 2026 was $1.5 billion, up 7% from $1.4 billion in the prior year quarter. The increase was driven by receivables growth.
Interest expense was $345 million in the third quarter of 2026, up 8% from $320 million in the prior year quarter, due to an increase in average debt to support our receivables growth and a higher average cost of funds.
The provision for finance receivable losses was $615 million in the third quarter of 2026, up from $488 million compared to the prior year period. During the third quarter of 2026, the allowance for finance receivable losses increased $146 million driven by receivables growth.
C&I Select Delinquency and Loss Ratios
September 30, 2026
June 30, 2026
September 30, 2025
Consumer loans:
30+ delinquency ratio
5.34 %
5.17 %
5.55 %
90+ delinquency ratio
2.26 %
2.15 %
2.35 %
30-89 delinquency ratio
3.08 %
3.02 %
3.20 %
Net charge-offs
6.89 %
7.77 %
6.67 %
Operating expense for the third quarter of 2026 was $453 million, up 6% from $427 million in the prior year quarter reflecting receivable growth and strategic investments in the business.
Funding and Liquidity
As of September 30, 2026, the Company had principal debt balances outstanding of $24.4 billion, 52% of which was secured. The Company had $936 million of cash and cash equivalents, which included $268 million of cash and cash equivalents held at regulated insurance subsidiaries or for other operating activities that are unavailable for general corporate purposes.
Cash and cash equivalents, together with the Company's $1.0 billion of undrawn committed capacity from an unsecured corporate revolver, $6.5 billion of undrawn committed capacity under revolving conduit facilities and credit card variable funding note facilities, and $12.3 billion of unencumbered receivables, provides significant liquidity resources.
Conference Call & Webcast Information
OneMain management will host a conference call and webcast to discuss the Company's results, outlook, and related matters at 9:00 am Eastern Time on Friday, October 30, 2026. Both the call and webcast are open to the general public. The general public is invited to listen to the call by dialing 877-407-0792 (U.S. domestic) or 201-689-8263 (international), and using conference ID 13762672, or via a live audio webcast through OneMain's investor relations website at http://investor.onemainfinancial.com. For those unable to listen to the live broadcast, a replay will be available on the website after the event. An investor presentation will be available on OneMain's investor relations website prior to the start of the conference call.
About OneMain Holdings, Inc.
OneMain Financial (NYSE: OMF) is the leader in offering nonprime consumers responsible access to credit and is dedicated to improving the financial well-being of hardworking Americans. We empower our customers to solve today's problems and reach a better financial future through personalized solutions across 48 states, available online and in more than 1,300 locations. OneMain is committed to making a positive impact on the people and the communities we serve. For additional information, please visit www.OneMainFinancial.com.
Use of Non-GAAP Financial Measures
We report the operating results of Consumer and Insurance using the Segment Accounting Basis, which (i) reflects our allocation methodologies for interest expense and operating costs, to reflect the manner in which we assess our business results and (ii) excludes the impact of applying purchase accounting (eliminates premiums/discounts on our finance receivables and long-term debt at acquisition, as well as the amortization/accretion in future periods). Consumer and Insurance adjusted pretax income (loss), Consumer and Insurance adjusted net income (loss), and Consumer and Insurance adjusted earnings (loss) per diluted share are key performance measures used to evaluate the performance of our business. Consumer and Insurance adjusted pretax income (loss) represents income (loss) before income taxes on a Segment Accounting Basis and excludes net loss resulting from repurchases and repayments of debt, restructuring charges, and other items and strategic activities. We believe these non-GAAP financial measures are useful in assessing the profitability of our segment.
We also use pretax capital generation and capital generation, non-GAAP financial measures, as a key performance measure of our segment. Pretax capital generation represents Consumer and Insurance adjusted pretax income, as discussed above, and excludes the change in our Consumer and Insurance allowance for finance receivable losses in the period while still considering the Consumer and Insurance net charge-offs incurred during the period. Capital generation represents the after-tax effect of pretax capital generation. We believe that these non-GAAP measures are useful in assessing the capital created in the period impacting the overall capital adequacy of the Company. We believe that the Company's reserves, combined with its equity, represent the Company's loss absorption capacity.
We utilize these non-GAAP measures in evaluating our performance. Additionally, these non-GAAP measures are consistent with the performance goals established in OMH's executive compensation program. These non-GAAP financial measures should be considered supplemental to, but not as a substitute for or superior to, income (loss) before income taxes, net income, or other measures of financial performance prepared in accordance with GAAP.
This document contains summarized information concerning the Company and its business, operations, financial performance and trends. No representation is made that the information in this document is complete. For additional financial, statistical and business related information see the Company's most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q filed with the U.S. Securities and Exchange Commission (the "SEC"), as well as the Company's other reports filed with the SEC from time to time, which are or will be available in the Investor Relations section of the OneMain Financial website (www.omf.com) and the SEC's website (www.sec.gov).
This document contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Statements preceded by, followed by or that otherwise include the words "anticipates," "appears," "assumes," "believes," "can," "continues," "could," "estimates," "expects," "forecasts," "foresees," "goal," "intends," "likely," "objective," "plans," "projects," "target," "trend," "remains," and similar expressions or future or conditional verbs such as "could," "may," "might," "should," "will" or "would" are intended to identify forward-looking statements, but these words are not the exclusive means of identifying forward-looking statements.
Forward-looking statements are not statements of historical fact but instead represent only management's current beliefs regarding future events, objectives, goals, projections, strategies, performance, and future plans, and underlying assumptions and other statements related thereto. You should not place undue reliance on these forward-looking statements. By their nature, forward-looking statements are subject to risks, uncertainties, assumptions and other important factors that may cause actual results, performance or achievements to differ materially from those expressed in or implied by such forward-looking statements. Important factors that could cause actual results, performance, or achievements to differ materially from those expressed in or implied by forward-looking statements include, without limitation, the following: adverse changes and volatility in general economic conditions, including the interest rate environment and the financial markets; the sufficiency of our allowance for finance receivable losses; increased levels of unemployment and personal bankruptcies; the current inflationary environment and related trends affecting our customers; natural or accidental events such as earthquakes, hurricanes, pandemics, floods or wildfires affecting our customers, collateral, or our facilities; a failure in or breach of our information, operational or security systems or infrastructure or those of third parties, including as a result of cyber incidents, war or other disruptions; the adequacy of our credit risk scoring models; geopolitical risks, including recent geopolitical actions; adverse changes in our ability to attract and retain employees or key executives; increased competition or adverse changes in customer responsiveness to our distribution channels or products; changes in federal, state, or local laws, regulations, or regulatory policies and practices or increased regulatory scrutiny of our business or industry; risks associated with our insurance operations; the costs and effects of any actual or alleged violations of any federal, state, or local laws, rules or regulations; the costs and effects of any fines, penalties, judgments, decrees, orders, inquiries, investigations, subpoenas, or enforcement or other proceedings of any governmental or quasi-governmental agency or authority; our substantial indebtedness and our continued ability to access the capital markets and maintain adequate current sources of funds to satisfy our cash flow requirements; our ability to comply with all of our covenants; the effects of any downgrade of our debt ratings by credit rating agencies; and other risks and uncertainties described in the "Risk Factors" and "Management's Discussion and Analysis" sections of the Company's most recent Form 10-K filed with the SEC and in the Company's other filings with the SEC from time to time.
If one or more of these or other risks or uncertainties materialize, or if our underlying assumptions prove to be incorrect, our actual results may vary materially from what we may have expressed or implied by these forward-looking statements. You should specifically consider the factors identified in this document that could cause actual results to differ before making an investment decision to purchase our securities. Furthermore, new risks and uncertainties arise from time to time, and it is impossible for us to predict those events or how they may affect us.
Forward looking statements included in this document speak only as of the date on which they were made. We undertake no obligation to update or revise any forward-looking statements, whether written or oral, to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events or the non-occurrence of anticipated events, whether as a result of new information, future developments or otherwise, except as required by law.
OneMain Holdings, Inc.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Quarter Ended
Fiscal Year
(unaudited, $ in millions, except per share amounts)
Sep 30,
2026
Jun 30,
2026
Mar 31,
2026
Dec 31,
2025
Sep 30,
2025
2025
2024
Interest income
$ 1,491
$ 1,417
$ 1,387
$ 1,416
$ 1,392
$ 5,455
$ 4,993
Interest expense
(345)
(326)
(322)
(323)
(320)
(1,272)
(1,185)
Net interest income
1,146
1,091
1,065
1,093
1,072
4,183
3,808
Provision for finance receivable losses
(615)
(610)
(465)
(542)
(488)
(1,997)
(2,040)
Net interest income after provision for finance receivable losses
531
481
600
551
584
2,186
1,768
Insurance
113
112
112
113
112
445
445
Investment
24
25
23
22
26
98
108
Gain on sales of finance receivables
16
16
16
14
17
64
23
Net loss on repurchases and repayments of debt
—
(1)
(3)
(1)
(39)
(67)
(34)
Other
59
55
49
45
47
180
153
Total other revenues
212
207
197
193
163
720
695
Operating expenses
(457)
(448)
(449)
(447)
(436)
(1,707)
(1,607)
Insurance policy benefits and claims
(53)
(44)
(52)
(48)
(48)
(198)
(189)
Total other expenses
(510)
(492)
(501)
(495)
(484)
(1,905)
(1,796)
Income before income taxes
233
196
296
249
263
1,001
667
Income taxes
(48)
(44)
(70)
(45)
(64)
(218)
(158)
Net income
$ 185
$ 152
$ 226
$ 204
$ 199
$ 783
$ 509
Weighted average number of diluted shares
115.5
115.8
117.3
118.3
119.4
119.3
120.1
Diluted EPS
$ 1.60
$ 1.32
$ 1.93
$ 1.72
$ 1.67
$ 6.56
$ 4.24
Book value per basic share
$ 29.59
$ 29.40
$ 29.21
$ 29.01
$ 28.53
$ 29.01
$ 26.74
Return on assets
2.6 %
2.3 %
3.4 %
3.0 %
3.0 %
2.9 %
2.0 %
Change in allowance for finance receivable losses
$ (146)
$ (104)
$ 46
$ (50)
$ (61)
$ (160)
$ (194)
Net charge-offs
(469)
(506)
(511)
(492)
(427)
(1,837)
(1,846)
Provision for finance receivable losses
$ (615)
$ (610)
$ (465)
$ (542)
$ (488)
$ (1,997)
$ (2,040)
Note:
Quarters may not sum to fiscal year due to rounding.
OneMain Holdings, Inc.
CONSOLIDATED BALANCE SHEETS (UNAUDITED)
As of
(unaudited, $ in millions)
Sep 30,
2026
Jun 30,
2026
Mar 31,
2026
Dec 31,
2025
Sep 30,
2025
Assets
Cash and cash equivalents
$ 936
$ 567
$ 834
$ 914
$ 658
Investment securities
1,550
1,649
1,614
1,590
1,657
Net finance receivables
26,273
25,145
24,447
24,833
24,465
Unearned insurance premium and claim reserves
(825)
(792)
(771)
(791)
(783)
Allowance for finance receivable losses
(3,069)
(2,923)
(2,819)
(2,865)
(2,815)
Net finance receivables, less unearned insurance premium and claim reserves and allowance for finance
receivable losses
22,379
21,430
20,857
21,177
20,867
Restricted cash and restricted cash equivalents
751
738
728
699
748
Goodwill
1,474
1,474
1,474
1,474
1,474
Other intangible assets
278
279
281
282
284
Other assets
1,349
1,287
1,230
1,252
1,297
Total assets
$ 28,717
$ 27,424
$ 27,018
$ 27,388
$ 26,985
Liabilities and Shareholders' Equity
Long-term debt
$ 24,074
$ 22,769
$ 22,396
$ 22,694
$ 22,338
Insurance claims and policyholder liabilities
530
552
566
576
578
Deferred and accrued taxes
18
16
55
35
42
Other liabilities
704
704
624
682
649
Total liabilities
25,326
24,041
23,641
23,987
23,607
Common stock
1
1
1
1
1
Additional paid-in capital
1,768
1,758
1,750
1,757
1,750
Accumulated other comprehensive loss
(86)
(54)
(53)
(41)
(47)
Retained earnings
2,773
2,710
2,680
2,579
2,500
Treasury stock
(1,065)
(1,032)
(1,001)
(895)
(826)
Total shareholders' equity
3,391
3,383
3,377
3,401
3,378
Total liabilities and shareholders' equity
$ 28,717
$ 27,424
$ 27,018
$ 27,388
$ 26,985
OneMain Holdings, Inc.
CONSOLIDATED KEY FINANCIAL METRICS (UNAUDITED)
As of
(unaudited, $ in millions)
Sep 30,
2026
Jun 30,
2026
Mar 31,
2026
Dec 31,
2025
Sep 30,
2025
Liquidity
Cash and cash equivalents
$ 936
$ 567
$ 834
$ 914
$ 658
Cash and cash equivalents unavailable for general corporate purposes
Allowance for finance receivable losses, net of tax *
2,302
2,192
2,114
2,149
2,111
Adjusted capital
$ 4,200
$ 4,049
$ 3,962
$ 4,008
$ 3,950
Net leverage (net adjusted debt to adjusted capital)
5.5x
5.5x
5.4x
5.4x
5.5x
*
Income taxes assume a 25% tax rate.
OneMain Holdings, Inc.
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES (UNAUDITED)
Quarter Ended
Fiscal Year
(unaudited, $ in millions)
Sep 30,
2026
Jun 30,
2026
Mar 31,
2026
Dec 31,
2025
Sep 30,
2025
2025
2024
Consumer & Insurance
$ 231
$ 194
$ 293
$ 247
$ 261
$ 988
$ 707
Other
—
(1)
—
—
(2)
(4)
(1)
Segment to GAAP adjustment
2
3
3
2
4
17
(39)
Income before income taxes - GAAP basis
$ 233
$ 196
$ 296
$ 249
$ 263
$ 1,001
$ 667
Consumer & Insurance pretax income
$ 231
$ 194
$ 293
$ 247
$ 261
$ 988
$ 707
Net loss on repurchases and repayments of debt
—
1
3
—
39
65
33
Restructuring charges
—
5
7
1
2
4
29
Other (1)
1
1
2
2
1
3
13
Consumer & Insurance adjusted pretax income (non-GAAP)
$ 232
$ 201
$ 305
$ 250
$ 303
$ 1,060
$ 782
Reconciling items (2)
$ 1
$ (4)
$ (9)
$ (1)
$ (38)
$ (55)
$ (114)
Consumer & Insurance
$ 26,283
$ 25,157
$ 24,463
$ 24,853
$ 24,490
$ 24,853
$ 23,598
Segment to GAAP adjustment
(10)
(12)
(16)
(20)
(25)
(20)
(44)
Net finance receivables - GAAP basis
$ 26,273
$ 25,145
$ 24,447
$ 24,833
$ 24,465
$ 24,833
$ 23,554
Consumer & Insurance
$ 3,071
$ 2,925
$ 2,821
$ 2,868
$ 2,818
$ 2,868
$ 2,710
Segment to GAAP adjustment
(2)
(2)
(2)
(3)
(3)
(3)
(5)
Allowance for finance receivable losses - GAAP basis
$ 3,069
$ 2,923
$ 2,819
$ 2,865
$ 2,815
$ 2,865
$ 2,705
Note:
Quarters may not sum to fiscal year due to rounding.
(1)
Includes strategic activities and other items.
(2)
Reconciling items consist of Segment to GAAP adjustment and the adjustments to Pretax income – segment accounting basis for C&I and Other. The adjustments to Other adjusted pretax income (loss) are not disclosed in the table above due to immateriality.
Consumer & Insurance financial information is presented on a Segment Accounting Basis. Delinquency ratios are calculated as a percentage of C&I consumer loan net finance receivables. Amounts may not sum due to rounding.
Defined Terms
Adjusted capital: adjusted tangible common equity plus allowance for finance receivable losses (ALLL), net of taxAdjusted tangible common equity (TCE): total shareholders' equity less accumulated other comprehensive loss less goodwill less other intangible assets plus junior subordinated debtAuto finance: financing at the point of purchase through a network of auto dealershipsAvailable cash and cash equivalents: cash and cash equivalents less cash and cash equivalents held at our regulated insurance subsidiaries or is unavailable for general corporate purposesAverage total assets: average of monthly average total assets (total assets at the beginning and end of each month divided by two) in the periodC&I adjusted diluted EPS: C&I adjusted net income (non-GAAP) / weighted average diluted sharesCapital generation: C&I adjusted net income less change in C&I allowance for finance receivable losses, net of taxCapital generation return on receivables*: annualized capital generation / C&I average net receivablesConsumer loans: personal loans and auto financeFinance receivables serviced for others: unpaid principal balance plus accrued interest of loans sold as part of our whole loan sale program plus auto finance loans originated by third parties.Gross charge-off ratio*: annualized gross charge-offs / average net receivablesManaged receivables: C&I net finance receivables plus finance receivables serviced for our whole loan sale partners plus auto finance loans originated by third partiesNet adjusted debt: long-term debt less junior subordinated debt less available cash and cash equivalentsNet charge-off ratio*: annualized net charge-offs / average net receivablesNet leverage: net adjusted debt / adjusted capitalOpex ratio: annualized C&I operating expenses / average managed receivablesOrigination volume: loans originated during the period, including those originated and sold to our whole loan sale partners that we continue to serviceOther net revenue: other revenues less insurance policy benefits and claims expensePersonal loans: loans secured by automobiles, other collateral or are unsecured and offered through our branch network, central operations, or digital platformPretax capital generation: C&I pretax adjusted net income less change in C&I allowance for finance receivable lossesPurchase volume: credit card purchase transactions plus cash advances less returnsReturn on assets (ROA): annualized net income / average total assetsReturn on receivables (C&I ROR): annualized C&I adjusted net income / C&I average net receivablesTotal revenue: C&I interest income plus C&I total other revenueUnencumbered receivables: unencumbered unpaid principal balance of consumer loans and credit cards. For precompute personal loans, unpaid principal balance is the gross contractual payments less the unaccreted balance of unearned finance charges. Credit card receivables include those in the trust that exceed the minimum for securing advances under credit card variable funding note facilities, which the Company can remove from the trust under the terms of such facilities, and exclude interest, fees, and closed accounts with balances*
Fiscal year 2024 adjusted for policy alignment associated with the Foursight acquisition.
OneMain Holdings, Inc.
Investor Contact:
Peter R. Poillon, 212-359-2432
[email protected]
Media Contact:
Maggie Gage, 202-538-9660
[email protected]
NEW YORK--(BUSINESS WIRE)--WisdomTree, Inc. (NYSE: WT), a modern global asset manager, today reported financial results for the third quarter of 2026.
$49.2 million of net income ($49.5(1) million, as adjusted). See “Non-GAAP Financial Measurements” for a reconciliation to net income.
$171.0 billion of ending AUM, an increase of 5.0% from the prior quarter arising from net inflows and market appreciation.
$4.6 billion of net inflows, across the United States and Europe primarily driven by inflows into our fixed income, commodity and U.S. equity products.
0.36% average advisory fee, unchanged from the prior quarter.
0.42% revenue yield(2), a 1 basis point decrease from the prior quarter due to lower transaction fees from our European ETPs and lower performance fees.
$179.4 million of operating revenues, an increase of 1.3% from the prior quarter due to higher average AUM, partly offset by lower transaction fees from our European ETPs and lower performance fees.
83.0% gross margin(1), essentially unchanged from the prior quarter.
41.3% operating income margin for the quarter (43.1% as adjusted), a 0.8 point increase (0.5 point increase, as adjusted) from the prior quarter primarily due to higher revenues.
39.8% operating income margin year-to-date (41.8% as adjusted), a 6.8 point increase (7.5 point(3) increase, as adjusted) from the prior-year period. The increase primarily reflected favorable operating leverage from revenue growth, partially offset by higher intangible amortization associated with the Ceres Partners, LLC (“Ceres”) and Atlantic House Holdings Limited (“Atlantic House”) acquisitions. Adjusted operating income excludes intangible asset amortization and acquisition-related costs.
$18.1 million aggregate principal amount of convertible senior notes due 2029 (the “2029 Notes”) retired, for aggregate cash consideration of $32.3 million. The conversion price of the 2029 Notes was $11.82.
$10.6 million of common stock repurchased, representing approximately 0.5 million shares at an average repurchase price of $21.29 per share.
$0.03 quarterly dividend declared, payable on November 25, 2026 to stockholders of record as of the close of business on November 11, 2026.
Update from Jarrett Lilien, WisdomTree President and COO
Update from Jonathan Steinberg, WisdomTree CEO
OPERATING AND FINANCIAL HIGHLIGHTS
Three Months Ended
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Consolidated Operating Highlights ($ in billions):
AUM—end of period
$
171.0
$
162.9
$
152.6
$
144.5
$
137.2
Net inflows/(outflows)
$
4.6
$
3.1
$
5.9
$
(0.3
)
$
2.2
Average AUM
$
170.5
$
164.2
$
154.7
$
140.7
$
130.8
Average advisory fee
0.36%
0.36%
0.36%
0.35%
0.35%
Revenue yield(2)
0.42%
0.43%
0.42%
0.42%
0.38%
Consolidated Financial Highlights ($ in millions, except per share amounts):
Operating revenues
$
179.4
$
177.2
$
159.5
$
147.4
$
125.6
Net income/(loss)
$
49.2
$
44.3
$
(23.1
)
$
40.0
$
19.7
Diluted earnings/(loss) per share
$
0.32
$
0.28
$
(0.17
)
$
0.28
$
0.13
Operating income margin
41.3%
40.5%
37.2%
40.5%
36.3%
As Adjusted (Non-GAAP(1)):
Operating revenues, as adjusted
$
179.4
$
177.2
$
159.5
$
147.4
$
125.6
Gross margin
83.0%
82.9%
84.4%
83.2%
82.2%
Net income, as adjusted
$
49.5
$
48.1
$
40.6
$
41.2
$
34.5
Diluted earnings per share, as adjusted
$
0.32
$
0.31
$
0.27
$
0.29
$
0.23
Operating income margin, as adjusted
43.1%
42.6%
39.3%
41.7%
38.3%
RECENT BUSINESS DEVELOPMENTS
WISDOMTREE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(Unaudited)
Three Months Ended
Nine Months Ended
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Sept. 30,
2026
Sept. 30,
2025
Operating Revenues:
Advisory fees
$
151,631
$
146,300
$
134,880
$
122,712
$
114,485
$
432,811
$
317,275
Management fees
5,420
5,369
5,231
4,908
—
16,020
—
Performance fees
3,778
5,964
2,955
7,105
—
12,697
—
Other revenues
18,546
19,527
16,404
12,709
11,131
54,477
29,044
Total revenues
179,375
177,160
159,470
147,434
125,616
516,005
346,319
Operating Expenses:
Compensation and benefits
44,770
43,718
47,517
37,273
33,791
136,005
100,406
Fund management and administration
30,532
30,229
24,880
24,830
22,353
85,641
64,319
Marketing and advertising
5,426
6,041
5,392
5,613
4,788
16,859
14,931
Sales and business development
4,820
4,938
4,197
4,045
3,943
13,955
12,312
Professional fees
4,263
4,098
3,308
3,596
3,505
11,669
9,464
Occupancy, communications and equipment
2,620
2,229
1,935
1,892
1,601
6,784
4,642
Depreciation and amortization
4,028
3,415
2,096
2,043
615
9,539
1,735
Third-party distribution fees
5,334
5,401
5,795
4,772
3,977
16,530
11,172
Acquisition-related costs
—
1,118
1,933
317
2,409
3,051
4,376
Other
3,460
4,162
3,067
3,306
2,980
10,689
8,514
Total operating expenses
105,253
105,349
100,120
87,687
79,962
310,722
231,871
Operating income
74,122
71,811
59,350
59,747
45,654
205,283
114,448
Other Income/(Expenses):
Interest expense
(13,520
)
(14,852
)
(11,023
)
(11,023
)
(8,466
)
(39,395
)
(19,397
)
Interest income
1,841
3,203
2,592
2,965
4,015
7,636
8,002
Loss on repurchase of convertible notes
—
(6,623
)
(62,302
)
(833
)
(13,011
)
(68,925
)
(13,011
)
Remeasurement of contingent consideration
2,069
(1,360
)
(2,562
)
(710
)
—
(1,853
)
—
Other losses and gains, net
(35
)
6,368
(637
)
317
1,325
5,696
1,713
Income/(loss) before income taxes
64,477
58,547
(14,582
)
50,463
29,517
108,442
91,755
Income tax expense
15,261
14,263
8,549
10,437
9,816
38,073
22,648
Net income/(loss)
$
49,216
$
44,284
$
(23,131
)
$
40,026
$
19,701
$
70,369
$
69,107
Earnings/(loss) per share—basic
$
0.33
$
0.30
$
(0.17
)
$
0.29
$
0.14(4
)
$
0.49
$
0.48
Earnings/(loss) per share—diluted
$
0.32
$
0.28
$
(0.17
)
$
0.28
$
0.13(4
)
$
0.46
$
0.47
Weighted average common shares—basic
147,570
149,001
138,005
136,340
139,584
144,894
141,736
Weighted average common shares—diluted
156,179
156,276
138,005
143,314
150,675
153,767
146,360
As Adjusted (Non-GAAP(1))
Total revenues
$ 179,375
$ 177,160
$ 159,470
$ 147,434
$ 125,616
Total operating expenses
$ 102,032
$ 101,619
$ 96,752
$ 85,936
$ 77,553
Operating income
$ 77,343
$ 75,541
$ 62,718
$ 61,498
$ 48,063
Income before income taxes
$ 65,679
$ 63,354
$ 54,654
$ 53,840
$ 45,318
Income tax expense
$ 16,199
$ 15,274
$ 14,061
$ 12,605
$ 10,842
Net income
$ 49,480
$ 48,080
$ 40,593
$ 41,235
$ 34,476
Earnings per share—diluted
$ 0.32
$ 0.31
$ 0.27
$ 0.29
$ 0.23
Weighted average common shares—diluted
156,179
156,276
152,372
143,314
150,675
QUARTERLY HIGHLIGHTS
Operating Revenues
Operating revenues increased 1.3% from the second quarter of 2026 due to higher average AUM, partly offset by lower transaction fees from our European ETPs and lower performance fees. Operating revenues increased 42.8% from the third quarter of 2025 due to higher average AUM, a higher average advisory fee, revenues arising from the Ceres and Atlantic House acquisitions and increased other revenues from our European listed ETPs. Our average advisory fee was 0.36% for the second and third quarters of 2026 and 0.35% for the third quarter of 2025. Operating Expenses
Operating expenses were essentially unchanged from the second quarter of 2026. Operating expenses increased 31.6% from the third quarter of 2025 primarily due to higher incentive compensation and headcount, as well as increased fund management and administration expenses, intangible asset amortization related to the Ceres and Atlantic House acquisitions and third-party distribution fees, partly offset by lower acquisition-related costs. Other Income/(Expenses)
Interest expense decreased 9.0% from the second quarter of 2026, reflecting a lower level of debt outstanding. Interest expense increased 59.7% from the third quarter of 2025, reflecting a higher level of debt outstanding and higher interest rates. Interest income decreased 42.5% and 54.1% from the second quarter of 2026 and the third quarter of 2025, respectively, reflecting a lower level of interest earning assets following recent debt retirements and stock repurchases. Contingent consideration related to the Ceres acquisition decreased from $15.8 million on June 30, 2026 to $13.7 million at September 30, 2026, resulting in a $2.1 million gain on remeasurement recognized during the third quarter of 2026. Other losses and gains, net, was a loss of $0.04 million for the third quarter of 2026. Gains and losses generally arise on our financial instruments and investments owned, as well as from the sale of gold and cryptocurrency earned from advisory fees paid by our physically-backed gold and crypto ETPs, foreign exchange fluctuations and miscellaneous items. Income Taxes
Our effective income tax rate for the third quarter of 2026 was 23.7%, resulting in income tax expense of $15.3 million. The effective tax rate differs from the U.S. federal statutory rate of 21.0% primarily due to non-deductible executive compensation and state taxes, partly offset by a reduction in the capital loss valuation allowance. Our adjusted effective income tax rate for the third quarter of 2026 was 24.7%(1). NINE MONTH HIGHLIGHTS
Operating revenues increased 49.0% as compared to 2025 due to higher average AUM, a higher average advisory fee, revenues arising from the Ceres and Atlantic House acquisitions and increased other revenues from our European listed ETPs. Operating expenses increased 34.0% as compared to 2025 primarily due to higher incentive compensation and headcount, as well as increased fund management and administration expenses, third-party distribution fees and intangible asset amortization arising from the Ceres and Atlantic House acquisitions. Significant items reported in other income/(expense) in 2026 include: an increase in interest expense of 103.1% due to a higher level of debt outstanding and higher interest rates; a decrease in interest income of 4.6% reflecting a lower level of interest earning assets following recent debt retirements and stock repurchases; a remeasurement gain of $4.4 million on British pounds held to complete the Atlantic House acquisition, net gains on our financial instruments owned of $2.0 million, net losses on our investments of $0.4 million and $0.6 million of foreign currency remeasurement gains on U.S. dollars held by foreign subsidiaries. Gains and losses also generally arise from the sale of gold earned on advisory fees paid by our physically-backed gold ETPs, other foreign exchange fluctuations and miscellaneous items. Our effective income tax rate for 2026 was 35.1%, resulting in an income tax expense of $38.1 million. The effective tax rate differs from the federal statutory rate of 21.0% primarily due to non-deductible amounts associated with the repurchase of convertible notes. CONFERENCE CALL DIAL-IN AND WEBCAST DETAILS
WisdomTree will discuss its results and operational highlights during a live webcast on Friday, October 30, 2026 at 11:00 a.m. ET, which, together with all earnings materials, can be accessed via WisdomTree’s investor relations website at https://ir.wisdomtree.com. A replay of the webcast will be available shortly after the call.
Participants also can dial in using the following numbers: (877) 407-9210 or (201) 689-8049. Click here to access the participant international toll-free access numbers.
To avoid delays, we encourage participants to log in or dial into the conference call 10 minutes ahead of the scheduled start time.
About WisdomTree
WisdomTree is a modern global asset manager with capabilities across public markets, private markets, tokenization and onchain finance. We offer a diverse suite of exchange-traded products, models and solutions, private market investments and blockchain-enabled products and services, helping investors shape their financial future and financial professionals grow their businesses. Through WisdomTree Onchain™, we combine tokenized investment products, infrastructure and distribution capabilities into an integrated financial services platform serving retail and institutional investors.
WisdomTree currently has approximately $175.0 billion in assets under management globally, inclusive of assets managed by Ceres as of the last reportable period.
For more information about WisdomTree visit: https://www.wisdomtree.com.
For more information about WisdomTree Onchain, visit: https://www.wisdomtree.com/onchain.
Please visit us on X at @WisdomTreeNews.
WisdomTree® is the marketing name for WisdomTree, Inc. and its subsidiaries worldwide.
The WisdomTree Connect™ institutional platform and WisdomTree Prime® digital wallet and digital asset services are made available through WisdomTree Digital Movement, Inc., a federally registered money services business, state-licensed money transmitter and financial technology company (NMLS ID: 2372500) or WisdomTree Digital Trust Company, LLC, and may be limited where prohibited by law. WisdomTree Digital Trust Company, LLC is chartered as a limited purpose trust company by the New York State Department of Financial Services to engage in virtual currency business. Visit https://wisdomtreeconnect.com, https://www.wisdomtreeprime.com or the WisdomTree Prime mobile app for more information.
PRODUCTS AND SERVICES AVAILABLE VIA WISDOMTREE CONNECT AND WISDOMTREE PRIME:
NOT FDIC INSURED | NO BANK GUARANTEE | NOT A BANK DEPOSIT | MAY LOSE VALUE | NOT SIPC PROTECTED | NOT INSURED, ENDORSED, INDEMNIFIED OR GUARANTEED BY ANY GOVERNMENT AGENCY
References to third-party platforms, protocols, or use cases are provided for informational purposes only and do not constitute an endorsement, recommendation, or solicitation by WisdomTree or its affiliates. WisdomTree and its affiliates do not control or operate such third-party platforms or protocols and are not responsible for their operation or performance.
_______________________ (1)
See “Non-GAAP Financial Measurements.”
(2)
Revenue yield is computed by dividing our annualized adjusted operating revenues as reported in the GAAP to Non-GAAP Reconciliation herein by our average AUM during the period.
(3)
Adjusted operating margin is calculated as adjusted operating income divided by total revenues. Adjusted operating income excludes intangible asset amortization of $7.3 million for the nine months ended September 30, 2026 (none in the prior year period) and acquisition-related costs of $3.1 million and $4.4 million for the nine months ended September 30, 2026 and 2025, respectively.
(4)
Earnings per share (“EPS”) is calculated pursuant to the two-class method as it results in a lower EPS amount as compared to the treasury stock method. In addition, the three months ended September 30, 2025 includes $0.7 million of stock repurchase excise taxes, which is excluded from net income, but is required to be added to net income to arrive at income available to common stockholders in the calculation of EPS. This item is excluded from our EPS when computed on a non-GAAP basis.
WISDOMTREE, INC. AND SUBSIDIARIES
KEY OPERATING STATISTICS
(Unaudited)
Three Months Ended
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
GLOBAL PRODUCTS ($ in millions)
Beginning of period assets
$
162,910
$
152,556
$
144,525
$
137,175
$
126,070
Add: Assets acquired—Ceres acquisition
—
—
—
1,812
—
Add: Assets acquired—Atlantic House acquisition
—
4,137
—
—
—
Inflows/(outflows)
4,622
3,063
5,934
(283
)
2,241
Market appreciation
3,453
3,154
2,097
5,821
8,864
End of period assets
$
170,985
$
162,910
$
152,556
$
144,525
$
137,175
Average assets during the period
$
170,504
$
164,150
$
154,654
$
140,686
$
130,760
Average ETPs and tokenized products during the period
$
168,466
$
162,151
$
152,716
$
138,871
$
130,760
Average ETP advisory fee during the period
0.36%
0.36%
0.36%
0.35%
0.35%
Total revenue yield
0.42%
0.43%
0.42%
0.42%
0.38%
Revenue days
92
91
90
92
92
Number of products—end of the period
434
428
414
405
397
ETPs AND ONCHAIN PRODUCTS
U.S. LISTED ETFs ($ in millions)
Beginning of period assets
$
99,014
$
90,946
$
88,521
$
88,293
$
85,179
Inflows/(outflows)
2,382
1,079
2,643
(1,108
)
(445
)
Market appreciation/(depreciation)
240
6,989
(218
)
1,336
3,559
End of period assets
$
101,636
$
99,014
$
90,946
$
88,521
$
88,293
Average assets during the period
$
101,620
$
96,585
$
91,742
$
88,074
$
87,205
Number of ETFs—end of the period
93
92
90
85
84
EUROPEAN LISTED ETPs ($ in millions)
Beginning of period assets
$
61,106
$
58,758
$
53,345
$
48,290
$
40,541
Add: Assets acquired—Atlantic House acquisition
—
4,137
—
—
—
Inflows
1,731
2,090
3,118
609
2,448
Market appreciation/(depreciation)
3,184
(3,879
)
2,295
4,446
5,301
End of period assets
$
66,021
$
61,106
$
58,758
$
53,345
$
48,290
Average assets during the period
$
65,874
$
64,649
$
60,193
$
50,102
$
42,853
Number of ETPs—end of the period
320
315
304
300
295
ONCHAIN AUM ($ in millions)
Beginning of period assets
$
761
$
867
$
770
$
592
$
350
Inflows/(outflows)
509
(110
)
98
179
238
Market appreciation/(depreciation)
3
4
(1
)
(1
)
4
End of period assets
$
1,273
$
761
$
867
$
770
$
592
Average assets during the period
$
972
$
917
$
781
$
695
$
702
Number of products—end of the period
19
19
19
19
18
PRIVATE ASSETS ($ in millions)
Beginning of period assets
$
2,029
$
1,985
$
1,889
$
—
$
—
Add: Assets acquired—Ceres acquisition
—
—
—
1,812
—
Inflows
—
4
75
37
—
Market appreciation
26
40
21
40
—
End of period assets
$
2,055
$
2,029
$
1,985
$
1,889
$
—
Average assets during the period
$
2,038
$
1,999
$
1,938
$
1,815
$
—
Number of products—end of the period
2
2
1
1
—
ETPs AND ONCHAIN PRODUCT CATEGORIES ($ in millions)
U.S. Equity
Beginning of period assets
$
46,371
$
41,511
$
41,427
$
40,977
$
38,617
Inflows
769
458
354
191
32
Market appreciation/(depreciation)
57
4,402
(270
)
259
2,328
End of period assets
$
47,197
$
46,371
$
41,511
$
41,427
$
40,977
Average assets during the period
$
47,740
$
44,884
$
42,394
$
41,161
$
40,024
Commodity & Currency
Beginning of period assets
$
37,586
$
40,310
$
36,980
$
31,705
$
26,696
Inflows
1,009
1,890
35
177
1,096
Market appreciation/(depreciation)
2,497
(4,614
)
3,295
5,098
3,913
End of period assets
$
41,092
$
37,586
$
40,310
$
36,980
$
31,705
Average assets during the period
$
41,206
$
41,749
$
41,458
$
33,824
$
28,162
International Developed Market Equity
Beginning of period assets
$
32,219
$
29,186
$
25,616
$
23,893
$
21,725
(Outflows)/inflows
(135
)
749
3,495
1,147
478
Market appreciation
422
2,284
75
576
1,690
End of period assets
$
32,506
$
32,219
$
29,186
$
25,616
$
23,893
Average assets during the period
$
32,909
$
32,022
$
29,349
$
24,708
$
22,481
Fixed Income
Beginning of period assets
$
22,658
$
22,395
$
21,074
$
22,509
$
22,543
Inflows/(outflows)
2,719
320
1,272
(1,358
)
(58
)
Market (depreciation)/appreciation
(200
)
(57
)
49
(77
)
24
End of period assets
$
25,177
$
22,658
$
22,395
$
21,074
$
22,509
Average assets during the period
$
23,862
$
22,179
$
21,187
$
21,422
$
23,128
Emerging Market Equity
Beginning of period assets
$
11,279
$
10,143
$
10,643
$
10,855
$
10,957
Outflows
(106
)
(106
)
(206
)
(508
)
(250
)
Market (depreciation)/appreciation
(80
)
1,242
(294
)
296
148
End of period assets
$
11,093
$
11,279
$
10,143
$
10,643
$
10,855
Average assets during the period
$
11,248
$
11,188
$
10,902
$
10,839
$
10,874
Alternatives
Beginning of period assets
$
5,708
$
1,580
$
1,379
$
1,155
$
814
Add: Assets acquired—Atlantic House acquisition
—
4,137
—
—
—
Inflows
52
31
207
163
231
Market appreciation/(depreciation)
92
(40
)
(6
)
61
110
End of period assets
$
5,852
$
5,708
$
1,580
$
1,379
$
1,155
Average assets during the period
$
5,865
$
4,462
$
1,620
$
1,270
$
929
Leveraged & Inverse
Beginning of period assets
$
3,464
$
3,663
$
3,275
$
2,913
$
2,631
Inflows/(outflows)
272
(354
)
565
(15
)
(52
)
Market (depreciation)/appreciation
(102
)
155
(177
)
377
334
End of period assets
$
3,634
$
3,464
$
3,663
$
3,275
$
2,913
Average assets during the period
$
3,665
$
3,772
$
3,785
$
3,097
$
2,750
Cryptocurrency
Beginning of period assets
$
1,596
$
1,783
$
2,242
$
3,168
$
2,087
Inflows/(outflows)
42
71
137
(117
)
764
Market appreciation/(depreciation)
741
(258
)
(596
)
(809
)
317
End of period assets
$
2,379
$
1,596
$
1,783
$
2,242
$
3,168
Average assets during the period
$
1,971
$
1,895
$
2,021
$
2,550
$
2,412
Headcount
438
414
357
360
338
Note: Previously issued statistics may be restated due to fund closures and trade adjustments.
Source: WisdomTree
WISDOMTREE, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
Sept. 30,
2026
Dec. 31,
2025
(Unaudited)
ASSETS
Current assets:
Cash, cash equivalents and restricted cash
$
299,740
$
311,732
Financial instruments owned, at fair value
41,014
107,117
Accounts receivable
72,696
64,452
Prepaid expenses
11,326
7,338
Other current assets
2,304
1,723
Total current assets
427,080
492,362
Fixed assets, net
548
431
Deferred tax assets, net
—
9,803
Investments
31,747
29,075
Right of use assets—operating leases
2,324
2,764
Goodwill
360,495
228,624
Intangible assets, net
823,447
748,957
Other noncurrent assets
1,445
925
Total assets
$
1,647,086
$
1,512,941
LIABILITIES AND STOCKHOLDERS’ EQUITY
LIABILITIES
Current liabilities:
Compensation and benefits payable
$
48,286
$
52,435
Fund management and administration payable
31,766
29,448
Payable to Gold Bullion Holdings (Jersey) Limited (“GBH”)
14,667
13,940
Income taxes payable
3,889
2,295
Operating lease liabilities
1,752
1,614
Convertible notes—current
—
149,604
Accounts payable and other liabilities
20,212
32,720
Total current liabilities
120,572
282,056
Convertible notes—long term
1,058,716
804,203
Contingent consideration
13,697
11,844
Deferred tax liabilities
7,776
—
Operating lease liabilities—long term
582
1,166
Total liabilities
1,201,343
1,099,269
STOCKHOLDERS’ EQUITY
Common stock, par value $0.01; 400,000 shares authorized:
Issued and outstanding: 151,154 and 140,713 at September 30, 2026 and December 31, 2025, respectively
1,512
1,407
Additional paid-in capital
168,751
189,244
Accumulated other comprehensive (loss)/income
(2,527
)
2,227
Retained earnings
278,007
220,794
Total stockholders’ equity
445,743
413,672
Total liabilities and stockholders’ equity
$
1,647,086
$
1,512,941
WISDOMTREE, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
Nine Months Ended
September 30,
2026
2025
Cash flows from operating activities:
Net income
$
70,369
$
69,107
Adjustments to reconcile net income to net cash provided by operating activities:
Advisory and license fees paid in gold, other precious metals and cryptocurrency
(69,127
)
(51,354
)
Loss on repurchase of convertible notes
68,925
13,011
Stock-based compensation
23,701
16,645
Depreciation and amortization
9,539
1,735
Amortization of issuance costs—convertible notes
3,546
2,151
Gains on financial instruments owned, at fair value
(2,015
)
(1,914
)
Increase in fair value of contingent consideration
1,853
—
Deferred income taxes
(1,512
)
2,628
Amortization of right of use asset
1,491
1,003
Imputed interest on payable to GBH
727
1,405
Losses on investments
435
49
Changes in operating assets and liabilities:
Accounts receivable
(2,887
)
582
Income taxes payable
1,294
(40
)
Prepaid expenses
(2,917
)
(2,351
)
Gold and other precious metals
69,733
49,686
Other assets
(27
)
(482
)
Fund management and administration payable
2,614
(749
)
Compensation and benefits payable
(8,412
)
(6,328
)
Operating lease liabilities
(1,480
)
(987
)
Accounts payable and other liabilities
(12,705
)
(540
)
Net cash provided by operating activities
153,145
93,257
Cash flows from investing activities:
Purchase of financial instruments owned, at fair value
(20,512
)
(25,314
)
Purchase of investments
(3,107
)
(17,553
)
Cash paid—software development
(2,659
)
(2,015
)
Purchase of fixed assets
(252
)
(154
)
Proceeds from the sale of financial instruments owned, at fair value
87,219
8,860
Cash paid—Atlantic House acquisition, net of cash acquired
(197,488
)
—
Net cash used in investing activities
(136,799
)
(36,176
)
Cash flows from financing activities:
Repurchase of convertible notes
(542,545
)
(36,681
)
Common stock repurchased
(61,506
)
(102,732
)
Dividends paid
(13,451
)
(13,218
)
Issuance costs—convertible notes
(12,593
)
(11,064
)
Proceeds from the issuance of convertible notes
603,750
475,000
Net cash (used in)/provided by financing activities
(26,345
)
311,305
(Decrease)/increase in cash flow due to changes in foreign exchange rate
(1,993
)
6,274
Net (decrease)/increase in cash, cash equivalents and restricted cash
(11,992
)
374,660
Cash, cash equivalents and restricted cash—beginning of year
311,732
181,191
Cash, cash equivalents and restricted cash—end of period
$
299,740
$
555,851
Supplemental disclosure of cash flow information:
Cash paid for income taxes
$
35,060
$
19,999
Cash paid for interest
$
45,128
$
15,198
NON-GAAP FINANCIAL MEASUREMENTS
In an effort to provide additional information regarding our results as determined by GAAP, we also disclose certain non-GAAP information which we believe provides useful and meaningful information. Our management reviews these non-GAAP financial measurements when evaluating our financial performance and results of operations; therefore, we believe it is useful to provide information with respect to these non-GAAP measurements so as to share this perspective of management. Non-GAAP measurements do not have any standardized meaning, do not replace nor are they superior to GAAP financial measurements and are unlikely to be comparable to similar measures presented by other companies. These non-GAAP financial measurements should be considered in the context with our GAAP results. The non-GAAP financial measurements contained in this press release include the following:
Adjusted Operating Income, Operating Expenses, Income Before Income Taxes, Income Tax Expense, Net Income and Diluted Earnings per Share
We disclose adjusted operating income, operating expenses, income before income taxes, income tax expense, net income and diluted earnings per share as non-GAAP financial measurements in order to report our results exclusive of items that are non-recurring or not core to our operating business. We believe presenting these non-GAAP financial measurements provides investors with a consistent way to analyze our performance. These non-GAAP financial measurements exclude the following:
Gains or losses on financial instruments owned: We account for our financial instruments owned as trading securities, which requires these instruments to be measured at fair value with gains and losses reported in net income. We exclude these items when calculating our non-GAAP financial measurements as the gains and losses introduce earnings volatility and are not core to our operating business.
Foreign currency remeasurement gains and losses on U.S. dollars held by foreign subsidiaries: GAAP requires account balances to be remeasured into an entity’s functional currency, with resulting gains and losses reported in net income. Foreign subsidiaries holding U.S. dollars remeasure these balances into their functional currencies and recognize the gains and losses. Also excluded are remeasurement gains on British pounds held to complete the Atlantic House acquisition. We exclude remeasurement effects from our non-GAAP financial measures, as they introduce earnings volatility, are not core to our operations and arise from balances denominated in our reporting currency.
Tax windfalls and shortfalls upon vesting of stock-based compensation awards: GAAP requires the recognition of tax windfalls and shortfalls within income tax expense. These items arise upon the vesting of stock-based compensation awards and the magnitude is directly correlated to the number of awards vesting/exercised, as well as the difference between the price of our stock on the date the award was granted and the date the award vested or was exercised. We exclude these items when calculating our non-GAAP financial measurements as they introduce earnings volatility and are not core to our operating business.
Remeasurement of contingent consideration arising from the Ceres acquisition: On October 1, 2025, we completed the Ceres acquisition for aggregate consideration consisting of (i) $275 million in cash payable at closing, subject to customary post-closing adjustments and (ii) contingent consideration of up to $225 million, payable in 2030, contingent upon Ceres achieving a compound annual growth rate in revenues of 12% to 22% during the measurement period of January 1, 2025 through December 31, 2029. GAAP requires contingent consideration to be re-measured each reporting period with changes in fair value reported in net income. We exclude changes in fair value of contingent consideration when calculating our non-GAAP financial measurements as these items are not core to our operating business.
Other items: Amortization of intangible assets, changes in deferred tax asset valuation allowance, imputed interest on our payable to Gold Bullion Holdings (Jersey) Limited (“GBH”), gains and losses recognized on our investments, losses related to convertible notes transactions and acquisition-related costs are excluded when calculating our non-GAAP financial measurements.
Adjusted Effective Income Tax Rate
We disclose our adjusted effective income tax rate as a non-GAAP financial measurement in order to report our effective income tax rate exclusive of items that are non-recurring or not core to our operating business. We believe reporting our adjusted effective income tax rate provides investors with a consistent way to analyze our income taxes. Our adjusted effective income tax rate is calculated by dividing adjusted income tax expense by adjusted income before income taxes. See above for information regarding the items that are excluded.
Gross Margin and Gross Margin Percentage
We disclose our gross margin and gross margin percentage as non-GAAP financial measurements because we believe they provide investors with a consistent way to analyze the amount we retain after paying third-party service providers to operate our ETPs. These measures also assist us in analyzing the profitability of our products. We define gross margin as total adjusted operating revenues less fund management and administration expenses. Gross margin percentage is calculated as gross margin divided by total adjusted operating revenues.
GAAP to NON-GAAP RECONCILIATION (CONSOLIDATED)
(in thousands)
(Unaudited)
Three Months Ended
Adjusted Net Income and Diluted Earnings per Share:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Net income/(loss), as reported
$
49,216
$
44,284
$
(23,131
)
$
40,026
$
19,701
Add back: Amortization of intangible assets arising from the Ceres and Atlantic House acquisitions, net of income taxes
2,426
1,969
1,087
1,086
—
(Deduct)/add back: (Decrease)/increase in fair value of contingent consideration, net of income taxes
(1,566
)
1,030
1,940
538
—
(Deduct)/add back: (Decrease)/increase in deferred tax asset valuation allowance on capital losses
(636
)
(1,615
)
151
(1,237
)
(24
)
Add back: Imputed interest on payable to GBH, net of income taxes
189
183
179
285
364
(Deduct)/add back: Foreign currency remeasurement (gains)/losses on U.S. dollar balances, net of income taxes
(98
)
36
(435
)
(141
)
—
(Deduct)/add back: (Gains)/losses on financial instruments owned, net of income taxes
(49
)
(2,143
)
668
8
(810
)
(Deduct)/add back: (Gains)/losses recognized on investments, net of income taxes
(2
)
(11
)
342
(75
)
734
Add back: Losses related to convertible notes transactions, net of income taxes
—
6,572
62,280
505
12,763
Deduct: Foreign currency remeasurement gains on British pounds held to complete the Atlantic House acquisition, net of income taxes
—
(3,277
)
—
—
—
Add back: Acquisition-related costs, net of income taxes
—
1,118
1,933
240
1,824
Deduct: Tax windfalls upon vesting of stock-based compensation awards
—
(66
)
(4,421
)
—
(76
)
Adjusted net income
$
49,480
$
48,080
$
40,593
$
41,235
$
34,476
Weighted average common shares—diluted
156,179
156,276
152,372
143,314
150,675
Adjusted earnings per share—diluted
$
0.32
$
0.31
$
0.27
$
0.29
$
0.23
Three Months Ended
Gross Margin and Gross Margin Percentage:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Operating revenues
$
179,375
$
177,160
$
159,470
$
147,434
$
125,616
Deduct: Fund management and administration
(30,532
)
(30,229
)
(24,880
)
(24,830
)
(22,353
)
Gross margin
$
148,843
$
146,931
$
134,590
$
122,604
$
103,263
Gross margin percentage
83.0%
82.9%
84.4%
83.2%
82.2%
Three Months Ended
Adjusted Operating Income and Adjusted Operating Income Margin:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Operating revenues
$
179,375
$
177,160
$
159,470
$
147,434
$
125,616
Operating income
74,122
71,811
59,350
59,747
$
45,654
Add back: Amortization of intangible assets arising from the Ceres and Atlantic House acquisitions
3,221
2,612
1,435
1,434
—
Add back: Acquisition-related costs
—
1,118
1,933
317
2,409
Adjusted operating income
$
77,343
$
75,541
$
62,718
$
61,498
$
48,063
Adjusted operating income margin
43.1%
42.6%
39.3%
41.7%
38.3%
Three Months Ended
Adjusted Total Operating Expenses:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Total operating expenses
$
105,253
$
105,349
$
100,120
$
87,687
$
79,962
Deduct: Amortization of intangible assets arising from the Ceres and Atlantic House acquisitions
(3,221
)
(2,612
)
(1,435
)
(1,434
)
—
Deduct: Acquisition-related costs
—
(1,118
)
(1,933
)
(317
)
(2,409
)
Adjusted total operating expenses
$
102,032
$
101,619
$
96,752
$
85,936
$
77,553
Three Months Ended
Adjusted Income Before Income Taxes:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Income/(loss) before income taxes
$
64,477
$
58,547
$
(14,582
)
$
50,463
$
29,517
Add back: Amortization of intangible assets arising from the Ceres and Atlantic House acquisitions
3,221
2,612
1,435
1,434
—
(Deduct)/add back: (Decrease)/increase in fair value of contingent consideration
(2,069
)
1,360
2,562
710
—
Add back: Imputed interest on payable to GBH
249
242
236
377
481
(Deduct)/add back: Foreign currency remeasurement (gains)/losses on U.S. dollar balances, net of income taxes
(132
)
68
(566
)
(205
)
—
(Deduct)/add back: (Gains)/losses on financial instruments owned
(65
)
(2,831
)
882
10
(1,070
)
(Deduct)/add back: (Gains)/losses recognized on investments
(2
)
(15
)
452
(99
)
970
Add back: Losses related to convertible notes transactions
—
6,623
62,302
833
13,011
Deduct: Foreign currency remeasurement gains on British pounds held to complete the Atlantic House acquisition, net of income taxes
—
(4,370
)
—
—
—
Add back: Acquisition-related costs
—
1,118
1,933
317
2,409
Adjusted income before income taxes
$
65,679
$
63,354
$
54,654
$
53,840
$
45,318
Three Months Ended
Adjusted Income Tax Expense and Adjusted Effective Income Tax Rate:
Sept. 30,
2026
June 30,
2026
Mar. 31,
2026
Dec. 31,
2025
Sept. 30,
2025
Adjusted income before income taxes (above)
$
65,679
$
63,354
$
54,654
$
53,840
$
45,318
Income tax expense
$
15,261
$
14,263
$
8,549
$
10,437
$
9,816
Add back: Tax benefit of intangible asset amortization arising from the Ceres and Atlantic House acquisitions
795
643
348
348
—
Add back/(deduct): decrease/(increase) in deferred tax asset valuation allowance on capital losses
636
1,615
(151
)
1,237
24
(Deduct)/add back: Tax (expense)/benefit arising from (decrease)/increase in fair value of contingent consideration
(503
)
330
622
172
—
Add back: Tax benefit on imputed interest
60
59
57
92
117
(Deduct)/add back: Tax (expense)/benefit on foreign currency remeasurement losses/(gains) on U.S. dollar balances
(34
)
32
(131
)
(64
)
—
(Deduct)/add back: Tax (expense)/benefit arising from (gains)/losses on financial instruments owned
(16
)
(688
)
214
2
(260
)
Deduct: Tax expense on foreign currency remeasurement gains on British pounds held to complete the Atlantic House acquisition
—
(1,093
)
—
—
—
Add back: Tax windfalls upon vesting of stock-based compensation awards
—
66
4,421
—
76
Add back: Tax benefit arising from convertible notes transactions
—
51
22
328
248
(Deduct)/add back: Tax (expense)/benefit on (gains)/losses on investments
—
(4
)
110
(24
)
236
Add back: Tax benefit on acquisition-related costs
This press release contains forward-looking statements that are based on our management’s beliefs and assumptions and on information currently available to our management. Although we believe that the expectations reflected in these forward-looking statements are reasonable, these statements relate to future events or our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue” or the negative of these terms or other comparable terminology. These statements are only predictions. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors, which are, in some cases, beyond our control and could materially affect results. Factors that may cause actual results to differ materially from current expectations include, among other things, the risks described below. If one or more of these or other risks or uncertainties occur, or if our underlying assumptions prove to be incorrect, actual events or results may vary significantly from those implied or projected by the forward-looking statements. No forward-looking statement is a guarantee of future performance. You should read this press release completely and with the understanding that our actual future results may be materially different from any future results expressed or implied by these forward-looking statements.
In particular, forward-looking statements in this press release may include statements about:
anticipated trends, conditions and investor sentiment in the global markets and ETPs; anticipated levels of inflows into and outflows out of our ETPs; our ability to deliver favorable rates of return to investors; competition in our business; whether we will experience future growth; our ability to develop new products and services and their potential for success; our ability to maintain current vendors or find new vendors to provide services to us at favorable costs; our ability to successfully implement our WisdomTree Onchain™ strategy relating to digital assets and blockchain-enabled financial services and achieve its objectives; our ability to successfully operate and expand our business in non-U.S. markets; the effect of laws and regulations that apply to our business; the potential benefits arising from the Ceres and Atlantic House acquisitions, including financial or strategic outcomes; and our ability to successfully implement our strategic goals relating to the acquisitions and integrate the acquired businesses. Our business is subject to many risks and uncertainties, including without limitation:
declining prices of securities, gold and other precious metals and other commodities and changes in interest rates and general market conditions can adversely affect our business by reducing the market value of the assets we manage or causing WisdomTree ETP investors to sell their fund shares and trigger redemptions; fluctuations in the amount and mix of our AUM, whether caused by disruptions in the financial markets or otherwise, including but not limited to events such as a pandemic or war, geopolitical conflicts, political events, acts of terrorism and other matters beyond our control, may negatively impact revenues and operating margins, and may impede our ability to refinance our debt upon maturity or increase the cost of borrowing upon a refinancing; competitive pressures could reduce revenues and profit margins; we derive a substantial portion of our revenues from a limited number of products, and, as a result, our operating results are particularly exposed to investor sentiment toward investing in the products’ strategies and our ability to maintain the AUM of these products, as well as the performance of these products and market-specific and political and economic risk; a significant portion of our AUM is held in products with exposure to U.S. and international developed markets, and we therefore have exposure to domestic and foreign market conditions and are subject to currency exchange rate risks; withdrawals or broad changes in investments in our ETPs by investors with significant positions may negatively impact revenues and operating margins; we face increased operational, regulatory, financial and other risks as a result of conducting our business internationally, and as we expand our digital assets product offerings and services beyond our existing ETP business; many of our ETPs have a limited track record, and poor investment performance could cause our revenues to decline; and we depend on third parties to provide many critical services to operate our business and our ETPs. The failure of key vendors to adequately provide such services could materially affect our operating business and harm WisdomTree ETP investors. Additional risks include those associated with the Ceres and Atlantic House acquisitions, including the risk that the integrations may be more difficult, time-consuming or costly than expected, or that expected benefits (including projected business growth, realization of synergies, or the ability to raise additional capital into the funds of the acquired businesses) may not be realized as anticipated. Other factors, such as general economic conditions, including currency exchange rate fluctuations, also may have an effect on the results of our operations. For a more complete description of the risks noted above and other risks that could cause our actual results to differ from our current expectations, see “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025.
The forward-looking statements in this press release represent our views as of the date of this press release. We anticipate that subsequent events and developments may cause our views to change. However, while we may elect to update these forward-looking statements at some point in the future, we have no current intention of doing so except to the extent required by applicable law. Therefore, these forward-looking statements do not represent our views as of any date other than the date of this press release.
GUANGZHOU, China, Oct. 30, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (“EHang” or the “Company”) (Nasdaq: EH), the world’s leading Advanced Air Mobility (“AAM”) technology platform company, today announced the establishment of an overseas regional hub in Thailand. The hub is intended to support international electric vertical take-off and landing (“eVTOL”) aircraft deployment, regional resource coordination and project implementation across Southeast Asia and other emerging markets.
By positioning aircraft and related resources closer to regional projects, the Thailand regional hub is expected to reduce transportation and coordination time, enable more flexible cross-market allocation, and help overseas projects move more efficiently from preparation to implementation.
In the near term, EHang plans to deploy an initial fleet of 25 units of EH216-S pilotless passenger-carrying eVTOL aircraft in Thailand. The regional fleet will support market-specific flight validation, operational preparation and project implementation across Southeast Asia and other emerging markets.
The hub is intended to support EHang’s broader product portfolio across passenger mobility, aerial logistics, emergency response and aerial media. The Company has already deployed approximately 1,200 units of GD4.0 formation drones in Thailand for its drone light show business, providing an established operational base for its aerial media activities in the market, with plans to expand the fleet to over 10,000 units.
Thailand serves not only as a local market for EHang’s AAM sandbox initiatives, but also as a strategic gateway for the Company’s overseas expansion across Southeast Asia and other emerging markets. EHang’s ongoing flight validation, regulatory engagement and established drone light show business in Thailand provide a practical foundation for the regional hub. Supported by Thailand’s regional connectivity, the hub is expected to strengthen EHang’s ability to serve projects in neighboring markets with greater speed, flexibility and coordination.
Building on this regional platform, EHang is advancing its Global Fast Track Program and AAM sandbox initiatives, establishing presence in Thailand, Sri Lanka, Vietnam and Malaysia while continuously exploring opportunities in other regional markets. The Thailand regional hub is intended to support these projects in a more responsive and coordinated manner by allocating aircraft and related resources according to local needs and project readiness.
Looking ahead, based on current plans, the Company expects the following near-term developments in key overseas projects:
In Sri Lanka, which joined EHang’s Global Fast Track Program in August 2026, sandbox launch and validation flights at Port City Colombo are expected to begin in November 2026, with commercial operations under the applicable local sandbox regulatory framework targeted to start by year-end.In Vietnam, which joined EHang’s Global Fast Track Program in September 2026, the Company is expected to conduct validation flights within the Hanoi sandbox area in November 2026.In Malaysia, EHang is preparing an initial EH216-S flight demonstration in Putrajaya in November 2026, following the sandbox cooperation on AAM announced with the Civil Aviation Authority of Malaysia (“CAAM”) in October.In Thailand, EHang plans to demonstrate EH216-S flights during the International Civil Aviation Organization (“ICAO”) AAM Symposium in Bangkok in December 2026. These anticipated developments, including aircraft deployment, flight validation, demonstrations and potential commercial operations, remain subject to applicable local laws and regulations, as well as completion of required operational preparations, safety assessments and relevant regulatory approvals.
About EHang
EHang (Nasdaq: EH) is a global-leading Advanced Air Mobility technology platform company dedicated to making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang focuses on the research, development and manufacturing of a diversified portfolio of pilotless electric vertical take-off and landing (eVTOL) aerial vehicles, covering a wide range of application scenarios including aerial tourism, intra-city commuting, inter-city travel, logistics transportation and emergency firefighting. EHang’s flagship product, the EH216-S, has obtained the world’s first type certificate (TC), production certificate (PC) and standard airworthiness certificate (AC) for pilotless passenger-carrying eVTOL aircraft issued by the Civil Aviation Administration of China (CAAC), and has entered operation under China’s first batch of commercial operation qualifications for pilotless passenger-carrying eVTOL. In addition, the Company’s long-range VT35 model further extends inter-city mobility scenarios, laying the foundation for a multi-tiered low-altitude mobility network. Leveraging its advanced autonomous flight technology and scalable operational infrastructure, EHang is redefining the transportation of people and goods — transcending cities, regions and natural barriers to usher in a new era of air mobility. For more information, please visit www.ehang.com.
Safe Harbor Statement
This press release may contain forward-looking statements within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by terminology such as “will,” “expects,” “anticipates,” “aims,” “future,” “intends,” “plans,” “believes,” “estimates,” “may” and other similar expressions. Statements that are not historical facts, including statements regarding management’s beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. Many factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to product certification, the Company’s expectations regarding demand for and market acceptance of its products, the commercialization of the Company’s unmanned aerial vehicle products and solutions and Advanced Air Mobility services, its relationships with strategic partners, its international deployment plans, regulatory sandbox initiatives, aircraft deployment, local operational approvals, the timing of flight validation and commercial operations in overseas markets, and the litigation currently involving the Company and potential litigation. The Company’s management has made such forward-looking statements based on current expectations, assumptions, estimates and projections. While the Company’s management believes that these expectations, assumptions, estimates and projections are reasonable, forward-looking statements are only predictions of future events and involve known and unknown risks and uncertainties that are difficult for the Company’s management to control. These risks and uncertainties may cause EHang’s actual results of operations, performance or achievements to differ materially from those expressed or implied by any forward-looking statements.